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Abstract (English)
The paradigm of end-to-end learning has revolutionized computer vision in recent years,
but clinical application is lagging behind. Image-based computer aided diagnosis systems
are still largely based on highly engineered and domain specific pipelines, which consist
of independent rule-based models reflecting the subtasks of image classification: Local-
ization of discriminative regions, feature extraction, and decision making. The promise
of superior decision making in end-to-end learning derives from removing domain specific
prior constraints of limited complexity and instead optimizing all system components si-
multaneously, directly based on the raw data and with respect to the ultimate task at
hand. The reasons for why these advantages have not found their way into clinics yet, i.e.
the challenges faced when developing deep learning based diagnosis systems, are mani-
fold: The fact that the generalization ability of learning algorithms scales with how well
available training data represents the true underlying data distribution does not play well
for medical applications. Annotated datasets in this domain are notoriously small, since
labeling involves costly delineation by experts and concatenation of datasets is often ham-
pered by privacy issues and patient rights. Moreover, medical datasets exhibit drastically
varying properties with respect to image modalities, acquisition protocols, or anisotropies
and the often ambiguous evidence in medical images may propagate to inconsistent or
erroneous training annotations. While the data shift between research environment and
real life results in diminished model robustness and is thus considered the key obstacle
towards clinical translation, this gap is often amplified by nuisance factors such as hard-
ware constraints or granularity of available annotations, which might lead to discrepancies
between the modeled task and the underlying clinical question.
This thesis studies the potential of end-to-end learning in clinical diagnosis systems
and presents contributions towards some of the key challenges that currently prevent
widespread clinical application.
First we attend to the last part of the classification pipeline, the categorization into
clinical pathologies. We demonstrate how replacing the current clinical standard of rule-
based decision making by large scale feature extraction followed by machine learning-based
classification significantly improves breast cancer classification on MRI and accomplishes
human-level performance. This approach is further showcased on cardiac diagnosis achiev-
v
ing the second rank in an international competition. Second, following the paradigm of
end-to-end learning, we substitute the biophysical model applied for image normaliza-
tion in MRI as well as the extraction of handcrafted features with a dedicated CNN
architecture and provide an in-depth analysis revealing hidden potential in learned im-
age normalization and a complementary value of learned representations over handcrafted
features. While this approach operates on regions of interest and hence relies on man-
ual annotation, in the third part, we include the task of localizing those regions into the
learning process to enable true end-to-end diagnosis starting at the raw images. We iden-
tify a largely neglected predicament between the strive for evaluating models at clinically
relevant scales on one side, and optimizing for e cient training under the burden of data
scarcity on the other side. We propose a deep learning model that helps to resolve this
trade-o↵, provide extensive experiments on three medical datasets as well as a series of
toy experiments that examines the behavior under limited training data in detail, and
open source a comprehensive framework including the first 3D implementations of preva-
lent object detection models. We identify further leverage points in existing end-to-end
learning systems, where domain knowledge can serve as an inductive bias to increase the
robustness of deep learning models in medical image classification aiming to pave the way
for application in clinical practice. To this end, we address the challenge of erroneous
training annotations by substituting the classification component of end-to-end object
detection for regression, which enables to train models directly on the continuous scale
of underlying pathological processes, thus elevating the models’ robustness against rater
confusions. Further, we address the challenge of input heterogeneities faced by trained
models when deployed across clinical sites by proposing model-based domain adaptation,
which enables to recapture the original training domain given altered inputs and thus
restores robust generalization. Finally, we address the highly unsystematic, elaborate and
subjective trial-and-error process of finding a robust set of hyperparameters for a given
task by condensing domain knowledge into a set of key design choices and systematic rules
enabling automated and robust deep learning pipeline configuration on a large variety of
medical datasets.
To conclude, the work presented here demonstrates the vast potential of end-to-end
learning algorithms compared to the clinical standard of compound engineered diagnosis
pipelines and presents solutions towards some of the key challenges preventing real life ap-
plication such as data scarcity, discrepancy between addressed task and underlying clinical
question, ambiguity in training annotations, or domain shifts across clinical sites. These
contributions tie in to the overarching goal of automating medical image classification -
an integral factor of the transformation required to shape the future of health care.
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Abstract (German)
Das Paradigma des End-to-End Lernens hat in den letzten Jahren die Bilderkennung revo-
lutioniert, aber die klinische Anwendung hinkt hinterher. Bildbasierte computergestützte
Diagnosesysteme basieren immer noch weitgehend auf hochtechnischen und domänen-
spezifischen Pipelines, die aus unabhängigen regelbasierten Modellen bestehen, welche die
Teilaufgaben der Bildklassifikation wiederspiegeln: Lokalisation von au↵älligen Regionen,
Merkmalsextraktion und Entscheidungsfindung. Das Versprechen einer überlegenen Ent-
scheidungsfindung beim End-to-End Lernen ergibt sich daraus, dass domänenspezifische
Zwangsbedingungen von begrenzter Komplexität entfernt werden und stattdessen alle
Systemkomponenten gleichzeitig, direkt anhand der Rohdaten, und im Hinblick auf die
letztendliche Aufgabe optimiert werden. Die Gründe dafür, dass diese Vorteile noch nicht
den Weg in die Klinik gefunden haben, d.h. die Herausforderungen, die sich bei der
Entwicklung Deep Learning-basierter Diagnosesysteme stellen, sind vielfältig: Die Tat-
sache, dass die Generalisierungsfähigkeit von Lernalgorithmen davon abhängt, wie gut
die verfügbaren Trainingsdaten die tatsächliche zugrundeliegende Datenverteilung abbil-
den, erweist sich in medizinische Anwendungen als tiefgreifendes Problem. Annotierte
Datensätze in diesem Bereich sind notorisch klein, da für die Annotation eine kostspielige
Beurteilung durch Experten erforderlich ist und die Zusammenlegung kleinerer Datensätze
oft durch Datenschutzauflagen und Patientenrechte erschwert wird. Darüber hinaus weisen
medizinische Datensätze drastisch unterschiedliche Eigenschaften im Bezug auf Bildmoda-
litäten, Bildgebungsprotokolle oder Anisotropien auf, und die oft mehrdeutige Evidenz in
medizinischen Bildern kann sich auf inkonsistente oder fehlerhafte Trainingsannotationen
übertragen. Während die Verschiebung von Datenverteilungen zwischen Forschungsumge-
bung und Realität zu einer verminderten Modellrobustheit führt und deshalb gegenwärtig
als das Haupthindernis für die klinische Anwendung von Lernalgorithmen angesehen wird,
wird dieser Graben oft noch durch Störfaktoren wie Hardwarelimitationen oder Granula-
rität von gegebenen Annotation erweitert, die zu Diskrepanzen zwischen der modellierten
Aufgabe und der zugrunde liegenden klinischen Fragestellung führen.
Diese Arbeit untersucht das Potenzial des End-to-End-Lernens in klinischen Diagnosesys-
temen und präsentiert Beiträge zu einigen der wichtigsten Herausforderungen, die derzeit
eine breite klinische Anwendung verhindern.
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Zunächst wird der letzten Teil der Klassifikations-Pipeline untersucht, die Kategorisie-
rung in klinische Pathologien. Wir demonstrieren, wie das Ersetzen des gegenwärtigen
klinischen Standards regelbasierter Entscheidungen durch eine groß angelegte Merkmals-
extraktion gefolgt von lernbasierten Klassifikatoren die Brustkrebsklassifikation im MRT
signifikant verbessert und eine Leistung auf menschlichem Level erzielt. Dieser Ansatz
wird weiter anhand von kardiologischer Diagnose gezeigt. Zweitens ersetzen wir, dem Pa-
radigma des End-to-End Lernens folgend, das biophysikalische Modell, das für die Bild-
normalisierung in der MRT angewandt wird, sowie die Extraktion handgefertigter Merk-
male, durch eine designierte CNN-Architektur und liefern eine eingehende Analyse, die
das verborgene Potenzial der gelernten Bildnormalisierung und einen Komplementärwert
der gelernten Merkmale gegenüber den handgefertigten Merkmalen aufdeckt. Während
dieser Ansatz auf markierten Regionen arbeitet und daher auf manuelle Annotation an-
gewiesen ist, beziehen wir im dritten Teil die Aufgabe der Lokalisierung dieser Regionen
in den Lernprozess ein, um eine echte End-to-End-Diagnose baserend auf den Rohbil-
dern zu ermöglichen. Dabei identifizieren wir eine weitgehend vernachlässigte Zwangslage
zwischen dem Streben nach der Auswertung von Modellen auf klinisch relevanten Skalen
auf der einen Seite, und der Optimierung für e zientes Training unter Datenknappheit
auf der anderen Seite. Wir präsentieren ein Deep Learning Modell, das zur Auflösung
dieses Kompromisses beiträgt, liefern umfangreiche Experimente auf drei medizinischen
Datensätzen sowie eine Serie von Toy-Experimenten, die das Verhalten bei begrenzten
Trainingsdaten im Detail untersuchen, und publiziren ein umfassendes Framework, das
unter anderem die ersten 3D-Implementierungen gängiger Objekterkennungsmodelle um-
fasst. Wir identifizieren weitere Hebelpunkte in bestehenden End-to-End-Lernsystemen,
bei denen Domänenwissen als Zwangsbedingung dienen kann, um die Robustheit von Mo-
dellen in der medizinischen Bildanalyse zu erhöhen, die letztendlich dazu beitragen sollen,
den Weg für die Anwendung in der klinischen Praxis zu ebnen. Zu diesem Zweck gehen
wir die Herausforderung fehlerhafter Trainingsannotationen an, indem wir die Klassifizie-
rungskompnente in der End-to-End-Objekterkennung durch Regression ersetzen, was es
ermöglicht, Modelle direkt auf der kontinuierlichen Skala der zugrunde liegenden patholo-
gischen Prozesse zu trainieren und so die Robustheit der Modelle gegenüber fehlerhaften
Trainingsannotationen zu erhöhen. Weiter adressieren wir die Herausforderung der Input-
Heterogenitäten, mit denen trainierte Modelle konfrontiert sind, wenn sie an verschiede-
nen klinischen Orten eingesetzt werden, indem wir eine modellbasierte Domänenanpassung
vorschlagen, die es ermöglicht, die ursprüngliche Trainingsdomäne aus veränderten Inputs
wiederherzustellen und damit eine robuste Generalisierung zu gewährleisten. Schließlich
befassen wir uns mit dem höchst unsystematischen, aufwendigen und subjektiven Trial-
and-Error-Prozess zum Finden von robusten Hyperparametern für einen gegebene Auf-
gabe, indem wir Domänenwissen in ein Set systematischer Regeln überführen, die eine
automatisierte und robuste Konfiguration von Deep Learning Modellen auf einer Vielzahl
von medizinischen Datensetzen ermöglichen.
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Zusammenfassend zeigt die hier vorgestellte Arbeit das enorme Potenzial von End-to-End
Lernalgorithmen im Vergleich zum klinischen Standard mehrteiliger und hochtechnisierter
Diagnose-Pipelines auf, und präsentiert Lösungsansätze zu einigen der wichtigsten Her-
ausforderungen für eine breite Anwendung unter realen Bedienungen wie Datenknappheit,
Diskrepanz zwischen der vom Modell behandelten Aufgabe und der zugrunde liegenden
klinischen Fragestellung, Mehrdeutigkeiten in Trainingsannotationen, oder Verschiebung
von Datendomänen zwischen klinischen Standorten. Diese Beiträge können als Teil des
übergreifende Zieles der Automatisierung von medizinischer Bildklassifikation gesehen
werden - ein integraler Bestandteil des Wandels, der erforderlich ist, um die Zukunft
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Radiological images enclose hidden treasures in form of unstructured information. The
exclusive value compared to other clinical data sources lies within the non-invasive char-
acterization of tissue or organs and its resolution in time and space. The task of unlocking
this potential and making it accessible to clinical decisions is referred to as medical im-
age analysis. Despite tremendous e↵orts from the computer science community since the
1960s [1, 2, 3], the readout of radiological images in clinical work life remains to be per-
formed by humans. This status quo is problematic in multiple ways: Global digitalization
and aging societies drive data growth in health care at an unprecedented speed. While the
amount of available data has increased by 878% between 2016 and 2018[4], the amount of
human resources for data interpretation has been near constant [5] - an alarming trend,
given that halving the time spent per report increases human error rate by 17% [6].
Moreover, the growing abundance of data itself represents a key aspect of the poten-
tial hidden in radiological images, which is currently sealed: Manual readouts result in
highly subjective and non-quantified free-text reports, which impede to aggregate infor-
mation beyond single patients [7]. In order to draw general conclusions that are able
to drive scientific and medical progress, however, information needs to be combined and
clustered across large cohorts, which requires systematic extraction and quantification.
This desideratum follows the paradigm of ”Precision Medicine”, a term coined in the
early 2010s to picture the vision of how digitalization will shape the future of health care
[8]. Specifically, it describes the scientific idea of leveraging growing data and compute
resources (”Big Data”) to comprehend medical data in its entirety, including genetic data
(”Genomics”, where ”-omics” signifies ”studying the totality of something”), proteomic
data (”Proteomics”) or metabolic data (”Metabolomics”). The ultimate goal of Precision
Medicine is to enable precise treatment tailored towards individual patients by means
of a holistic patient biomarker, which is generated by aggregation of the patient’s entire
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1. Introduction
Figure 1.1.: Increasing number of deep learning related publications at MICCAI
2014-2019. The international conference on Medical Image Computing and Com-
puter Assisted Intervention (MICCAI) is the largest of its kind in the field of medical
image computing. This figure shows how the ratio of deep-learning related contribu-
tions has drastically increased in recent years and how this trend e↵ectively doubled
the size of the conference.
clinical information and subsequent analysis with respect to vast pools of standardized
data cohorts. In 2014, ”Radiomics”, i.e. the comprehensive and quantitative study of ra-
diological images in form of large-scale visual measurements, was proposed as an addition
to the data pool [9, 10, 11]. Examples for the complementary value added by Radiomics
are time and space resolution of underlying pathologic processes: The precise location of
a tumor and its progress over time or the motion of a beating heart are not accessible
from genetic or proteomic data.
Regarding the transformation of raw images into clinical decisions, i.e. the cassification
of medical images, however, Radiomics only addresses a fraction of the task: Necessary
steps commonly include normalization of images, registration of modalities, localization
of Regions of Interest (ROIs), extraction of features and clinical categorization. Thus,
while Radiomics is able to generalize the feature extraction process by applying compre-
hensive and task-agnostic sets of measurements, the associated clinical workflow either
still relies on manual e↵ort for the remaining steps or integrates Radiomics as part of
a Computer Assisted Diagnosis (CAD) system. These CAD systems, first introduced in
the 1980s [12], constitute highly engineered, compound and task-specific pipelines with
limited performance and cost e ciency and thus have failed to achieve widespread clinical
usage [13, 14].
There is one recent course of events, however, that has been able to re-spark the hope
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for successful automation of medical image classification: Starting in 2015, deep learning
methods took the field by storm. Figure 1.1 shows, exemplary for the largest conference
in medical image analysis, how the ratio of contributions related to deep learning went
from 9% in 2014 to 78% in 2019 and how this trend e↵ectively doubled the size of the
conference. This development further manifests in the reporting of remarkable image
classification results including human-level or even superhuman-level performance of deep
learning methods e.g. in breast cancer detection [15], skin cancer detection [16], analy-
sis of electrocardiograms [17] or interpretation of chest x-rays [18]. The overwhelmingly
positive research outcomes have spawned high expectations regarding the impact of deep
learning on the future of health care, for instance improvement in overall e ciency, the
prevention of medical errors that will a↵ect almost every patient during their lifetime [19],
or the detection of novel signals of disease that clinicians are unable to perceive [20, 21].
Despite the evident potential, however, deployment in clinical practice is lagging behind:
A review from 2019 showed that at the time merely 14 deep learning based systems have
been approved by the U.S Food and Drug administration for clinical use [22]. The cau-
tious attitude towards clinical approval follows a disappointing wave of first generation
systems such as IBM Watson, that dashed against over-inflated expectations [23]. The
discrepancy between successful AI research and stuttering performance in real life ap-
plications is a widely discussed issue and generally referred to as the ”AI chasm” [24].
In the medical domain, a fraction of this chasm can be related to unrealistic or biased
setups of human benchmark evaluations [25, 26], incongruous evaluation metrics [27], or
socio-environmental factors in prospective deployment [28], but the question remains as
to what are the profound and underlying challenges of deep learning in medical image
classification. What impedes this powerful technology from enhancing the live of patients
and health care workers?
The answer to this question lies within the very nature of deep learning, i.e. the pos-
tulate to fit heavily over-parametrized functions to raw data and thus to optimize all
system components simultaneously, in an end-to-end fashion and with respect to the ulti-
mate target. In theory, the superiority of end-to-end learning derives from minimization
of inductive biases and the implied ability to generate highly complex decision bound-
aries that are able to catch even the tiniest peculiarities in the data [29]. In practice,
however, and especially in application domains, this advantageous e↵ect is hampered by
data scarcity: The annotated data available at training time commonly represents only
a fraction of the underlying data distribution, thus generated decision boundaries turn
out overly complex and with limited generalization to unseen data. In Medical Imaging,
the generalization problem is fueled by domain specific characteristics such as notoriously
small datasets available for model development, high cost of manual expert annotations,
large image sizes, input shifts due to varying scanner protocols across clinical sites or am-
biguities in images that propagate to erroneous annotations [30]. Taken together, these
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peculiarities amplify the data shift between research environments and clinical practice
resulting in insu cient robustness of deep learning-based medical image classification,
hence preventing successful real life deployment [27]. Thus, what are the means to ad-
dress this issue and which attempts are currently made by research?
As the generalization problem is inherent to machine learning it is widely tackled by
the respective community itself. Research on regularization techniques, representation
learning, semi-supervised or self-supervised learning, out of distribution modeling or do-
main adaptation can all be related to the underlying challenge of generalizing beyond
training data [29]. There is, however, an additional leverage point that needs to be seized
from within the applied research domain: On a broader perspective, the success-story
of deep learning is a story of overcoming domain expertise. Knowledge, aggregated over
decades and condensed into rule-based systems to solve scientific problems, in many cases
has been revealed by deep learning as a constraint that is better left aside. In the context
of limited training data, however, the removal of any piece of domain knowledge from
a model essentially replaces an inductive bias with additional degrees of freedom during
the learning process and hence increases the amount of data required to fit the associated
parameters. Vice versa, domain knowledge has the potential to serve as an inductive bias
that shortcuts the learning process and alleviates the data burden [31]. Thus, depending
on the task and the available data, in every model there exists a sweet spot between
inductive biases and learning parameters.
Taken all together, it is crucial for research in applied domains such as medical image
analysis to scrutinize the dogma of end-to-end learning, i.e. to carefully counterbalance
the power of deep learning with the potential of domain knowledge, in order to accomplish
the model robustness required for real life application.
1.1. Contributions
Following the above statement, this thesis studies the challenges and opportunities of end-
to-end learning in medical image classification throughout four methodological chapters.
Medical Image Classification based on Handcrafted Features (Chap. 4)
As a first step, we attend to the last part of the classification pipeline, i.e. the catego-
rization of entities into clinical pathologies based on handcrafted features. Specifically,
we explore the potential of replacing rule-based decision making as currently deployed in
clinical standard, which is often based on a single or few extracted features, with mul-
tivariate learning algorithms based on large-scale Radiomics. The main contributions in
this chapter are:
• We achieve human-level performance in breast cancer lesion classification on Di↵u-
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sionWeighted Magentic Resonance Imaging (DWI) by substituting a mono-parametric
decision threshold with large-scale Radiomics feature extraction followed by a ma-
chine learning classifier [32].
• We provide insights about further parts of the diagnosis pipeline such as an in-depth
analysis of Radiomics features or the exploitation of domain knowledge to enhance
the image normalization model.
• We further apply the approach of large scale feature extraction followed by machine
learning classifiers to cardiac disease classification on MRI, thereby extend the fea-
ture set by a novel group of time-series measurements over the cardiac cycle, and
achieve the second rank in an international competition [33, 34].
Medical Image Classification based on Learned Representations (Chap. 5)
We further follow the paradigm of end-to-end learning, i.e. the idea that enabling simulta-
neous optimization of all pipeline components with respect to the ultimate clinical target
improves upon compound rule-based diagnosis pipelines. To this end, we substitute the
biophysical model applied for image normalization in DWI as well as the extraction of
handcrafted (Radiomic) features with respective learning algorithms, which operate on
previously annotated Regions of Interest (ROIs) in the image. The main contributions in
this chapter are:
• We propose a Convolutional Neural Network (CNN) architecture designed to inte-
grate the biophysical model for image normalization, handcrafted feature extraction
as well as clinical categorization, so as to enable ROI-classification of breast lesions
on DWI by means of learned representations [35].
• We reveal potential hidden in DWI by demonstrating the benefits of learned image
normalizations as compared to the biophysical model currently deployed in clinical
research.
• We provide results indicating a complementary value of representations learned in
the CNN with respect to handcrafted feature extraction [36].
End-to-end Medical Image Classification (Chap. 6)
When including the task of localizing ROIs into the learning process to enable true end-
to-end diagnosis starting at the raw images, there are three current deep learning method-
ologies to be considered that attend to the problem at three di↵erent levels of granularity :
Whole Image classification for patient level decisions, Object detection for object level de-
cisions, and Semantic Segmentation for pixel-level decisions. These three levels translate
to specific model evaluation metrics and in return answer to di↵erent clinical questions.
We identify a largely neglected predicament between the strive for crossing the AI chasm
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by evaluating models at clinically relevant scales on one side, and optimizing for e cient
training under the burden of data scarcity on the other side. The main contributions in
this chapter are:
• We propose a deep learning model that enables end-to-end object detection and clas-
sification on medical images by aligning the model output to the clinically relevant
scale while maintaining data e cient training [37].
• We provide an in-depth analysis of the prevalent models from object detection,
semantic segmentation and instance segmentation operating in 2D as well as 3D by
means of comparative studies on Breast DWI, Lung Computed Tomography (CT)
and a series of toy experiments.
• We open source the Medical Detection Toolkit, the first comprehensive framework
for object detection on medical images including e.g. modular implementations of
all explored models operating in 2D and 3D [38].
• We apply our approach to the task of lung cancer staging on Positron Emission
Tomography - Computed Tomography (PET-CT) and perform a sensitivity study
under varying clinical training scenarios [39].
Increasing Robustness of Medical Image Classification (Chap. 7)
We continue the path of exploring pitfalls in existing end-to-end learning systems that
currently hamper robust generalization. To this end, we identify key leverage points where
domain knowledge can be condensed into inductive biases and increase the robustness of
end-to-end models in medical image classification aiming to pave the way for application
in clinical practice. The main contributions in this chapter are:
• Robustness against rater confusion: We address the challenge of erroneous training
annotations by substituting the classification component of end-to-end object detec-
tion for regression, which enables to train models directly on the continuous scale of
underlying pathological processes [40].
• Robustness against input variations: When trained models are deployed across clin-
ical sites they commonly face performance drops due to input domain shifts such as
missing or altered modalities. We inject domain knowledge in form of a biophysical
model that recaptures the original training domain from altered inputs and thus
restores robust model generalization. [41].
• Robust Hyperparameters: We address the highly unsystematic, cumbersome and sub-
jective trial-and-error process of finding a robust set of hypereparameters for a given
task by condensing domain knowledge into a set of key design choices and systematic
rules thus enabling automated and robust deep learning pipeline configuration on a




The outline of this thesis is as follows: Chapter 2 introduces the fundamentals of medical
imaging techniques, current procedures of cancer diagnosis and the State of the Art in
medical image classification. Chapters 4-7 represent methodological chapters as outlined
in Section 1.1. Finally, Chapter 8 provides concluding thoughts and an outlook on the




2.1. Medical Imaging Techniques
This section is to large parts based on the book ”Medizinische Physik: Grundlagen -
Bildgebung - Therapie - Technik” by Schlegel et al. [43].
2.1.1. Magentic Resonance Imaging
Since the beginning of the 1980s Magnetic Resonance Imaging (MRI) has become a widely
used medical imaging technique, which is able to image a wide variety of anatomical re-
gions and to provide answers to a wide range of morphological and functional questions
[43]. MRI allows to generate high-resolution, good-contrast medical images without expo-
sure to harmful radiation, while drawbacks include long acquisition times, relatively high
hardware costs and agnosticism to bone and calcium. MRI measures the magnetic reso-
nance of nuclei after excitation by an external magnetic field. Due to the high abundance
of hydrogen in the human body and its advantageous magnetic interaction properties,
most medical applications of MRI are targeted towards measuring magnetic resonance of
hydrogen nuclei. Specifically, the inherent property of a quantum-mechanic spin in nuclei
and the fact that this spin couples to external magnetic fields is exploited by applying
radio frequency pulses to the tissue in order to excite the nuclear spin onto a higher energy
level. The subsequent relaxation emits an electromagnetic signal (”resonance”), which is
measured in a receiver coil in terms of time and frequency resolution. By means of an in-
verse Fourier Transformation and due to a multi-coil setup inducing linear field gradients
along spatial axes, the spatial information of magnetic resonance can be reconstructed
from these measurements in hindsight. Thereby, di↵erent pulse sequences and timings
(”contrasts”) result in varying image modalities, such as a ”T1-weighted” (focused on
measuring the resonance parallel to the external magnetic field) or ”T2-weighted” (fo-




The contrast in MRI, for example between neighboring tissues, can be additionally in-
creased by application of appropriate MRI contrast agents [43]. The mode of action of
such contrast medium in MRI is not based on direct imaging of a substance as such, but
its magnetic interaction with the environment. Complementary clinical information in
contrast-enhanced images derives from the fact that metabolic changes in diseased tissue
a↵ect the absorption capabilities of contrast medium. Most clinically used MRI contrast
agents a↵ect the measurement by changing the T1 relaxation time after excitation. Dur-
ing the last 30 years there has been rapid improvement of existing and development of
new MRI contrast agents. Currently, there exist di↵erent, largely overarching classifica-
tions of MRI contrast agents that are based on a variety of features such as the nature of
their core, their e↵ect on the surrounding space or their chemical or magnetic properties.
MRI contrast agents may be administered by injection into the blood stream or orally, de-
pending on the subject of interest. Recent studies found that injection of contrast agents
might be harmful, e.g. via allergic reactions, the rarely occurring nephrogenic systemic
fibrosis, or intracerebral deposits, even though no evidence for short-term sequelae has
been demonstrated so far [44, 45, 46, 47]. Further, contrast enhancement considerably
increases acquisition time compared to conventional MRI [43].
Di↵usion Weighted MRI
A light-weight alternative to invasive and time consuming contrast enhanced MRI is Di↵u-
sion Weighted Magentic Resonance Imaging (DWI). Given an appropriate pulse sequence,
MRI is able to measure molecular di↵usion, i.e. the Brownian motion of water molecules.
The di↵usion of water in vivo depends on cellular parameters such as cell dimensional-
ity, compartmentation and transport processes [Posse et al., 1993]. In simplified terms,
the mobility of water molecules is expected to decrease with higher cell density, such as
in cancerous tissue, rendering DWI a widely utilized technique in cancer imaging: The
di↵usion signal is measured as the spin echo between two pulses, where nuclei changing
their location between the pulses result in reduced signal [48]. Thus, voxels representing
cancerous tissue are expected to light up in DWI, because the the di↵usion and hence
the relative signal attenuation is lower in this location. In clinical scenarios the di↵usion
signal is interfered by non-linear e↵ects involving the localization gradient fields of MRI
[49]. Hence, in practice multiple measurements under varying gradient factors b (higher
b-values indicate a larger time di↵erence between the two pulses of the spin echo sequence
and thus increase the di↵usion component of the measurement) are preformed and subse-
quently fit by a biophysical model to extract the Apparent Di↵usion Coe cient (ADC):
S(b) = S
0
exp ( b ADC) (2.1)
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Here, S
0
denotes the signal before di↵usion pulsing and S(b) the signal after di↵usion puls-
ing depending on the gradient factor b. Note that on ADC maps the relation to di↵usivity
is inverted compared to raw b-value images, i.e. lower Brownian motion corresponds to
lower intensity voxels.
While the conventional DWI model is based on the assumption that water di↵usion fol-
lows a Gaussian behavior such that water molecules di↵use without any restriction, in
living tissue, di↵usion is commonly restricted by tissue microstructure and shows non-
Gaussian phenomena. Recently, Jensen et al. proposed Di↵usion Kurtosis Imaging (DKI)
to account for this non-Gaussian component in di↵usion behavior by extending the DWI
model (Equation 2.1) by an Apparent Kurtosis Coe cient (AKC), which indicates the










Previous studies found that DKI substantially increases sensitivity compared to conven-
tional DWI on gliomas [52, 53], hepatocellular carcinomas [54], prostate cancers [55, 56],
and breast lesions [57]. While employing biophysical mdoels like in Equation 2.1 or 2.2 is
the current clinical standard, Chapter 5 will present a model that integrates this process
into a learning algorithm and provides evidence that learning signal exploitation on DWI
yields superior performance on downstream tasks such as classification.
2.1.2. Computed Tomography
In Computed Tomography (CT), tissue is X-rayed from multiple angles to generate 3D
images of local densities [43]. Compared to MRI, CT comes with high resolutions, short
acquisition times, no constraint on molecular response such as to hydrogen, and broad
availability of scanners. At the same time, patients absorb considerate doses of radiation
throughout acquisition. The functionality of X-rays is based on emitting photons and
counting them after traversal of matter. Reduction compared to the initial photon count
can be related to absorption or scattering along the way and hence to the density of the
radiated matter. CT scanners are built with the x-ray source and the detector rotating
around the subject, such that measurements are successively acquired from many di↵erent
angles. The line integrals resulting from X-ray absorption in each measurement can be
inverted and analytically transformed to 3D Cartesian coordinates under certain assump-
tions on the scanner geometry. In contrast to MRI, the resulting 3D density map of the
probe denotes a quantitative measure, i.e. intensities range on an absolute scale that is
quantified in terms of Houndsfield Units (HU).
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Positron Emission Tomography - Computed Tomography
Positron Emission Tomography (PET) is a nuclear medicine functional imaging technique,
which depicts the spatial distribution of metabolic or biochemical activity in the body.
Therefore, a radioactive tracer is injected into the patient’s blood circulation prior to im-
age acquisition. In oncology, tracers are designed to exhibit glucose-like properties, thus
expected to be taken up by fast-growing cancerous cells with high energy consumption.
As the radioisotopes of the tracer undergo positron emission decay, the emitted positron
travels in tissue for a short distance until interaction with an electron. This encounter
produces a pair of annihilation (gamma) photons moving in approximately opposite di-
rections, which are subsequently detected by the PET scanner.
Positron Emission Tomography - Computed Tomography (PET-CT) combines a PET
scanner and an x-ray computed tomography (CT) scanner in a single gantry, in order to
acquire sequential images from both devices in the same session. PET-CT has revolu-
tionized medical diagnosis in many fields, due to the complementary clinical information
obtained from functional PET imaging, while ensuring spatial alignment to the highly
resolved CT scan. Many diagnostic imaging procedures in oncology, surgical planning,
radiation therapy and cancer staging have been changing rapidly under the influence
of PET-CT availability, and centers have been gradually abandoning conventional PET
devices and substituting them by PET-CTs. Drawbacks of PET-CT include high cost
regarding the combined scanner as well as the radioactive tracer of PET in general [43].
2.2. The Diagnosis of Cancer
Cancer is the second leading cause of death worldwide [58] and represents an increas-
ing burden under aging populations and higher life expectancies. Large scale studies
throughout the last decades have shown that early detection is crucial, as it enables cura-
tive treatment and significantly improves patient outcomes [59]. However, this is not true
for all cases. Many cancers are over-diagnosed, e.g. benign or non-invasive cancers that
will not be clinically relevant for many years or even a patient’s entire lifetime. In such
cases, diagnosis leads to unnecessary costs for the patient such as anxieties or invasive
follow-up procedures with associated discomfort, health risks, or impaired subsequent life
quality as as well as to unnecessary financial costs and increased workload for the health
care system. Under-diagnosis, i.e. delayed or missing detection of clinically relevant can-
cers, on the other hand, increases mortality and morbidity of patients. Thus, the careful
tuning of diagnosis pipelines towards optimal patient outcome remains a challenging task.
This section depicts the chain of clinical procedures currently performed for diagnosis
of breast cancer including the ongoing discussions on which diagnoses truly improve pa-
tient outcome. Breast cancer as the example of choice allows to provide background
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information for the studies presented in Chapters 4 - 7, but also constitutes the most
common cancer worldwide with 11.6% of all diagnosed cases (en par with lung cancer),
which amounts to 1 in 8 women developing invasive breast cancer over the course of their
lifetime [58]. Further, since breast cancer can arise at a relatively young age, it is the
leading cause of death in women under 50 [60] and the second leading cause of death from
cancer in women in general [58]. Moreover, early detection and thus a thoroughly designed
diagnosis pipeline are imperative in breast cancer, as it increases the 5 year survival rate
from 27% for distant cancer (already spread to other body parts when diagnosed) to 99%
for cancer that is localized (limited to the original site) at the time of diagnosis [61]. Since
breast cancer is 100 times more likely to occur in women than in men [58], the remainder
of this section will focus on female breast cancer.
2.2.1. Breast Cancer Anatomy
As a mammary gland, the female breast is composed of di↵ering layers of tissue. Glandular
tissue is structured in multiple lobes, where the milk is produced and subsequently drained
via lactiferous ducts to the nipple (see Figure 2.1 left). The lobes are held in place
by surrounding fibrous tissue and the remaining space is filled with fatty tissue. The
proportion between fibroglandular and fatty tissue is referred to as the density of the
breast and constitutes a relevant factor for breast cancer increasing the risk by up to
4-5 times [62]. This is because cancer commonly begins inside the glandular tissue, i.e.
in a lobe or a duct (see Figure 2.1). Since Lobular Carcinoma in Situ (LCIS) (in situ
stands for ”in its original place”) are neither visible in imaging diagnostics nor clinically
relevant, their detection is mostly incidental during biopsy of neighboring lesions. Ductal
Carcinoma in Situ (DCIS), on the other hand, are visible in some imaging techniques but
not yet clinically relevant, fueling controversial discussions about whether they should be
detected by diagnostic procedures or not [60]. In situ cancers are not life-threatening,
but commonly increase the risk of developing invasive cancer later on. Clinical relevance
is given as soon as the cancer starts to invade neighboring tissue, which is referred to as
Invasive Lobular Carcinoma (ILC) or Invasive Ductal Carcinoma (IDC). In the subsequent
stages, cancer cells can break away from the original tumor in the breast and travel via
the lymph system or blood system to other parts of the body, such as the liver, brain,
bones, or lungs, where secondary tumors, also referred to as metastases, are developed.
2.2.2. Current Diagnosis Steps
Cancer Diagnosis is performed as a chain of subsequent procedures, where each step aims
to resolve ambiguities of the previous step, while typically increasing the level of cost for
the patient and the health care system. The traditional trajectory of breast cancer diag-
nosis is initiated by symptomatic cases, where e.g. a lump is detected in the breast during
physical examination by the patient or a physician. Such suspicious findings are further ex-
amined by means of diagnostic mammography, a low-dose X-ray image acquisition, where
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Figure 2.1.: Breast Anatomy and Types of Breast Cancer. Left: Glandular tissue is
structured in multiple lobes, where the milk is produced and subsequently drained
via lactiferous ducts to the nipple. The remaining space is filled with fatty tissue
(bright). Image from [63]. Right: Cancer begins in either a lobe or a duct, where
it can remain unnoticed for long times (”in situ”). If the cancer starts to invade
neighboring tissue, it becomes clinically relevant. Image from [64].
the breast is compressed between two parallel plates to reduce the tissue thickness pen-
etrated by X-rays, which is often experienced as painful by patients. The interpretation
of mammographic images follows a standardized protocol, the Breast-Imaging Reporting
and Data System (BI-RADS), which allows for concise and unambiguous understanding
of patient records between multiple doctors and medical facilities [65]. The BI-RADS
scale comprises the numerical codes 0-6 indicating the malignancy of the suspicious lesion
(0: Incomplete evidence, 1: Negative, 2: Benign, 3: Probably benign, 4: Suspicious, 5:
Highly suggestive of malignancy, 6: Known biopsy with proven malignancy (only occurs
in follow-up mammography for treatment response assessment)). Patients with BI-RADS
0 or 3 are typically called for follow-up mammography, while patients with BI-RADS 4 or
5 are sent to biopsy, which is typically performed as a minimal-invasive procedure, where
a sample of tissue or fluid is extracted from the suspicious area by means of a hollow
needle and histopathologically examined under a microscope for accurate assessment of
malignancy. This ultimate stage of the diagnosis chain is associated with high discomfort
and anxiety among patients [66].
The traditional ”symptomatic” diagnosis setup has several flaws, one of them being that
clinically relevant cancer is often visible on radiological images before symptoms are devel-
oped (referred to as ”lead time”) [60]. Since pre-symptomatic detection has been shown to
win precious time for curative treatments and improve patient outcomes, many developed
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nations have implemented large-scale mammography screening programs [67, 68], where
every women above the age of 40 or 50 receives X-ray mammography in intervals of one
or two year (depending on country) aiming for a presumptive identification of unrecog-
nized disease in an apparently healthy and asymptomatic population. While randomized
controlled clinical trials provide evidence that mammographic screening does reduce mor-
tality from breast cancer [69, 70, 71], the resulting diagnosis chain still su↵ers from high
amounts of underdiagnosed and overdiagnosed cases [72]. Both can be related to the
sensitivity profile of X-ray mammography, i.e. the distribution of sensitivity levels across
di↵erent tumor biologies, which is not fully suitable to the clinical task of breast cancer
detection [60]: While an ideal diagnosis procedure exhibits high sensitivity in clinically
relevant, aggressive and high-grade cancer, and low-sensitivity in clinically irrelevant, be-
nign, or low-grade lesions (diagnosis of low-grade disease may not contribute to a true
survival benefit [73]), the sensitivity profile of X-ray mammography appears to behave
inverse. One explanation is that mammography relies on the depiction of architectural
and morphological features that reflect pathophysiological processes associated with slow
growth and in turn with cancers of often limited clinical relevance such as DCIS [60].
The resulting overdiagnosis manifests in 50% of mammographic findings being identified
as benign by subsequent biopsies, revealing half of the performed biopsies as unneces-
sary [74, 75, 76] and indicating a tremendous burden for patient life quality as well as
the health care system [77]. At the same time, aggressively growing and invasive cancer
exhibits imaging phenotypes such as roundish shapes or smooth borders rendering them
often indistinguishable from ubiquitous benign lesions in X-ray mammography [60]. The
resulting underdiagnosis is further amplified by the fact that dense breast tissue con-
siderably reduces sensitivity in X-ray mammography [78], and constitutes the prevalent
reason behind breast cancer remaining a major cause of death for women [79]. While
various attempts are made at improving the interpretation of X-ray mammograms with
deep learning algorithms [15, 80, 81], it is an ongoing discussion whether the flaws associ-
ated with this imaging technique can be compensated for, or whether the future of breast
cancer diagnosis might require a fundamental shift towards other imaging modalities.
2.2.3. MRI Screening - The Future of Breast Cancer Diagnosis?
Due to lack of availability, long acquisition time and high associated cost, MRI is currently
not used for broad screening of the population, but reserved for a small group of high risk
patients. Further, MRI is performed at later stages of the diagnostic chain, such as for
resolving ambiguities of previous findings or assessing treatment response. The commonly
used MRI sequence for this task is Contrast-enhanced T1-weighted MRI. Despite the lack
of large-scale randomized clinical trials of MRI screening, studies indicate that MRI is able
to double or even triple sensitivity compared to mammography independent of risk factor
[82, 83, 84]. Specifically, in contrast to X-ray mammography the sensitivity profile of MRI
appears to suit the task of breast cancer detection, with high sensitivities for aggressive
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and invasive high-grade cancer and low sensitivities for low-grade disease. This can be
explained by the unsurpassed soft-tissue contrast in MRI, the fact that breast density does
not a↵ect image evidence such as in mammography, as well as the correlation between
angiogenic activity (which drives the take-up of contrast agent) and cancer growth [60].
The reduced sensitivity of low-grade DCIS has been used as an argument against MRI as a
standalone screening technique, but recent understanding of DCIS related implications on
overdiagnosis, i.e. the assumption that the non-detection of such low-grade DCIS might
be clinically desirable, might call for reconsideration of this argument [73].
E↵orts to improve availability and bring down costs to establish MRI as a frontline tool
in breast cancer diagnosis range from tailoring abbreviated sequencing protocols to de-
signing new scanners tuned for high patient throughput acquisition [60]. Arguably, the
most promising recent development towards a widely applicable, light-weight and highly
accurate MRI technique for breast cancer diagnosis is the acquisition of DWI (see Section
2.1.1). This method refrains from administration of contrast agent, which is an invasive
procedure associated with health risks (as elaborated on in Section 2.1.1) and thus su↵ers
from diminished acceptance among the population. Moreover, DWI is able to bring down
acquisition time to around 7 minutes [85]. First studies have shown that measuring di↵u-
sion is superior in assessing the malignancy of breast lesions compared to mammography
and as a consequence enables drastic reduction of false positive findings [86, 85, 87]. An
explanation is that di↵usivity is correlated to integrity of cellular structure, which in turn
is related to speed of cellular growth. Such micro-scale information is unaccessible for X-
ray imaging, which describes density of cell patterns on a macro-scale (see Section 2.1.2).
Moreover, DWI might be able to reduce false positive findings compared to Contrast-
enhanced MRI [88, 89]. Chapters 4-7 present studies on how learning algorithms can
automate and improve breast cancer diagnosis based on this emerging imaging technique.
In summary, breast cancer diagnosis is a fast developing field of research with hetero-
geneous opinions and vibrant discussions on defining the right steps towards improved
patient outcome. One concept that large parts of the community seem to agree on is
the importance of ”risk stratification”, i.e. the step away from ”one-fits-all” screening
programs towards personalized diagnostic procedures by means of prior risk assessment of
individual patients in terms of e.g. family history, gene sequencing or breast density. This
way, resources of current health care systems could be thoughtfully allocated to where they
are needed most: For patients with low-risk and low breast density X-ray mammography
is expected to su ce, patients with intermediate risk or high breast density could undergo
light-weight MRI such as DWI, while high-risk patients could be treated by means of the
entire palette of diagnostic tools. This transformation ties in nicely with the concept of
”precision medicine” (see Chapter 1) as a vision for the future of digitalized health care.
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Classification of Images, i.e. their interpretation and allocation to semantic categories,
roughly involves three tasks:
1. Localization of discriminative regions (or Regions of Interest (ROIs)) in the image,
i.e. areas containing evidence related to the task at hand such as objects or image
patterns.
2. Delineation of ROIs in terms of measurements, e↵ectively transforming spatial in-
formation regarding precise image localization into semantic information in form of
quantized features.
3. Application of decision thresholds in the mono- or multivariate features space aiming
to assign the underlying image to predefined semantic categories.
In the medical domain, the three tasks have traditionally been projected into single com-
ponents of engineered, and task-specific classification pipelines involving high amounts
of domain knowledge such as feature sets tailored towards application in di↵erent parts
of the human body. Since then, the paradigm of end-to-end learning and the implied
decrease of relevant domain knowledge has lead to a drastic generalization of method-
ologies, which in turn has caused a shift of research focus away from the engineering of
task-specific systems towards the successful adaptation of existing deep learning methods.
As a consequence, the methodological State of the Art (SotA) in Medical Image Classi-
fication has become increasingly aligned with the corresponding SotA in deep learning
research. This Section will provide a short overview of current SotA algorithms relevant
to Medical Image Classification while sensitizing the reader to two major challenges that
currently prevent end-to-end learning systems from clinical application: Model robustness
under limited training data and the clinical relevance of evaluation scales.
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3.1. Medical Image Classification based on Handcrafted Features
Before the era of end-to-end learning systems, conventional machine-learning techniques
were limited in their ability to process natural data in their raw form essentially only cov-
ering the last of the three subtasks involved in image classification outlined above. Thus,
for decades, constructing a pattern-recognition system required careful engineering and
considerable domain expertise to design an upstream feature extractor that transformed
the raw data (such as the pixel values of an image) into a suitable internal representation
or feature vector, from which downstream learning system could detect or classify patterns
in the input. This section will introduce Radiomics, an e↵ort from the medical domain in
the early 2010s to get away from engineering features highly tailored to specific tasks and
towards standardized large-scale measurements, as well as two types of machine learning
classifiers relevant for the scope of this thesis: Random Forests and Neural Networks.
Radiomics Feature Extraction As briefly mentioned in Chapter 1, Radiomics de-
scribes the comprehensive understanding and quantification of information in radiological
images and ties into an overarching data pool of a patient’s quantized clinical information
with the ultimate goal to improve patient care by enabling personalized treatment [8].
Thereby, Radiomics comprises large-scale extraction of features from images regarding in-
tensity statistics, shape, or texture [9, 10, 11]. Radiomics studies have been able to reveal
insightful correlations between imaging biomarkers and underlying clinical or genetic pro-
filing e.g. for categorization of cancer [90], early metastases [91] or protein expression [92].
Due to the fact that Radiomic features describe local image patterns such as associated
with single objects, their extraction commonly requires upstream image processing like
localization of Regions of Interest (ROIs) in form of manual annotation. Chapter 4 will
showcase successful applications of Radiomics features combined with machine learning
classifiers for breast cancer classification on DWI and cardiac diagnosis on MRI.
Random Forest Random forests are an ensemble learning method for classification,
regression and other tasks that operate by constructing a multitude of decision trees
[93]. A trained decision tree constitutes a combination of if-then statements, which are
expressed as nodes in a tree-like structure, where each node represents a linear cut on a
single variable. New inputs are classified by propagation through the tree until reaching
an end node (”leaf node”), which has been assigned to a certain class during training
and thus represents the classification decision. The tree structure is built during training,
where new nodes are successively generated with associated rules by optimizing for class
separation until a stopping criterion is met and the current node is defined as a leaf node.
Neural Network Feedforward Neural Networks, also referred to as Multilayer Perceptron
(MLP)s when implemented as shallow classifiers, are built of processing units (”neurons”)
each representing a nonlinear transformation by means of internal parameters (”weights”).
Neurons are arrayed parallely, i.e. several independent neurons processing the same input
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vector, forming a network layer, while a neural network is composed of multiple layers
stacked on top of each other. In MLPs, the stacking of layers is implemented in a ”fully
connected” fashion, i.e. each of a layer’s neurons has a connection (i.e. network weight)
to each of the previous layer’s neurons. In classification tasks, the ultimate network layer
is commonly modeled as a categorical softmax distribution over class targets Y , which
allows to describe the neural network as a conditional probability distribution P (Y |X,W )
depending on some input vectorX and the weightsW . The network weights are iteratively
updated in a supervised fashion, i.e. by sampling mini-batches of input-target-tuples
(X, Y ) from the training data distribution while minimizing some loss function [29].
3.2. Medical Image Classification based on learned Representa-
tions
Bias Variance Trade-o↵ The advantages of substituting handcrafted feature extraction
with data-driven learning of representations are manifold: Integrating feature extraction
and classification into a single neural network architecture allows for optimizing both sys-
tem components simultaneously, based on task-specific observations, and with respect to
the ultimate target. Moreover, learning representations enables dynamic adaptation of
context scale, i.e. is not restricted to local image patterns such as Radiomics features,
but allows to encode global dependencies. While Neural Networks are universal function
approximators [94], i.e. in theory able to learn arbitrarily complex relations between high
dimensional inputs and associated targets, the ability of original MLP architectures to
process raw data such as images is limited mainly due to a phenomenon referred to as
the bias-variance-tradeo↵ [95]. The inductive bias of a model is the set of assumptions
driving a model’s predictions on unseen data, where erroneous assumptions may lead to
so-called bias error. In order to achieve the ability to generalize to unseen data, this bias
error needs to be counterbalanced with a model’s variance, i.e. the error from modelling
noise in the training data rather than underlying patterns with causal relations to the
target (”overfitting”), such as in over-parametrized models. The tradeo↵ between the two
errors is commonly controlled by model complexity, i.e. the number of model parameters
1 , but depends on further external factors such as the amount and diversity of training
data and the general complexity of the task (such as the level of target-related evidence in
the input). As a consequence, if an MLP architecture were to be scaled up to operate on
high-dimensional inputs such as raw images, the resulting increase in model parameters
(typically by several orders of magnitude) would render the model prone to overfitting
and in return hamber the ability to generalize to unseen data.
Convolutional Neural Networks The watershed for representation learning in image
1
There is recent evidence suggesting the definition of model complexity might be more complex e.g. excludes
certain topological factors of the network architecture [96].
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classification by means of neural networks was the introduction of Convolutional Neural
Network (CNN)s in the late 1980s [97], which derive their success from drastically reduc-
ing the amount of network parameters compared to MLPs. This is achieved by condensing
domain knowledge regarding translational invariance of objects in images into an informed
inductive bias, i.e. one that does not increase bias error while reducing model variance.
The additional bias e↵ectively constraints the space of possible solutions during gener-
alization, which is implemented by replacing the fully connected layering of MLPs with
convolutional filters, i.e. local operators that successively scan over the image, enabling to
learn the detection of edges, motifs, or objects in one set of weights shared across spatial
locations. This economical dealing with model parameters allows for stacking of large
numbers of layers in a network without overshooting the model’s variance, which eventu-
ally coined the term deep learning. CNNs for whole image classification are implemented
as encoding architectures, where convolutional layers are intermitted by pooling layers,
which reduce the spatial size of the array of filter outputs (”feature maps”), e↵ectively
trading in spatial precision for semantic richness in learned representations. This e↵ect is
amplified by the fact that the ”e↵ective receptive field”, i.e. the area of input pixels being
connected to a single neuron via consecutive convolution operations, increases throughout
the network architecture allowing for capturing higher-level abstractions. The concept
of learning hierarchical representations has proven very e↵ective in images, because it
exploits the property that evidence in images often comes in compositional hierarchies,
in which higher-level features are obtained by composing lower-level ones, e.g. local com-
binations of edges form motifs, motifs assemble into parts, and parts form objects. The
delayed success of CNNs for natural image recognition tasks starting with AlexNet in 2012
[98] and later VGG in 2015 [99] is attributed to insu cient compute and data resources
at the time of their introduction.
Medical Application While CNN encoders as described above technically allow for
implicit localization of ROIs and thus can be trained in end-to-end settings, i.e. op-
erating on the raw images without previous annotations (see Section 3.3 for SotA and
examples), this scenario is sometimes not feasible in the medical domain: Assigning the
training signals derived from scalar class targets to high dimensional inputs becomes a
highly ambiguous task, if the ROIs containing task-related evidence comprise only a small
fraction of this input. This issue is commonly amplified in the medical domain by no-
toriously limited training data, and ultimately leads to high model variance and poor
generalization ability. In contrast, datasets of classification tasks on natural images such
as ImageNet [98] often depict a single centric object of considerable size, rendering im-
plicit localization of ROIs feasible. In compensation for the described challenges in the
medical domain, there exists an intermediate step in medical image classification aiming
to make use of learned representations while still relying on previous detection of ROIs
(by clinicians or upstream detection systems), by applying CNNs on cropped patches en-
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compassing these ROIs. This setup is also referred to ”false positive reduction” (bearing
on previously annotated ROI candidates) and is often performed in tasks involving small
ROIs in large images such as classification of lung nodules in chest CTs [100, 101] or
breast lesions in mammography [102]. One focus of this thesis is to study the potential
of end-to-end learning in clinical diagnosis systems by starting with compound classifica-
tion pipelines as applied in clinical standard and successively substituting components for
learning algorithms ultimately deploying end-to-end models. Thereby, Chapter 5 show-
cases the intermediate step of ROI-based false positive reduction, which we will refer to as
”Roi-to-end” in the remainder of this thesis, so as to distinguish it from true end-to-end
training on raw images, on breast cancer classification in DWI, where associated lesions
(i.e. ROIs) exhibit particularly small sizes, since images were acquired as part of an early
detection screening program.
3.3. End-to-end Medical Image Classification
End-to-end learning in image classification describes the integration of all subtasks, i.e.
localization of ROIs, extraction of semantic features, and decision making, into one single
learning algorithm and training all components simultaneously, directly on the raw data,
and with respect to the ultimate target. This is a highly desirable scenario for the medical
domain, since it refrains from any task-specific engineering and alleviates the workload
of clinicians by automating the process of annotation of ROIs. While CNN encoders
(see Section 3.2) model the localization of ROIs implicitly, there exist further end-to-end
learning algorithms tailored to solving this task explicitly by employing spatially resolved
class targets and generating spatially resolved predictions. Thereby, the spatial resolu-
tion of annotations and predictions comes at di↵erent granularity levels which implies an
unfolding of the classification task onto varying scales: Encoding architectures reduce the
high-dimensional image input to a single distribution over target class probabilities (as
elaborated on above), i.e. assign one single category to an entire image, hence address
the classification task on image level (or patient level in medical terms). Object detec-
tion models, on the other hand, output multiple predictions per image on object level,
each composed of coordinates and per-object class distributions. Finally, semantic seg-
mentation models output class distributions on pixel-level , i.e. in form of segmentation
maps, essentially categorizing each individual pixel. Accurate di↵erentiation of these lev-
els is highly important in medical image classification, because each addresses di↵erent
tasks and comes with specific evaluation metrics essentially counting correctly and in-
correctly classified instances of the respective granularity level, i.e. patients, objects, or
pixels, respectively. Thus, the granularity level of a model’s output predictions directly
answers to a specific clinical questions (while the inverse mapping from clinical task to
suitable granularity level of classification is less straightforward due to several nuisance
factors discussed in Section 3.4). This section introduces the algorithmic SotA associated
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Figure 3.1.: Granularity Levels in Medical Image Classification. This figure visualizes
the three levels of granularity in classification of medical images, the associated
computer vision methodology, model examples, and output structure. Each scale
comes with specific evaluation metrics, that determine which clinical question is
addressed. References for model examples: AlexNet [98], VGG [99], ResNet [103],
DenseNet [104], Mask R-CNN [105], Retina Net [106], YOLO [107], U-Net [108],
DeepLab [109].
with di↵erent levels of granularity in image classification as well as associated clinical
applications. An introduction to evaluation metrics in image classification is provided in
Appendix A.
Patient Level: Whole Image Classification
Image classification on patient-level, i.e. the task of assigning a single class label to an
entire image, is commonly modeled by encoding architectures as described in Section 3.2.
While the fundamental architecture of CNN encoders has not changed since the intro-
duction in the late 1980s [97], research since focused on controlling gradient instabilities
observed when stacking many layers by means of residual connections [103] or dense con-
nections [104]. Additionally, feature map normalization schemes such as batch-norm or
instance-norm have demonstrated considerable improvements [110, 111].
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Patient-level classification is required for any clinical question that is ultimately inter-
ested in whether a patient is healthy or not, and in case of the latter which type of
clinical condition is present. This includes for instance the diagnosis of primary cancer
[70, 112, 113]. As described in Section 3.2, the implicit modeling of ROI localization is
hampered in practice due to severe credit assignment problems of scalar training labels
in high-dimensional inputs (”which part of the input image should the scalar training
signal be assigned to during backpropagation?”), which renders models prone to overfit-
ting. Nevertheless, recent studies have reported human-level performance of such models
in clinical tasks, while overcoming the credit assignment issue by either training on enor-
mous datasets [18] (roughly 760000 chest radiographs), operating on images with high
task-related evidence, i.e. comprising one centric ROI of considerable size such as in der-
moscopy [16], or enhancing the training signal by employing annotations of higher spatial
resolution [15, 114, 115]. While employing annotations of higher levels of granularity com-
monly requires subsequent aggregation of model predictions in order to evaluate on the
clinically relevant level, Chapter 6 will present a solution that enables end-to-end training
on multiple levels thus removing the need for aggregation.
Pixel Level: Semantic Segmentation
In contrast to encoding architectures, pixel-level predictions require models with spatially
resolved output. To this end, the first Fully Convolutional Networks replaced the densely
connected classification component at the end of SotA encoding architectures at the time
such as AlexNet [98] or VGG [116] by 1 ⇥ 1 convolutions enabling subsequent upsam-
pling of feature maps [117]. These first attempts focused on exploiting existing encoders
pre-trained on large natural image datasets and neglected the upsampling part of the
model, predicting at resolutions 32 times smaller than the input thus resulting in highly
asymmetric architectures. The current SotA in biomedical image segmentation is the
U-Net [108] architecture, which was presented shortly after and introduced a principled
way of combining the high-level semantic information of later layers with the fine-grained
localization of earlier layers. Instead of generating spatially resolved output by means
of ad-hoc upsampling operations, the U-Net adds a decoder part to the network, which
successively combines coarser features with more localized features in convolutional layers,
i.e. in a learned fashion, essentially mirroring the encoder part of the network. The U-Net
is complemented by skip connections, which shortcut signals of each resolution stage in
the encoder to the corresponding resolution stage in the decoder, allowing to successively
recombine features of di↵erent scales. The resulting encoder-decoder architecture gener-
ates otuput at full spatial resolution with respect to the input.
Pixel-level predictions are relevant, where the exact extend or shape of structures is of in-
terest such as in radiotherapy planning [118], intra-operative support [119], tumor growth
monitoring [120]. Moreover, segmentation maps are often used as intermediate represen-
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tations for subsequent measurements such as in cardiac diagnosis [34] or diagnosis (see
Section 4.1.2) or retinal disease [121].
Object Level: Object Detection
While prediction at full resolution as performed by segmentation models might seem as
the richest possible output representation, it comes with several flaws: Models operating
solely on pixels have no notion about what constitutes an object or di↵erent instances
of classes in an image. As a consequence, any such computer vision task interested in
classification of multiple objects in an image, commonly referred to as object-detection
tasks, would require aggregation of pixel predictions in ad-hoc postprocessing steps. Per-
haps unsurprisingly, the respective field of research converged to architectures similar to
the U-Net, the Feature Pyramid Network (FPN), where instead of upsampling predic-
tions to full resolution, coarser representations at earlier stages of the decoder commonly
associated with motifs of higher abstraction such as objects are extracted for subsequent
detection and classification. The current SotA in object detection is roughly divided
into two groups, which di↵er in how the detection and classification task based on the
FPN features is implemented: So-called two-stage detectors first discriminate objects from
background (”class agnostic”) while simultaneously regressing bounding box coordinates
by means of a Region Proposal Network (RPN) [105, 122, 123]. Subsequently, proposals
are categorized after resampling them to a fixed grid (”RoiAlign”), thus ensuring scale-
invariance for categorization. One-stage detectors, on the other hand, have been proposed
to perform class-aware categorization directly inside the RPN [106, 107, 124]. In general,
prediction of multiple objects per image is implemented by generating predictions at all
spatial locations of the feature map in a fully convolutional fashion, i.e. by scanning
the RPN over the feature map while sharing weights. The excessive amount of result-
ing predictions is reduced in a subsequent filtering process referred to as Non-maximum
Surpression (NMS), where predictions are clustered according to IoU and all but the
prediction with highest confidence score per cluster are discarded. Since the scales of
objects may vary drastically, i.e. range from few pixels to areas covering most parts of the
image, the RPN generates predictions based on multiple resolution stages (or ”pyramid
levels”) of the FPN while sharing weights between stages. Moreover, additional guidance
in form of priors on the predicted box coordinates (”anchor boxes”) has shown empirical
improvements. Thereby, multiple predictions per spatial locations corresponding to dif-
ferent anchor boxes are generated while not sharing weights, essentially aiming at training
di↵erent classifier experts for varying box ratios. These anchor boxes are implemented by
not predicting the coordinates of ground truth boxes directly, but instead modifying the
coordinate targets during training to represent the delta between the target coordinates
and the most overlapping prior box. If additional per-instance pixelwise predictions are
generated and evaluated, the task is referred to as instance segmentation. This additional
output can e.g. be achieved by implementing an additional head network on the extracted
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FPN features trained to predict pixel-maps per object proposed by the RPN, such as in
Mask R-CNN [105].
Object level classification is clinically relevant, when studying a disease in more detail
such as the spread or stage of cancer, i.e. when the clinical interest lies within the
existence, rough position and category of all individual objects of interest such as in de-
lineation of multiple sclerosis lesions [125], lung cancer staging [126], or multiple myeloma
staging [127]. Object-level outputs are further generated as a proxy for patient-level tasks,
when hardware constraints prevent end-to-end patient-level training (detailed discussion
in Section 6.7).
3.4. Discussion
While in rule-based decision making, prior knowledge is condensed into predefined con-
straints that serve as the model’s inductive bias, i.e. the set of assumptions used to
generate predictions on unseen data, in learning algorithms task-specific inductive biases
are captured by training on observations [31] 2. Thus, a learning algorithm’s ability to gen-
eralize to unseen data scales with the amount and quality of training data. This is a great
advantage, because, in contrast to rule-based systems, performance is not sealed by the
complexity of decision boundaries. However, if the data available at training time denotes
a poor representation of the underlying data distribution, such as commonly occurring
in medical imaging tasks, the inductive biases resulting from training do not enable the
model to robustly generalize to unseen data. End-to-end learning algorithms, where an
entire data processing pipeline is learned mostly from observations, carries the described
data dependency to extremes. This challenge is amplified in the medical domain by the
fact that medical datasets are notoriously small and su↵er from distribution shifts due to
varying scanner types, scanner sequences, scanner protocols or ambiguous annotations,
and renders model robustness towards unseen data characteristics the prevalent obstacle
in the strive for clinical application [27, 30, 25, 22]. To this end, the work presented in
Chapters 4-6 will examine the e↵ects when successively replacing rule-based components
of clinical classification pipelines by learning algorithms, i.e. benchmark performances and
draw conclusion about the potential of learning algorithms under data constraints. More-
over, the idea behind CNNs to condense prior knowledge about the domain into inductive
biases in order to reduce model variance and in return improve the generalization ability
of deep learning models will serve as blueprint for the work presented in Chapters 6 and 7.
Thereby, we move beyond mere architectural modifications and explores leverage points
in all components representing a model’s inductive bias: Training data, architecture, loss
function, and optimization [128]. We introduce new constraints regarding architecture
2
The inductive biases derived from training are to be considered as an addition to initial inductive bias given by
the model architecture such as in Convolutional Neural Network (CNN)s (see Section 3.2)
25
3. State of the Art in Medical Image Classification
in Section 7.2, regarding loss function in Chapter 6 and Section 7.1, and finally touch
upon all four components by systematizing the process of hyperparameter configuration
in Section 7.3.
Another key obstacle preventing end-to-end learning systems from clinical application
is the discrepancy between model evaluation in research environments and actual clini-
cal requirements [27, 129, 130]. While Figure 3.1 might convey the impression that the
choice of granularity level for a clinical task is straightforward, there are in fact several
nuisance factors, that may introduce a discrepancy between the researchers objectives and
the clinical question to be addressed, such as hardware constraints or vast di↵erences in
training e ciency associated to annotations at di↵erent levels. Chapter 6 will address this
challenge and present a solution that maintains data e cient training while accounting
for clinical relevance of evaluation scale.
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Handcrafted Features
The current clinical standard of computer-aided image classification is mostly embodied
by engineering task-specific compound pipelines. We study the potential of end-to-end
learning for clinical diagnosis by starting with current practice systems and gradually
substituting single pipeline components for learning algorithms while carefully tracking
the e↵ects. As a first step, we attend to the last part of the classification pipeline,
i.e. the categorization of entities into clinical pathologies based on handcrafted features.
Specifically, we explore the potential of replacing univariate rule-based decisions with
machine learning classifiers. The main contributions in this chapter are:
• We achieve human-level performance in breast cancer lesion classification on DWI
by substituting a mono-parametric decision threshold with large scale Radiomics
feature extraction followed by a machine learning classifier [32].
• We provide insights about further parts of the diagnosis pipeline such as an in-depth
analysis of Radiomics features or the exploitation of domain knowledge to enhance
the image normalization model.
• We apply the approach of large scale feature extraction followed by machine learning
classifiers to cardiac disease classification on MRI, thereby extending the feature set
by a novel group of time-series measurements over the cardiac cycle, and achieve the
second rank in an international competition [33, 34].
As kindly permitted by the Radiological Society for North America (RSNA), the sections
of this chapter regarding breast lesion classification reproduce parts of the following pub-
lication:
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Bickelhaupt, S.*, Jaeger, P. F.*, Laun, F. B., Lederer, W., Daniel, H., Kuder, T. A.,
Wuesthof L., Paech D., Bonekamp D., Radbruch A., Delorme S., Schlemmer H. P., Steu-
dle F. H., Maier-Hein, K. H. (2018). Radiomics Based on Adapted Di↵usion Kurtosis
Imaging Helps to Clarify Most Mammographic Findings Suspicious for Cancer. Radiol-
ogy, 287(3), 761–770. * equal contribution
The study on cardiac diagnosis was submitted to an international competition [34] and
further published in the associated proceedings [33].
4.1. Problem Statements
4.1.1. Breast Lesion Classification on DWI
As elaborated on in Section 2.2.2, current breast cancer diagnosis and large-scale mam-
mography screening in particular su↵er from high amounts of false positive findings:
Around 50% of women who are sent to biopsy are over-diagnosed, i.e. sent based on
a false positive mammography finding [74, 75, 76]. The invasive procedure of biopsy and
the associated waiting time for results constitute a significant mental and physiological
burden for these patients. While parts of the breast cancer radiology community suggest
to improve breast cancer diagnosis by shifting towards MRI as a standalone screening
method replacing mammography [60], such considerations seem ambitious in context of
current availability of MRI and the pace at which fundamental transformations in health
care systems typically proceed. In this context, integration of additional lightweight and
noninvasive imaging such as DWI (see Section 2.1.1 into the current diagnositc chain has
been proposed as a reasonable first step towards widespread MRI-based breast cancer
diagnosis [131]. In this scenario, women with suspicious lesions (BI-RADS 4 or 5, see Sec-
tion 2.2) are sent to additional DWI acquisition aiming to filter out false positive findings
before sending patients to biopsy.
In current clinical standard, malignancy of suspicious lesions on Di↵usion Weighted Ma-
gentic Resonance Imaging (DWI) is assessed by first manually annotating the ROIs, sub-
sequently fitting a biophysical model to each individual voxel to extract the Apparent
Di↵usion Coe cient (ADC) or more recently the Apparent Kurtosis Coe cient (AKC)
(see Section 2.1.1), computing the median coe cients per ROI over voxels, and finally ap-
plying simple cut-based thresholds on those [132]. On the other hand, there is a growing
research community applying Radiomics to extract supplementary computational infor-
mation on the imaged tissue by using either MR imaging or conventional x-ray mammog-
raphy [133, 134, 135, 136, 9]. Previous Radiomics studies mainly were focused on revealing
correlations between a radiomics signature and the underlying clinical or genetic profiling
(eg, OncotypeDX categories [90], early metastases [91] and protein expression [92]), but
not used for clinical diagnosis directly.
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Figure 4.1.: Proposed Radiomics Pipeline for Clarification of Breast Lesions suspi-
cious for Cancer based on Di↵usion weighted Imaging. First, a DKI model
is fit to the b-values of individuals pixels in the previously annotated ROI. The
resulting ADC and AKC coe cient maps are the basis for large-scale Radiomics
feature extraction. Finally, a random forest performs multivariate classification to
reduce the dimension of the feature vector into a binary decision regarding the ma-
lignancy of lesions.
In this study, we propose to enhance the current clinical research practice in 3 steps
(See Figure 4.1):
1. Extend the DKI model by a vector ✓(b) as a patient specific calibration utilizing a
separatly annotated fat area.
2. Replace the simple median aggregation of voxel coe cients by extracting a set of
Radiomics features from the coe cient maps based on first order statistics, shape
and texture.
3. Train a Random forest for classification based on extracted features to account for
multivariate dependencies between Radiomics features.
4.1.2. Cardiac Disease Classification on MRI
We further applied the approach of Radiomics feature extraction followed by machine
learning classifiers to a public competition on cardiac diagnosis, the Automated Cardiag
Diagnosis Challenge (ACDC) [34]. The goal of this two-part challenge, where first three
cardiac structures had to be automatically segmented from MRI and secondly patients
had to be categorized into 5 disease categories, is to improve upon the clinical practice of
cardiac diagnosis. In current practice, first cardiac structures are segmented by applying
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semi-automatic systems followed by rule-based decision making based on shape-related
measurements of segmented structures [137, 138, 139]. While it was theoretically possible
to address the challenge using end-to-end classification by means of a CNN that directly
maps raw input images to pathologies, the challenge dataset clearly did not provide suf-
ficient training data (100 training cases, 20 per disease category) for this approach. As
described in Section 3.2, especially the mapping of high dimensional images to scalar val-
ues is su↵ering from weak training signals, i.e. a credit assignment problem that renders
the model prone to overfitting. Hence we decided against end-to-end learning and opted
for a domain knowledge-guided approach, which we adjudged feasible given the encoun-
tered data burden. Specifically, we applied an ensemble of UNet inspired architectures
[108] (see Section 3.3) for segmentation of cardiac structures including the Left Ventricular
Cavity (LVC), Right Ventricular Cavity (RVC) and Left Ventricular Myocardium (LVM)
on each time instance of the cardiac cycle. Subsequently, information was extracted from
the segmented time-series in form of comprehensive features handcrafted to reflect diag-
nostic clinical procedures. Thereby, we extended the set of standard Radiomics features
by introducing additional measurements describing volume behavior over time. Based on
all extracted features we trained an ensemble of heavily regularized Multilayer Percep-
trons (MLP) and a Random Forest Classifier (see Section 3.1) to predict the pathologic
target class. Figure 4.2 shows an overview of the proposed pipeline [33].
Since the ground truth of cardiac pathologies in this dataset is determined by applying
rule-based cuts on shape features based on the manual annotations of cardiac structures,
benchmarking our machine-learning based classification against corresponding rule-based
approaches does not allow for comparison between them, but merely gives indication of
robustness against variations in segmentations (deviations of rule-based predictions from
the ground truth could be attributed to deviations of underlying predicted segmentations
from the original manual ground truth segmentations). We generally expect increased
robustness against variations in segmentations when applying machine-learning classifiers
over rule-based decision making, since the latter is commonly based on merely one or two
features and thus more prone to be a↵ected by segmentation bias [34]. Further, learning-
based decision making can easily be ”calibrated” to a new dataset (which often come
with deviating annotation styles) by re-training, while explicit rules are considered global
domain knowledge and therefore require careful justification when altered. However, as
argued above such studies involve quality assurance of automated segmentation, and thus
go beyond the scope of this thesis. As a consequence, this study intents to serve as a vivid
showcase for a successful machine learning-based diagnosis pipeline (we achieved the first
rank in the segmentation task and the second rank in the classification task) rather than
to draw scientific conclusions regarding the superiority over rule-based decision making.
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Clinical Motivation and Related Work
Analysis of cardiac function plays an important role in clinical cardiology for patient
management, disease diagnosis, risk evaluation, and therapy decision [137, 140, 138]. The
progressive course of heart failure can be associated with cardiac remodeling, which results
in poor prognosis for the patient due to diminished contractile systolic function, reduced
stroke volume or malignant arrhythmia. Clinical manifestations comprise changes in size,
mass, geometry, regional wall motion and function of the heart [141], which can be as-
sessed temporally and monitored non-invasively by cardiac magnetic resonance imaging
(CMRI). In today’s clinical routine, the huge benefits of comprehensive quantitative mea-
surements are still not exploited due to the associated labour time, subjective biases and
lack of reproducibility. Accurate automatic approaches for simultaneous multi-structure
segmentation and CAD are thus desirable assets for a large spectrum of cardiac diseases.
CAD approaches originate from the field of lesion detection and classification [142], thus
primarily used to focus on texture information to discriminate healthy from pathological
tissue. Medrano-Gracia et al. investigated global shape variations of the left ventricle in a
large cohort of an asymptomatic population [143]. They found the major principal modes
of shape variation to be associated with known clinical indices of adverse re-modelling,
including heart size, sphericity and concentricity. Later, Zhang et al. used a supervised
method to extract the most discriminatory global shape changes associated with remodel-
ing after myocardial infarction [144]. The resulting shape model was able to discriminate
patients from asymptomatic subjects with 95% accuracy. However, to the best of our
knowledge, a comprehensive CAD system for di↵erent cardiac re-modelling pathologies
and myocardial infarct patients has not been proposed before.
4.2. Utilized Datasets
Breast Lesion Classification on DWI
To the best of our knowledge, the dataset utilized in this study constitutes the largest
of its kind at the time of publication. DWI data of 222 consecutive patients examined
in two study centers in 2014–2016 were included in this analysis [32, 85, 132, 145, 146].
95 patients were examined at the first study site and included for method development
and training (mean age: 58.6 years ±6.6; 61 malignant and 34 benign). 127 patients
from the second study site were included in the independent test set (mean age: 58.2
years ±6.8; 61 malignant and 66 benign lesions). Women included in the study were
those who received a final indication for histopathologic analysis of the lesion by means of
breast biopsy because of a BI-RADS category 4 or 5 finding (see Section 2.2) on an x-ray
screening mammogram. After receiving this final indication for breast biopsy, patients
were invited to participate in the study, with the MR imaging examination being per-
formed before the biopsy. Exclusion criteria were general exclusion criteria for performing
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Figure 4.2.: Overview of the Proposed Pipeline for Automated Cardiac Diagnosis on
Cine-MRI. Segmentation predictions from a 2D and a 3D model are averaged and
used to extract instant and dynamic volume features, which are fed into an ensemble
of classifiers for disease prediction.
an MR imaging examination (eg, ferromagnetic implants, severe claustrophobia, allergies
to contrast agents and others) (n = 1) or unwillingness to participate in the study (n = 2).
MR images were acquired by using 1.5-T MR imaging devices from two di↵erent ven-
dors (for explanation of the following protocol data see Section 2.1.1). At the first study
site the imaging device (Aera; Siemens Erlangen, Germany) was used with an 18-channel
breast coil in 95 patients for the training set. At the second study site the imaging device
(Ingenia; Philips, Best, The Netherlands) was used with a two channel breast coil with
additive elements on the MR imaging table for the independent test set of 127 patients.
All women were imaged in the prone position with the breast not compressed but softly
supported by foam material. All MR imaging examinations were performed before biopsy.
A full diagnostic breast MR imaging protocol was performed as previously described, in-
cluding DWI sequences. DWI was performed with transverse echo-planar imaging by
using a single-shot technique at the first study site and multishot with readout segmenta-
tion at the second site. Section orientation was axial and section thickness was 3mm at
both study sites. b values were set to 0, 100, 750 and 1500 smm 2. Imaging time for the
DWI sequence was around 4 minutes at the first site and around 7 minutes at the second
site.
After acquisition, all images were read out by two expert radiologists to identify all in-
dex lesions in consensus using the DWI source images with b values of 750 smm 2 and
1500 smm 2 and the T2-weighted morphologic images. Information on index lesion lo-
calization was given in the x-ray screening mammographic report. The abbreviated MR
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Figure 4.3.: Set of di↵usion-weighted images at di↵erent b-values for one patient.
Additional example segmentation on the b = 1500 smm 2 image.
imaging protocol provided to the reader consisted of a T2-weighted morphologic sequence
and the DWI sequence. The index lesions as described in the x-ray mammography screen-
ing report were located by using the complementary information of both the DWI and
T2-weighted sequences and were manually segmented in the DWI sequence on all sec-
tions visible, resulting in a three-dimensional volume image of the lesion. Lesions were
segmented by using the inner border of the lesion to minimize partial volume e↵ects. For
this purpose, the DWI image with the highest b value that provided visibility of the lesion
was used. Thus, lesions clearly visible with all b values were segmented on sections with a
b value of 1500 smm 2, while lesions not visible on sections with a b value of 1500 smm 2
were segmented on sections with a b value of 750 smm 2 .
Subsequent biopsy, i.e. cancer burden and histopathologic evaluation of the lesions re-
vealed 122 (54.9%) malignant lesions in the group of 222 patients, with the most common
malignant lesion being invasive ductal carcinoma in 90 (73.77%) patients. Among the
benign lesions, which were found in 100 (45.04%) patients, the most common lesions
described were fibrosis, in 21 (21%) patients, and fibroadenoma in 20 (20%) patients.
The described histopathological information is utilized as ground truth for training the
machine learning model in this study. Figure 4.3 shows a DWI series for an exemplary
patient. Extended information on histopathology of lesions and size statistics is provided
in Appendix B.
Cardiac Disease Classification on MRI
The ACDC dataset [34] comprises short-axis cine-MRI of 150 patients acquired at the
University Hospital of Dijon using two MR scanners of di↵erent magnetic strengths (1.5
T and 3.0 T). Each time-series is composed of 28 to 40 3D volumes, which partially or
completely cover the cardiac cycle. As typical for CMRI, the data is characterized by a
high in-plane resolution ranging from 0.49 to 3.69mm2 and a low resolution in the direction
of the long axis of the heart (5   10mm slice thickness). Note that some data exhibit
severe slice misalignments, which originate from di↵erent breath hold positions between
slice stack acquisitions. Structures of interest, namely Left Ventricular Cavity (LVC),
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Left Ventricular Myocardium (LVM) and Right Ventricular Cavity (RVC) were segmented
manually by clinical experts on End Dyastolic (ED) and End Systolic (ES) phase instants.
Four pathological groups and one group of healthy patients are evenly distributed in the
dataset: patients with previous Myocardial Infarction (MINF), Dilated Cardiomyopathy
(DCM), Hypertrophic Cardiomyopathy (HCM), Abnormal Right Ventricle (ARV) and
normal (healthy) subjects (NOR). Additional information for all patients is provided in
form of height and weight. The dataset has been split by the challenge organizers into 100
training and 50 test patients. Segmentation and classification ground truth is provided
only for the 100 training cases. All reported test set results were obtained by submitting
our predictions to the online evaluation platform.
4.3. Methodology
4.3.1. Breast Lesion Classification on DWI
Enhancing the Biophysical Model by Fat Area Calibration
In recent clinical research, Di↵usion Kurtosis Imaging (DKI) is performed in the annotated
regions of interest on the raw b-value data to extract the ADC and AKC biomarkers (as
described in Section 2.1.1). While the literature uses a constant value for the background
signal intensity level as in equation 2.2, we introduce a data-dependent intensity level
calibration vector ✓(b). This vector is determined as the intensity of an additionally


















The e↵ect of this factor on classification performance is studied in a subsequent analysis
by comparing the final results when using ✓ as described versus setting ✓ equal to 0.
The signal intensities for b = 0 are omitted during the fit because of drastic instabilities,
instead, they are utilized as a third free-fit parameter. DKI is performed on each individual
voxel in the ROI. The resulting ADCs are required to be within 0   3.5 µm2 ms 1 and
AKCs within 0 3. Voxels yielding values outside of these intervals are excluded from the
ROI and considered background for the remainder of the analysis. These requirements are
applied to exclude outliers caused by artifacts such as flow or motion without distorting
correctly determined values. The upper limit of ADCs is chosen as the expected ADC
value of 3.25 µm2 ms 1 for free water, and the upper limit of AKCs was based on common
assumptions and observations from the literature [51, 57, 147]. Examples for the resulting
normalized image maps containing ADCs and AKCs are displayed in Figure 4.4).
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Figure 4.4.: Example regions of interest from raw DWI images and resulting ADC and
AKC maps. Two-dimensional sections of a three-dimensional acquisition of images
of a malignant tumor. Di↵usion Weighted Magentic Resonance Imaging with b
values of (a) 0, (b) 100, (c) 750, and (d) 1500 smm 2. Apparent Di↵usion Coe cient
map and Apparent Kurtosis Coe cient map show the resulting pixel values after
Kurtosis fitting. Notably, white pixels inside lesion constitute background after
exclusion for not matching the fit criteria.
Feature Extraction
In contrast to computing the mean or median over coe cient maps, in this study we
propose to perform large scale Radiomic feature extraction on the ADC and AKC maps
by using the Medical Image Interaction Toolkit [148]: First, four Daubechies wavelet
transforms are performed on the two input maps, yielding a total of 10 image variations.
These wavelet decompositions of the original images evaluate the radiomics features at
varying spatial frequencies and resolutions with pronounced focus on edge information,
along the three spatial directions. Subsequently, the following features are extracted:
• 21 firstorder statistics calculated from the histogram of voxel intensities using first-
order statistics
• 17 volume and shape features including diametral, volumetric and surface measure-
ments, as well as shape features such as compactness or sphericity.
• 321 texture features so as to characterize the topography of intensity distribution
and periodicity in the tumor volume as well as co-occurrence, run-length, size-zone,
and neighborhood gray level based features.
A detailed description of utilized features is provided in Appendix C. The obtained feature
vectors of the 10 image variations are concatenated, yielding a final vector containing 3590
features. Finally, the age of the patients is added as an additional clinical parameter.
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Random Forest Training
A Random Forest Regressor (see Section 3.1) is trained for dimensionality reduction, i.e.,
mapping the Radiomics feature vector to a one-dimensional malignancy score. Biopsy
results of the 222 patients are utilized as ground truth information during training. Since
the true class balance between benign and malignant lesions for this clinical scenario is
estimated to be around 0.5 (following the 50% false positives in mammography [149]), the
Random Forest output can be interpreted as a probability of malignancy for each lesion.
A Regression Forest is preferred over a Classification Forest here, because it comes with
a continuous output and hence enables ROC analysis, i.e. empirical choosing of working
points for deployment on the individual test set. No feature selection is applied to the
data beforehand, since Random Forests perform intrinsic feature selection. For training,
a five-fold cross validation is performed on the training set. Besides the model param-
eters, the hyper-parameters of the model, e.g., number of estimators, maximal depth of
the trees or the random state were optimized during validation. This was done using grid
search and yielded the following results: number of estimators = 300, maximum depth
= 5. Thereby, it is crucial to fix the hyper parameters before unblinding the test dataset
to avoid information leakage, which can lead to overfitting on the test set. Finally, the
multivariate model is fixed and deployed on the independent test data. Note, that no
changes are made to the model at this point and no ground truth information of the test
data has been used during previous model development. For further enhancement of the
predictions, an ensemble of 100 Random Forests is trained each using di↵erently shu✏ed
subsample splits of the training set during cross-validation. The final prediction for each
patient is then given by the average over the predictions of all 100 models.
4.3.2. Cardiac Disease Classification on MRI
Segmentation of Cardiac Structures
For the fist step, the segmentation of cardiac target structures, we resample all volumes
to 1.25⇥ 1.25⇥ 10mm per voxel (for 3D UNet and feature extraction) and 1.25⇥ 1.25⇥
Z
orig
mm per voxel (for 2D UNet) to account for varying spatial resolutions. The grey
level information of every image was normalized to zero-mean and unit-variance. We
tackle the segmentation using an ensemble of modified 2D and 3D UNets [108, 150] (see
Section 3.3). We carefully adapted the architecture to cope with specific challenges of
CMRI: Due to low z-resolution of the input, pooling and upscaling operations are carried
out only in the x-y-plane. Context in the z-dimension is solely aggregated through the
3D convolutions. Each feature extraction block consists of two padded 3 ⇥ 3 ⇥ 3 con-
volutions, followed by batch normalization and a leaky ReLU nonlinearity. Due to the
shallow nature of the network (18 layers) no residual connections are utilized. The initial
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number of 26 feature maps is doubled (halved) with each of the 4 pooling (upscaling)
operations, resulting in a maximum of 416 feature maps at the bottom of the U-shape.
Deep supervision (as in [151]) is implemented by generating low resolution segmentation
outputs via 1⇥ 1⇥ 1 convolutions before each of the last two upscaling operations, which
are upscaled and aggregated for the final segmentation.
The 3D model was trained for 300 epochs in a 5-fold cross validation using the ADAM
solver and a pixel-wise categorical cross-entropy loss. The initial learning rate of 5 · 10 4
was decayed by 0.98 per epoch, where an epoch was defined as 100 batches, each com-
prising four training examples. Training examples were generated as random crops of size
224⇥ 224⇥ 10 taken from randomly chosen training cases and phase instances (ED/ES).
The 2D model’s architecture is equivalent to the 3D approach except for 2D convolutions.
Due to the lower memory requirements, we increased the number of initial feature maps
to 48. The network is trained with a batch size of 10 and input patches of size 352⇥ 352





















where u is the softmax output of the network and v denotes a one hot encoding of the
ground truth segmentation map. Both u and v are of size i⇥ k with i being the number
of pixels in the training patch and k 2 K being the classes. To accomplish the training of
a well generalizing model on limited data, we used a broad range of data augmentation
techniques, such as mirroring along the x and y axes, random rotations, gamma-correction
and elastic deformations. Due to the low z-resolution all data augmentation was performed
only in the x-y-plane. To account for the presence of slice misalignments, we artificially
increased the number of misaligned slices by motion augmentation for the training of the
3D model: All slices within the training batch were perturbed with a probability of 10%
and a random o↵set drawn from N (0, 20). To obtain the final segmentations, softmax
outputs of both networks were resampled to the original voxel resolution of the input
image and then averaged.
Feature Extraction
We extract two sets of features from the previously segmented structures to perform
disease classification. All features were designed to quantify the traditional assessment
procedures of expert cardiologists by describing static and dynamic properties of the
structures of interest (see Table 4.1).
Instant features Extracted from the two labeled ED and ES time instants as provided by
the ACDC dataset, these features cover local and global shape information (circumfer-
ence, circularity, LVM thickness, etc.), local variations (size of RVC at the apex, LVM
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Figure 4.5.: Time-series segmentation of cardiac structures on cine-MRI. Time-series
segmentation for RVC (red), LVM (green), LVC (blue) and their corresponding
volume dynamics. The example shows the central slice in z direction of a healthy
patient (NOR).
thickness between RVC and LVC), simple texture descriptors (mass) as well as additional
meta information (body mass index, weight, height). Notably, all thicknesses, circumfer-
ences and circularities are computed on the individual x-y-planes and aggregated over the
z-dimension. The body surface is estimated from weight and height using the Mosteller
formula.
Dynamic volume features We deployed the trained segmentation model to predict the
anatomical structures in all time steps of the CMRI (see Figure 4.5). This allows for
exploitation of volume dynamics throughout the entire cardiac cycle independent of the
predefined ED/ES. These volume dynamics are quantified in form of first order statistics
(median, standard deviation, kurtosis, skewness) complemented by characteristics of the
cardiac cycle’s minimum and maximum volumes: We found the time instants of these
extrema to not match the predefined ED/ES instants in the majority of patients. This
finding is accounted for by computing volume, volume ratios and ejection fractions based
on the determined actual minimum (v
min
) and maximum (v
max
) volume of the cardiac
cycle. Finally, the synchrony of contraction between LVC and RVC is measured in form






The features described in section 4.3.2 were used to train an ensemble of 50 Multilayer
Perceptron (MLP)s and a Random Forest for pathology classification. The MLP’s ar-
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Table 4.1.: List of extracted features for cardiag diagnosis task. The two sets of features
extracted for disease classification and the corresponding cardiovascular structure
(RVC, LVM, LVC). All instant features (except for additional patient information)
are extracted on both ED and ES.
*this feature was calculated in the x-y-plane and aggregated over slices in z.
** v
min,LVM
was determined at t(v
min,LVC
).





std thickness of LVM between LVC and RVC⇤
mean thickness of LVM between LVC and RVC⇤
mean circularity⇤ x x
max circumference⇤ x x
mean circumference⇤ x x
RVC size at most apical LVM slice⇤
RVC to LVC size ratio at most apical LVM slice⇤




patient body mass index







dynamic ejection fraction x x⇤⇤ x
volume median x x x
volume kurtosis x x x
volume skewness x x x























chitecture consists of four hidden layers, each containing 32 units, followed by batch
normalization, leaky ReLU nonlinearity and a Gaussian noise layer (  = 0.1). Each MLP
was trained on a random subset of 75% of the training data, while the remaining 25% were
used for epoch selection. Further regularization was provoked by only presenting a ran-
dom subset of 2/3 of the features to each MLP. We trained all MLP for 400 epochs (with
a patience of 40 epochs) using the ADAM solver with an initial learning rate of 5 · 10 4,
decayed by 0.97 per epoch. An epoch was defined as a set of 50 batches containing 20
patients each. Additionally, we trained a random forest with 1000 trees. During testing,
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the softmax outputs of all MLPs were averaged to obtain an overall MLP score, which
was averaged subsequently with the random forest output to obtain the final ensemble
prediction.
4.4. Results
4.4.1. Breast Lesion Classification on DWI
Evaluation metrics
Since this study is intended to enter the clinical workflow as a follow-up on mammography,
we are interested in decreasing the number of false-positive decisions, while not producing
new false-negative results. Hence, we choose our sensitivity working point, such that a
sensitivity of at least 98% is retained, with the aim of providing sensitivity that is com-
parable to that of core-needle biopsy, for which sensitivities ranging from 87% to greater
than 97% have been reported [152, 153, 154, 155, 156]. Subsequently, this threshold is
applied to the test set to evaluate the quality of decisions. In case a lesion contained
too few voxels (< 4) for Radiomics analysis, the associated prediction was automatically
set to be malignant. If no lesion was observed on the raw images during annotation, the
sample was predicted to be benign. Di↵erences in performance were evaluated by com-
paring the AUC using the method of DeLong et al. [157]. Since this study focuses on the
clinically relevant section of the AUC where the sensitivity was predefined to exceed 98%,
a pAUC is evaluated in a bootstrapping approach. Di↵erences in specificity are evaluated
by means of the McNemar test. The model was additionally evaluated at the sensitivity
and specificity thresholds of a radiologist’s performance, who given the full protocol, i.e.
additional MRI modalities including contrast enhancement.
Feature importance
Table 4.2 shows a ranking of the 20 most important Radiomics features determined as the
mean decrease in impurity, which calculates feature importance as the sum over the num-
ber of tree splits (across all tress) that include the feature, proportionally to the number
of samples it splits. Advanced features based on texture or shape were shown to be less
meaningful for the classification than simple first-order statistics.
Statistical Analysis
The thresholds applied on voxel coe cients resulting from DKI reduced the median num-
ber of voxels per lesion by 36.6%. However, because of a heterogeneous distribution of
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Table 4.2.: Radiomics Features Ranked by the Mean Decrease in Impurity of the
Random Forest. Further description of Radiomics features can be found in Ap-
pendix C. Data in parentheses are number of discrete grey values. N, L, V correspond
to di↵erent wavelet transformations (N = no transformation). RMS denotes Root
Mean Square, co-occ denotes co-occurrence
Table 4.3.: Final results of evaluation comparing the radiomics model to the univari-
ate Parameters in the independent test set. Data in parentheses are 95%
confidence intervals (CIs), and data in brackets are numerators and denominators.
Partial AUC is with sensitivity set to at least 98%. All P values are reported with
respect to the corresponding radiomics performance. NA denotes ”not available”.
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Figure 4.6.: Receiver Operating Characteristic Curve for the Radiomics model, AKC
median and ADC median. Dots illustrate the working points resulting from the
applied sensitivity threshold   98%.
excluded voxels within the lesions, the overall lesion sizes were reduced only marginally. To
compare the performance of the radiomics analysis to univariate quantitative assessment,
we studied the medians of the fit output parameters computed in every individual ROI
on the independent test set (ADC median and AKC median). Table 4.3 shows that the
Radiomics model performs best (AUC 0.911; 95% confidence interval [CI]: 0.861, 0.962) in
comparison with the ADC median (0.841; 95% CI: 0.772, 0.910) and AKC median (0.874;
95% CI: 0.813, 0.936). For the full AUC analysis, this di↵erence was only significant
when Radiomics was compared to ADCs (P < 0.001). In the clinically relevant section
of the AUC (pAUC), Radiomics performed significantly better than both univariate ap-
proaches (Radiomics versus AKC: P = 0.02, radiomics versus ADC: P < 0.001). Figure
4.6 visualizes these results.
Applying the decision rule of sensitivity   0.98 on the training set, i.e. choosing a work-
ing point on the ROC, yields the threshold value t
c
= 0.46 on the Random Forest output
to di↵erentiate between benign and malignant lesions. Sensitivity and specificity val-
ues resulting from deploying t
c
on the test set are shown in Table 4.3. The Radiomics
model reduced the amount of false positive findings from 66 to 20 (specificity 0.697 [46
of 66]) while only one true positive result was missed (sensitivity 0.984 [60 of 61]). In
the comparison of specificity values at equal sensitivity values, the Radiomics approach
showed significant superiority with respect to ADC (0.485, P < 0.001) and AKC (0.530,
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Table 4.4.: Results of standard ADC Fit and Subsequent Radiomics Analysis on the
Independent Test Set. Data are percentages with 95% CIs in brackets and nu-
merators/denominators in parentheses. All P values are reported with respect to the
corresponding Radiomics performance. Abbreviations: AUC = area under the curve,
se = sensitivity, sADC = standard ADC
P = 0.02). Evaluation of the diagnostic performance of an experienced breast radiologist
who used the full diagnostic protocol (including the contrast-enhanced MR imaging se-
quences) on the test set revealed a sensitivity of 0.918 (56 of 61) and specificity of 0.742
(49 of 66). To provide a comparison to the Radiomics model, we adjusted the working
point of the Radiomics model by either setting the specificity or the sensitivity identical
to the radiologist. The Radiomics model provided identical diagnostic indexes for the
identical sensitivity (resulting specificity, 74.2% [49 of 66]) and specificity (resulting sen-
sitivity, 91.8% [56 of 61]) compared to the radiologist. As expected, BI-RADS 5 lesions
had a much higher malignancy rate in the test set (95.8% [23 of 24]) when compared
with BI-RADS 4a and 4b lesions (36.9%, [38 of 103]). Analysis of the Radiomics model
shows that all clarified false-positive results were BIRADS 4a or 4b and the single benign
lesion, which was wrongly categorized as BI-RADS 5 in previous mammography, was not
identified correctly. Details on the sensitivity and specificity of the Radiomics model for
each subgroup are demonstrated in Table 4.3. To evaluate the e↵ect of the proposed fat
suppression factor ✓(b), we repeated the Radiomics analysis while setting ✓(b) = 0. We
found a significant performance loss when taking out ✓(b), for AUC (0.845; 95% CI: 0.780,
0.911; P = 0.001) and specificity (51.5% [34 of 66]; P < 0.001). We also compared our
model to the performance of a standard ADC fit (as opposed to DKI), which is obtained
by setting AKC=0 in equation 4.1, in order to evaluate the benefits of the AKC.
We observe slightly better performance for standard ADC compared to DKI, but a large
decrease in performance when utilizing it as input for the radiomics analysis (see Table
4.4).
To isolate the credit for improvement to the model itself rather than entangled with the
benefits of DWI compared to mammography, we tested if reported significance tests still
hold when manual predictions for invisible lesions (two in the training set and 21 on the
test set) were excluded from the analysis. Table 4.5 shows that all reported significances
still hold. As expected, specificity and accuracy decreased with all methods because of the
proportional increase of misclassified lesions in the dataset. The Radiomics model yields
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Table 4.5.: Final Results when Omitting Nonvisible Lesions Comparing Performances
of the Test Set to Cross Validation Results. Data are percentages with 95% CIs
in brackets and numerators/denominators in parentheses. All P values are reported
with respect to the corresponding Radiomics performance. Abbreviations: AUC =
area under the curve, se = sensitivity
an AUC of 0.87 (95% CI: 0.79, 0.94) with sensitivity of 0.984 (60 of 61) and specificity
of 0.556 (25 of 45). In order to assess the dependency of results on human noise induced
in the ROI annotation process (”inter-reader variability”), we deployed the Radiomics
model on a test set with alternative ROIs manually segmented by a second reader. No
significant changes were observed, only a marginal improvement in AUC (0.918; 95% CI:
0.870, 0.910) and slightly higher sensitivity of 100% [61 of 61] at equal specificity (69.7%
[46 of 66]).
4.4.2. Cardiac Disease Classification on MRI
We trained the classification ensemble on the ACDC training data using the features
described in Section 4.3.2. In a five fold cross-validation, a classification accuracy of 94%
was achieved. The individual performance of the MLP ensemble and Random Forest
were 93% and 92%, respectively. The test set accuracy was 92%. Confusion matrices are
provided in Figure 4.7, indicating equal perfomance among classes in the cross-validation,
and di culties in distinguishing DCM from MINF patients on the test set. Feature
computation took 15 s for instant features and less than one second for the dynamic
volume features.
4.5. Discussion
We presented a machine learning model based on Radiomics features extracted from Dif-
fusion Kurtosis Imaging of microstructural breast tissue that reduces false positive results
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Figure 4.7.: Cross validation and test set results for classification task of cardiac di-
agnosis competition. Confusion matrices of the ensemble predictions from cross-
validation on the training set (left) and on the test set (right). Rows correspond to
the predicted class and columns to the target class, respectively.
by 70% in lesions classified as BI-RADS 4 or 5 at screening mammography while retaining
sensitivity greater than 98%. Our model was evaluated on an independent test set with
di↵ering MR imaging machines from a separate study sites in order to simulate clinical
application. We achieve human-level performance on an independent test set comprising
images from a di↵erent clinical site acquired from a di↵erent scanner, when comparing
to a radiologist that was allowed to consult the full imaging protocol including contrast-
enhanced sequences. When ranking all features extracted with Radiomics, we found that
advanced features based on texture or shape were less significant for classification than
simple first-order statistics. This was presumably due to the relatively small regions of
interest in our datasets (median size: 21 voxels) and indicates the utilized dataset as a
di cult setup for Radiomics, since a significant amount of the associated features de-
scribes non-local voxel dependencies. Sun et al. [87] reported higher AUCs of 0.974 for
AKC compared to our results. However, their study was performed on a dataset with-
out independent validation and with predominately large lesions (benign: 1.9 cm ±1.0,
malignant: 2.4 cm ±1.0) as opposed to our dataset (see Table B.2). Furthermore, their
ratio of DCIS, which are notoriously hard to categorize based on imaging, was relatively
low (8.8%, [5 / 57]) compared to our dataset (22.9%, [14 of 61], see Table B.1). Since
DWI of the breast is challenged by high tissue heterogeneity with intermittent fat and
glandular tissue, we enhanced current kurtosis fitting strategies by introducing a fat tissue
correction term, ✓(b), in analogy to the air volume correction term suggested by Jensen et
al. [51]. In comparison to standard kurtosis, this adjusted model significantly improved
di↵erentiation between malignant and benign lesions. In the independent test set of 127
women, the Radiomics analysis allowed 70% (46 of 66) of the false-positive findings to
be detected by means of noninvasive imaging, while retaining sensitivity of 98.4% (60
of 61) for malignant lesions. This is similar to the reduction of false-positive results as
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reported for full contrast-enhanced MR mammography when added to BI-RADS 4 lesions
detected with other imaging modalities [158]. In comparison with full contrast-enhanced
MR imaging mammography, however, the approach as presented here might be of special
value, because no gadolinium based contrast agents must be given to patients, thus re-
ducing the risk of adverse e↵ects and costs for the examination [159]. Costs might be a
further aspect to be considered, because acquisition time for the DWI sequence used for
the kurtosis fitting was less than 7 minutes, allowing for an increased number of patients
examined with the method as previously suggested for DWI sequences [85]. This study
has several limitations: The model depends on the quality of manual segmentation, thus
lesions that were incorrectly segmented, either because of the limited experience of the
reader or because of limited visibility on the images, could be missed in malignancy clas-
sification. Inter-reader variability was assessed by deploying the fixed Radiomics analysis
model on the test set, with alternative regions of interest manually segmented by an in-
dependent reader, demonstrating similar diagnostic performance, and further indicating
the robustness of the model. Some lesions considered benign with the approach were
classified as benign because of their non-visibility on DWI, thus the incremental benefit
of the Kurtosis model was not only due to the Radiomics analysis but also to the under-
lying DWI sequence, which must be considered when interpreting our results. We also
showed, however, that results of all applied significance tests remained significant when
non-visible lesions were excluded from the analyses. The rate of malignant lesions can
be considered atypical, with more malignant lesions than expected in clinical practice on
the test set for the BI-RADS subgroups. However, the values of sensitivity and speci-
ficity did not decrease on the test set. Another limitation is that the choice of ✓ may
not have correctly reflected the fat signal intensity fractions in the actual lesion regions
of interest. Indeed, it is very challenging to correctly obtain fat signal intensity fractions
in each single voxel with MR imaging artifacts spreading the fat signal in di↵erent areas.
The improved performance for di↵erentiating benign and malignant lesions by using our
choice of ✓ seems to confirm that this was a first step in the right direction to account for
residual fat signal intensity. In conclusion, a radiomics breast cancer model based on DWI
with adapted kurtosis fitting allowed for improved di↵erentiation between malignant and
benign breast lesions in both training and independent test datasets acquired by using
MR imaging machines from di↵erent vendors at di↵erent institutions. Our results sup-
port further evaluation of the use of optimized Di↵usion Weighted Magentic Resonance
Imaging (DWI) with multivariate analysis based on Radiomics features to di↵erentiate
between malignant and benign breast lesions.
We further presented a fully automatic processing pipeline for Cardiac Disease Classi-
fication on MRI. There, we started by developing an accurate multistructure segmen-
tation method trained solely on ED and ES phase instances, but capable of processing
the entire cardiac cycle. Our approach revolves around the use of both a 2D and 3D
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model, leveraging their respective advantages through ensembling. The resulting pipeline
is robust against slice misalignments, di↵erent CMRI protocols as well as various patholo-
gies. We achieved the first place in the segmentation part of the challenge. Based on the
segmentations generated by our model, geometrical features are extracted and utilized
by an ensemble of classifiers to predict the diagnosis, yielding promising outcomes. We
ranked second in the classification part of the challenge with an accuracy of 92% [34]. Our
fully automatic processing pipeline constitutes an attractive software for clinical decision
support due to the visualization of intermediate segmentation maps, the comprehensive
quantification of cardiologic assessment and the rapid processing speed of less than 40 s.
Possible future improvements of the model concern data augmentation and the architec-
ture of the segmentation network as well as a regularization objective as used in [160].
Given continuously growing datasets, training the cardiac diagnosis task directly on the
raw images might soon be feasible and surpass the performance of the presented multi-step
pipeline following the premise of end-to-end learning.
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5. Medical Image Classification based on
Learned Representations
We further follow the dogma of end-to-end learning, i.e. the idea that enabling simulta-
neous optimization of all pipeline components with respect to the ultimate clinical target
improves upon compound rule-based diagnosis pipelines. To this end, we substitute the
handcrafted feature extraction (Radiomics) deployed in Chapter 4 by a learning algorithm
allowing to learn representations directly on crops of annotated Regions of Interest in the
images (”Roi-to-end”, see Section 3.2). The presented study showcases this approach by
means of breast lesion classification on DWI. Thus, a second focus of this chapter is set
on further integrating the biophysical model applied for image normalization in DWI (see
Section 2.1.1) into the learning algorithm and study the potential hidden in operating
on the raw Di↵usion Weighted Magentic Resonance Imaging (DWI) signal as opposed to
operating on ADC or AKC maps. The main contributions in this chapter are:
• We propose a Convolutional Neural Network (CNN) architecture designed to inte-
grate the biophysical model for image normalization, handcrafted feature extraction
as well as clinical categorization, so as to enable ROI-based classification of breast
lesions on DWI [35].
• We reveal potential hidden in DWI by demonstrating the benefits of learned image
normalizations as compared to the biophysical model currently deployed in clinical
research.
• We provide results indicating a complementary value of representations learned in
the CNN with respect to handcrafted feature extraction [36].
The parts of this chapter regarding evaluation of learning DWI image normalization model
were presented at MICCAI 2017 and published in the respective proceedings [35]. The
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comparison against Radiomics was presented at the annual meeting of the International
Society for Magnetic Resonance Imaging in Medicine (ISMRM) and is available at [36].
5.1. Problem statement
In DWI, the signal behavior at di↵erent di↵usion gradients is quantitatively characterized
by fitting biophysical models to the signal and inferring apparent tissue properties from
them (see Section 2.1.1). The state of the art method in breast cancer DWI is DKI, where
the ADC and AKC are extracted representing Gaussian and non-Gaussian di↵usion, re-
spectively [51, 50]. Using DKI, state of the art results for breast lesion classification have
been reported recently [161, 87]. Methods relying on biophysical models for image nor-
malization, however, are simplified approaches to physical processes, making them prone
to partial information loss and dependent on explicit prior physical knowledge resulting
in potential fitting instabilities and limited generalization abilities. These shortcomings
have led to an emergence of a broad spectrum of signal and noise models designed under
di↵erent assumptions. Recent studies in brain imaging have shown how deep learning
can circumvent some of the disadvantages related to classical model-based approaches
in di↵usion MRI data processing [162, 163, 164, 165]. However, the currently existing
learning-based approaches cannot be more knowledgeable since they utilize the classical
model-based approach as ground truth during training. Thus, the performance of exist-
ing model-free approaches is currently sealed, and the main benefit of machine learning
application in this domain so far was found in the reduction of requirements on the input
data side, e.g. saving acquisition time.
In this study, we show in a first clinical scenario how model-free di↵usion MRI can be
integrated into a deep learning algorithm, thus directly relating clinical information to
the raw input signal. By backpropagating this information through an integrative CNN
architecture, simultaneous and target-specific optimization of image normalization, signal
exploitation, representation learning and classification is achieved.
5.2. Utilized Dataset
The dataset is identical to the one in Section 4.2. However, as this project represents
a shift towards methodological research compared to the approach from Chapter 4, we
prioritized the number of training cases over the clinically interesting aspect of testing
under a input domain shift. Thus, we opted for mixing patients from both study sites
into one dataset and run evaluation in a nested cross-validation over all cases (details on




The recently proposed q-space Deep Learning method [162] uses neural networks to imitate
model-based approaches like DKI by training them on model-derived parameters, i.e. the
networks are trained to imitate the biophysical models. In contrast to that method, we
aim to replace the model-based approaches by not using any model-related parameters
as training target. Instead we train our approach directly on targeted clinical decision.
By integrating the data processing pipeline from annotated ROI to clinical decision into
a CNN, this valuable information is backpropagated through the network optimizing all
pipeline components on the specific clinical task. This enables our approach to yield
performances beyond model-based methods. The proposed architecture consists of four
modules:
Input and Image Normalization Module The proposed CNN architecture is devel-
oped to operate directly on the di↵usion-weighted images as input, where each of the four
b-value images is assigned to a corresponding input channel of the network. For the task
of lesion classification every image is cropped to a bounding box around the segmented
ROI and voxels outside of the ROI are set to 0. Intensity calibration over the data cohort
can be essential when working with raw MRI signal intensities. To facilitate this step, we
measure the mean signal intensity of an additional ROI placed in a fat area of a breast
in each image. The measured value is arrayed to match the shape of the corresponding
lesion ROI and provided to the CNN as a fat intensity map in an additional input channel.
Note, that this method corresponds to the calibration vector ✓ introduced in Section 4.3.1.
Signal Exploitation Module This CNN component is designed to mimic the biophysical
model fit. The input is processed by layers of 1x1 convolutions, which only convolve the
signals in each separate voxel across the input channels. This method is equivalent to
applying an independent multilayer perceptron to each voxel, like it is done in q-space
Deep Learning, i.e it enables the network to exploit the information contained in the
di↵erently weighted signals for independent voxels. The additional input channel for
image normalization extends the set of di↵erently weighted signals in every voxel by the
corresponding value of the fat intensity map, thus transferring normalizing information
about the image into all 1x1 convolutions. Three layers of 1x1 convolutions are applied
transforming the input data into 512 feature maps. In analogy to model-based di↵usion
coe cients, we term these representations Deep Di↵usion Coe cient (DDC), where each
of the 512 feature maps corresponds to one coe cient.
Representation Learning Module Feature extraction is an integral part of the diagno-
sis pipeline. While in Chapter 4 we replaced the clinical practice of computing median as
a single feature by large scale Radiomics feature extraction, we now follow the dogma of
end-to-end learning and integrate this component into the CNN by means of a represen-
tation learning module (see Chapter 3.2). To this end, the DDC maps from the previous
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Signal Exploitation Module are processed by two blocks of three 3⇥ 3 convolutional lay-
ers, while downsampling the input sizes between the blocks using 2⇥ 2 max pooling. In
principal, this component can be repeated arbitrarily often, but is limited in the case of
lesion classification by the relatively small input sizes of the ROIs.
Binary Classification Module The final convolutional layer containing the learned
representations in form of feature maps is followed by a global average pooling layer,
which aggregates the representations by transforming each feature map into a single mean
value. Note, that this all convolutional architecture allows for variable input sizes by
avoiding any classical dense layers [103], which we exploit by processing ROIs of di↵erent
sizes through the same network. The output is a vector with the length of the number
of feature maps containing the representations. This feature vector is used as input
for a softmax layer transforming the features into class probabilities, which the binary
classification is performed on using a categorical cross entropy loss function. By training
the proposed network architecture in an ”Roi-to-end” fashion, image calibration, signal
exploitation and representations are learned simultaneously and optimized directly for the
classification problem.
5.4. Experimental Setup
Designing an appropriate experimental setup is crucial in this study, in order to be able to
assign credit for experimental results to the correct modifications of the diagnosis pipeline.
To investigate the potential improvement of the proposed approach for clinical decision
making, a two step evaluation is performed. First, the performance of model-free signal
exploitation is assessed by a DDC-score against the means of the model-based coe cients
ADC and AKC. The DDC-score is generated by applying global average pooling directly
on the 512 DDC feature maps and running a linear classifier on top of the resulting
512-dimensional vector to obtain a single scalar score. In a second experiment, the Roi-
to-end (R2E) approach, i.e. the simultaneous optimization of all DWI data processing
components, is evaluated by comparing it against a model-based CNN method. For this
benchmark, the R2E architecture is modified by feeding parametric maps of ADC and
AKC into the representation module instead of the learned DDC feature maps. For
simplicity, the benchmark method is referred to as the Fit-to-end method (F2E). All
experimental setups and the detailed network architecture are shown in Figure 5.1.
Training Details
Experiments were run using 10-fold cross validation (CV) with 80% training data, 10%
validation data, and 10% inner loop test data, where the validation data was used for
hyper parameter search and the corresponding loss as a stopping criterion. Batches were
generated by randomly sampling 25 slices of each target class. The size of the input layer
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Figure 5.1.: Proposed CNN Architecture and Experimental Setup. Detailed network
architecture for the di↵erent experimental setups explored in this paper. All con-
volutional layers are followed by ReLU activation functions. The 5 input channels
receive the di↵usion-weighted images at four b-values plus the fat intensity map.
R2E is the proposed ent-to-end Convolutional Neural Network (CNN) (not count-
ing the reliance on manual lesion localization in form of ROI annotations.), F2E is
the fit-to-end baseline, where a CNN is run on the output of the biophysical model
fit parameters. DDC denotes a linear classifier run directly on top of the learned
signal fit outputs, the Deep Di↵usion Coe cient (DDC). ADC and AKC are me-
dians over the respective coe cient maps resulting from the biophysical model fit
turned into univariate decision rules as applied in clinical practice.
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was chosen according to the size of the largest lesion in the batch, while zero padding
the smaller lesions. Note, that this method results in batches of variable shape, which
is accounted for by the model’s all convolutional architecture. All images were masked
according to the segmented lesion, i.e. voxels outside the ROI were set to 0. Data
augmentation was performed batch-wise by randomly mirroring or rotating. Dropout
was applied to all convolutional layers with p = 0.5. The learning rate was initialized at
lr = 0.0005 and decreased each epoch by a factor 0.985. The model was trained using
categorical cross-entropy loss over 12 epochs, processing 100 batches per epoch. Inference
was done by processing each slice j of a patient i individually and weighting the obtained
predictions p
i,j
with the number of voxels v
i,j
in the slice against the overall number of















An ensemble of fifteen networks was trained for each fold of the CV and the resulting p
i
for one patient were averaged for the final ensemble prediction.
Statistical Evaluation
Models were compared by evaluating the AUC on the test set. The decision threshold t
c
was chosen at sensitivity = 0.96. This relatively high threshold matches the sensitivity of
core-needle biopsy as reported in literature [154], thus ensuring the integrative character
of DWI as a follow-up study of mammography. The resulting specificities at t
c
, i.e. the
percentage of removed false positives from the test set, were tested for significance using
the McNemar-Test. Note, that statistics were calculated across all CV folds, i.e. test set
predictions of each fold were collected and fused to a final test set containing all patients.
5.5. Results
Table 5.1 shows a comparison among all methods explored in this study. On the studied
dataset with 100 benign lesions (false positive mammographic findings) and 122 malignant
lesions (true positive mammographic findings), the decision threshold is set for all methods
to a sensitivity of 0.967, which corresponds to correctly identifying 118 out of the 122 true
positives. The R2E approach shows best performances with an accuracy of 0.815±0.0260
and a specificity at t
c
of 0.630± 0.0480, correctly identifying 63 of the 100 false-positives.
This significantly (p-value < 0.01) improves the clinical decisions with respect to the F2E
method, which has an accuracy of 0.743± 0.0292 and a specificity at t
c
of 0.470± 0.0496,
correctly identifying 47 of the 100 false-positives. Comparing classification performances
of the coe cients without additional representation learning, the DDC show the highest





Table 5.1.: TestData Results of the CNN for Lesion Classification Including All Meth-
ods Explored in this Study. AUC denotes Area Under the Receiver Operating
Characetristic Curve, Spec. denotes specificity, Sens. denotes sensitivity, and t
c
de-
notes the threshold value on the output softmax probability. R2E is the proposed
ent-to-end Convolutional Neural Network (CNN) (not counting the reliance on man-
ual lesion localization in form of ROI annotations.), F2E is the fit-to-end baseline,
where a CNN is run on the output of the biophysical model fit parameters. DDC is
a linear classifier run directly on top of the learned signal fit outputs, the Deep Dif-
fusion Coe cient (DDC). ADC and AKC are medians over the respective coe cient
maps resulting from the biophysical model fit turned into univariate decision rules
as applied in clinical practice.




R2E 0.907± 0.038 0.630± 0.048 (0.967)   0.40
F2E 0.886± 0.043 0.470± 0.050 (0.967)   0.34
DDC 0.868± 0.043 0.530± 0.050 (0.967)   0.29
ADC 0.827± 0.056 0.450± 0.050 (0.967)  1.83
AKC 0.799± 0.056 0.450± 0.050 (0.967)   0.85
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Table 5.2.: Test Data Results of the CNN vs. Radiomics study on Breast Lesion
Classification. CNN corresponds to the proposed Roi-to-end Convolutional Neural
Network (CNN) identical to R2E in Table 5.1. Radiomics denotes the pipeline from
Chapter 4, where a Random Forest is trained on top of Radiomics features extracted
from the DKI model. Ensemble denotes the ensemble of the two.




Ensemble 0.927± 0.032 0.690± 0.048 (0.967)   0.42
CNN (R2E) 0.907± 0.038 0.630± 0.048 (0.967)   0.40
Radiomics 0.905± 0.041 0.600± 0.048 (0.967)   0.33
the model-based coe cients ADC and AKC, which both show an accuracy of 0.734±0.0295




While the previous experiments focus on revealing potentials sealed by the biophysical
model fit by means of a CNN (corresponding to R2E in Table 5.1), the question remains as
to whether the introduction of representation learning into the model yields performance
superior to the handcrafted Radiomics feature extraction such as in Chapter 4. While
theory suggests, that feasibility of learning representations scales with the amount of
provided training data, in contrast to a fix set of measurements such as in Radiomics,
it is unclear whether the dataset utilized in this study is su ciently large in order to
observe the expected e↵ects. Further, we are interested in whether the representations
learned from the task-specific data contain complementary value over the handcrafted set
of task-agnostic measurements. The Radiomics pipeline is identical to the one in Section
4.3.1, i.e. a Random Forest trained on top of Radiomics features extracted from the DKI
model, except for retraining on the updated train test splits described in Section 5.2. In
order to study the complementary value of learned representations, we compare against
an ensemble of CNN and Radiomics, where we train the two methods separately and
subsequently average the two corresponding output scores for each patient. Results are
shown in Table 5.2. Output histograms of all compared methods are shown in Figure 5.2
and ROC curves are shown in Figure 5.3. Both in AUC and in specificity at a predefined
cut-o↵ sensitivity > 96%, the ensemble performed superior to Radiomics and CNN. On
the same metrics, no significant di↵erences were found between Radiomcis and CNN,
however, at low sensitivities (0   50%) the CNN showed higher separation power than
Radiomics, while at a sensitivity spectrum of 80  90%, separation power was lower.
56
5.5. Results
Figure 5.2.: Output Histograms of CNN vs. Radiomics Experiments. Output his-
tograms of Radiomics (rad), the CNN (=R2E) and the ensemble of the two (ens)
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Figure 5.3.: ROC curve for CNN vs. Radiomics Experiments. ROC curve displaying
sensitivity (true positive rate) over 1-specificity (false positive rate) for Radiomics




This study’s results show that our CNN approach significantly improves clinical decision
making compared to the current clinical state of the art of fitting biophysical models to
the data. We first demonstrate, how data-driven signal exploitation in DWI, i.e. our
learned Deep Di↵usion Coe cient (DDC), outperforms the current model-based methods
and show in a second step how this approach can be integrated into a CNN architecture.
On the dataset of breast DWI, the Roi-to-end training is able to prevent an additional 16
out of 100 women from overdiagnosis with respect to the benchmark method, where we
trained a CNN on top of model-based coe cients ADC or AKC. This benchmark aims
at a clear credit assignment for improvement of our approach to the data-driven signal
exploitation and its integrability to joint optimization. In contrast to recent data-driven
methods like q-space deep learning, which are trained to mimic model-related parame-
ters, our Roi-to-end training is optimized directly with respect to the targeted clinical
decision. This enables our approach to optimize all components of the data processing
pipeline simultaneously on a specific task, thus not being limited by model assumptions.
A limitation to our approach is the dependence on manual segmentation of lesions, which
will be addressed in Chapter 6. The multi-centric character of the utilized dataset hints
upon the generalization and normalization abilities of the method across di↵erent input
characteristics.
As for the comparison against the Radiomics approach from Chapter 4 (see Figure 4.1),
the performance di↵erences across sensitivity spectra indicate a complementary nature
of learned CNN representations w.r.t Radiomics features. This results in a considerably
superior performance for the ensembled model. The similar standalone performances of
CNN and Radiomics do not confirm the findings of previous studies conducted on mam-
mograms [166] and contrast enhanced MRI [167], where Radiomics outperformed CNN by
far. The irritating results in these studies might be related to the fact, that neither of the
two studies adapted the CNN architecture to the specific problem, but either used a large
fully connected model [166], which is prone to overfitting on small datasets, or deployed
an AlexNet pretrained on ImageNet for feature extraction [167]. The latter is a transfer
learning appraoch, which are subject to a controversial discussion in the field of medical
image analysis: There is strong evidence, that the domain gap between medical datasets
and natural iamge datasets such as ImageNet are too large in order for generalizing e↵ects
to occur such as aimed for with transfer learning [168]. Remarkably, the achieved AUC
performances of all explored models are superior to the respective models of the contrast
enhanced MRI study [167], which hints upon the great potential of DWI in breast imaging.
Possible reasons for the relative improvement of our CNN over Radiomics compared to
the mentioned studies are the Roi-to-end training from scratch, the adapted light-weight
network architecture, but also dataset specific properties hampering Radiomics perfor-
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mance on this dataset such as adversely impact of small lesion sizes to advanced feature
groups such as shape or texture. The fact that the CNN does not considerably outper-
form the Radiomics baseline hints upon the limited training data available in this study.
Following the premises of end-to-end learning, we expect the CNN performance to scale
with growing datasets and thus naturally outperform Radiomics baselines in the future.
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While the previous two chapters studied the potential of learning algorithms in clinical
diagnosis systems, one important part of the pipeline was not taken into account: The
localization of Regions of Interest (ROIs) in the image. The Random Forest model based
on Radiomics features presented in Chapter 4 as well as the CNN presented in Chapter 5
relied on previous manual annotation of lesions (or previous automated annotation of car-
diac structures in the case of cardiac diagnosis, see Section 4.1.2). This scenario, however,
fails to significantly alleviate the current workload related to human readout of medical
images, which is to a large extend assigned to location of ROIs [169]. Further, framing
localization as an extra step is not fully in line with the dogma of end-to-end learning,
meaning in this case localization is not part of the simultaneous optimization process with
respect to the ultimate clinical task of clinical diagnosis.
When including the task of localizing ROIs into the learning process to enable true end-
to-end diagnosis starting at the raw images, there are three current deep learning method-
ologies to be considered that attend to the problem at three di↵erent levels of granularity:
Whole Image classification for patient level decisions, object detection for object level
decisions, and semantic segmentation for pixel-level decisions (see Section 3.3). These
three levels of image classification translate to specific model evaluation metrics and in
return answer to di↵erent clinical questions. We identify a largely neglected predicament
between the strive for crossing the AI chasm by evaluating models at clinically relevant
scales on one side, and optimizing for e cient training under the burden of data scarcity
on the other side. The main contributions in this chapter are:
• We propose a deep learning model that enables end-to-end object detection and clas-
sification on medical images by aligning the model output to the clinically relevant
scale while maintaining data e cient training [37].
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• We provide an in-depth analysis of prevalent models from object detection, semantic
segmentation and instance segmentation operating in 2D as well as 3D by means of
comparative studies on Breast DWI, CT of the Lung and a series of toy experiments.
• We open source the Medical Detection Toolkit, the first comprehensive framework
for object detection on medical images including e.g. modular implementations of
all explored models operating in 2D and 3D [38].
• We apply our approach to the task of lung cancer staging on Positron Emission
Tomography - Computed Tomography (PET-CT) and perform a sensitivity study
under varying clinical training scenarios [39].
This work was presented as an oral at the Machine Learning for Health Workshop at
Neurips 2019 and is scheduled to be published in the Proceedings of Machine Learning
Research [37]. The associated code framework, the Medical Detection Toolkit, is available
at https://github.com/mic-dkfz/medicaldetectiontoolkit . The applied study on
Lung PET-CT was awarded a Research Seed Grant on behalf of the European Society of
Radiology and is currently in submission [39].
6.1. Problem Statement
When transforming raw images to clinical decisions, it is important to consider that there
exist three levels of granularity in classification of medical images. This section builds on
the introduction of the di↵erent levels provided in Section 3.3 and discusses the associated
implications for researchers and clinicians. Figure 6.1 visualizes the described setup and
is recommended to be followed along with the text.
While choosing the appropriate model type for a specific task might seem obvious by
simply following the classification scale of the associated clinical interest (such as de-
picted in Figure 3.1), in practice, this decision is distorted by nuisance factors such as
the scale of annotations in the provided training data. Since the three model groups are
defined by the scale of their output, the scale of associated training annotations is inher-
ent to the respective group. Thus, whole image classification is trained with single scalar
labels, object detectors is trained with bounding boxes and respective category scores,
and semantic segmentation models are trained with pixel-wise annotation maps. As a re-
sult, there exists a ranking in data e ciency between the three model types following the
spatial resolution of respective annotations: While pixel-wise annotations provide explicit
supervision for the task of localizing objects in images, bounding boxes only represent
rough location estimates, and scalar labels provide no spatial information and thus leave
the localization task implicitly to the learning process, which drastically increases the
amount of required training data (see Section 3.2).
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Figure 6.1.: Conflicts of Choosing a Level of Granularity for Classification in Medical
Images. This figure builds upon Figure 3.1 and visualizes the conflict between
research factors and clinical factors regarding the questions as to which classification
scale a task should be addressed at. While the clinical scale is directly derived
from a underlying medical interest, there are several nuisance factors influencing
the researcher’s decision such as available annotations and the associated impact
on data e ciency for the learning process. As a consequence, the clinical interest
is often ignored (red arrow), which leads to models being proposed in literature
that are evaluated with metrics operating on clinically irrelvant scales (see dashed
boxes tying evaluation metrics to clinical questions of the respective scale). A valid
workaround in the form of output aggregation, on the other hand, introduces brittle
aggregation heuristics (orange arrow) into otherwise end-to-end learning models.
References for model examples: AlexNet [98], VGG [99], ResNet [103], DenseNet
[104], Mask R-CNN [105], Retina Net [106], YOLO [107], U-Net [108], DeepLab
[109].
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Thus, incentives in end-to-end medical image classification are currently high to neglect
the clinical interest associated with a task and opt for models that are trained on the
highest resolution of available training annotations. In our experience, the most common
case of a discrepancy between clinical interest and model output scale are segmentation
algorithms proposed to address clinical questions at object-level. This observation is in
line with the overwhelming popularity of semantic segmentation methods in the biomed-
ical sector [170], which could be related to the fact that delineation of structures in 3D
images by radiologists is typically performed on the pixel-level resulting in a large ratio of
medical datasets with pixel-wise annotations. Examples for segmentation models applied
to object-level tasks can be found in the detection of prostate cancer [171, 172], lung
lesions [173, 174], breast cancer [175, 176, 177], liver tumors [178, 179, 173, 180], kidney
tumors [173], multiple sclerosis lesions [173], skin lesion [181], or angiodysplasia lesions
[182]. To stress the magnitude of this issue, all segmentation models operate and predict
on pixel-level, i.e. there is no inherent notion about the concept of objects such as lesion
or tumor, which means they are not able to answer questions regarding the existence,
location or category of these objects.
The resulting discrepancy of granularity levels in classification between research studies
and clinical interest is a vivid manifestation of the AI chasm [24] (as discussed in Chapter
1). While it is technically possible to aggregate model predictions to coarser levels during
clinical deployment, i.e. from pixel-level to object-level or from there to patient-level in
an additional post-processing step, this only superficially closes the gap, because model
evaluation and hence model selection lies in the past and hence remains on the finer scale
(see red arrow in Figure 6.1). Notably, each classification scale is tied to evaluation metrics
operating on the respective scale (see Appendix A). In this context, and as emphasized by
several studies recently, evaluation metrics represent the ”glue” that connects research to
future real life application and hence should be given the highest priority when designing
a research project and the corresponding model [27, 129, 130] (see dashed boxes in Figure
6.1). One valid strategy in order to circumvent the discrepancy of classification scales
accurately is to incorporate the aggregation of output predictions into the research study
and directly evaluate the model on the scale of clinical interest (see orange arrow in Fig-
ure 6.1). However, this additional post-processing step introduces ungraceful and brittle
heuristics into an otherwise end-to-end trained learning system. Figure 6.2 shows an ex-
emplary sketch of the ambiguous decisions faced when aggregating pixel-level predictions
to an object-level score. In this study, we put forward the hypothesis that learning to
predict objects end-to-end yields performance superior to ad hoc heuristics.
Taken all together, we identify a predicament between the strive for end-to-end object pre-
diction when answering to clinical questions at object-level, and the strive for exploitation
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Figure 6.2.: Aggregation of Pixel-level Predictions to Object-level score. This sketch is
targeted at visualizing the ambiguities faced when attempting to identify connected
components (i.e. objects) in a pixel map and assign respective object-level scores
(corresponding to the orange arrow in Figure 6.1). In this example, pixels have been
classified on a continues scale between foreground (i.e. ”belongs to lesion”, dark
blue) and background (light-blue). The continuous softmax outputs of individual
pixels shall now be aggregated to one lesion and given a respective lesion score. What
should the intensity threshold be to decide whether a pixel lies inside or outside of
the lesion, i.e. how should the connected component be identified? And as a second
step, what should the overall object score for this lesion be and how should it be
obtained? Assigning the highest value of lesion pixels as the lesion score might lead
to a bias towards false-positive predictions over the entire dataset, while assigning
the mean or median value across lesion pixels as the lesion score might lead to false
negatives. In this study, we hypothesize that there lies a considerable performance
gain in learning this process as part of an end-to-end model to circumvent the brittle
rule-based aggregation step.
65
6. End-to-end Medical Image Classification
of pixel-wise annotations enabling data e cient training thus alleviating the data burden
typically faced in medical imaging. When considering to work around this predicament
by aggregating pixel-wise predictions of segmentation models to object scores, we are left
with a trade-o↵ between diminished model robustness due to the introduction of brittle
rule-based post-processing, or diminished model robustness due to the transformation of
pixel-wise annotations to bounding boxes for object detection training.
This study demonstrates a straight-forward yet e↵ective strategy on how to convert avail-
able pixel-wise annotations into significant performance gains on object-level detection
tasks. To this end, we propose Retina U-Net, which is based on the plain one-stage de-
tector Retina Net [106] (see Section 3.3), complemented by architectural elements of the
U-Net, a very successful model for semantic segmentation of medical images [108] (see
Section 3.3). From an object detection perspective, the decoding part of Retina Net is
complemented by additional high resolution levels to learn the auxiliary task of semantic
segmentation and enable data e cient training by exploitation of pixel-wise annotations.
From a segmentation perspective, the proposed architecture retrofits the U-Net with two
sub-networks operating on coarser feature levels of the decoder part to allow for end-to-end
object scoring (and obviating the need for brittle heuristic post-processing). Regarding
the choice of a one-stage detector, we argue that the explicit scale invariance enforced
by the re-sampling operation in two-stage detectors is not helpful in the medical domain,
since unlike in natural images, where object scale is an artifact in form of varying distances
between object and camera, in medical images object scale encodes semantic information.
We demonstrate the e↵ectiveness of our model on the task of detecting and categorizing
lesions on two medical datasets and support our analysis by a series of toy experiments
that help shed light on the reasons behind the observed performance gains. Finally, we
apply Retina U-Net to the task of lung cancer staging on PET-CT data and study the
performance and failure cases under varying training scenarios.
6.2. Related Work
For background information on object detection methodology please see Section 3.3. Since
object detection in natural images is increasingly formulated as an instance segmentation
problem (see Section 3.3), several two-stage object detectors utilize additional instance-
based segmentation labels during training ([105, 183, 122]). However, we argue that this
setup does not fully exploit semantic segmentation supervision for the following reasons:
• The mask loss is only evaluated on cropped proposal regions, i.e. context gradients
of surrounding regions are not backpropagated.
• The proposal region as well as the ground truth mask are typically resampled to a
fixed-sized grid (known as RoIAlign ([105])).
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Figure 6.3.: Retina U-Net Architecture in 2D. From a Retina Net perspective we add pyra-
mid levels (i.e. feature maps) P0 and P1, so as to backpropagate rich training signals
from a full resolution pixel-wise loss into the feature pyramid network, thereby fa-
cilitating the learning process in coarser feature maps used for object detection.
From a U-Net perspective we enable end-to-end object detection via a head network
operating on the coarse pyramid levels P2-P5.
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• Only positive matched proposals are utilized for the mask loss, which induces a
dependency on the region proposition performance.
• Gradients of the mask loss do not flow through the entire model, but merely from
the corresponding pyramid level upwards.
Auxiliary tasks for exploiting semantic segmentation supervision have been applied in two
stage detectors with bottom-up feature extractors (i.e. encoders) [184, 185]. In the one-
stage domain, the work of [186] performs semantic segmentation on top of a single-shot
detection (SSD) architecture for instance segmentation, where segmentation outputs are
assigned to box proposals in a post-processing step. [187] propose a similar architecture,
but learn segmentation in a weakly-supervised manner, using pseudo-masks created from
bounding box annotations.
As opposed to bottom-up backbones for feature extraction, we follow the argumentation
of feature pyramid networks [188], where a top-down (i.e. decoder) pathway is installed
to allow for semantically rich representations at di↵erent scales. This concept is adapted
from state-of-the-art segmentation architectures [108, 189] and used in both current one-
and two-stage detectors. Recent approaches report to use semantic segmentation as an
auxiliary training signal, but apply it to lower resolution feature maps only [190, 191].
[192] learn semantic segmentation at full resolution, but down-sample all feature maps to
the bottleneck’s spatial resolution before feeding them to the detection module, thereby
discarding all multi-scale information in the detection task. In contrast, we propose a
one-stage detector based on a Feature Pyramid Network (FPN) performing semantic seg-
mentation on full resolution and object detection on multiple scales, which allows to
naturally fuse existing state-of-the-art models from both domains resulting in the sim-
ple Retina U-Net architecture. [193] converged to an architecture similar to ours while
working on the inverse setup, i.e. enhancing segmentation performance by additionally
training on bounding box labels.
6.3. Methods
6.3.1. Retina Net
The basis of our proposed model is the Retina Net, a simple one-stage detector based





for classification and bounding box regression, respectively (see Figure 6.4c).
Here P
j
denotes the feature-maps of the jth decoder level, where j increases as the res-
olution decreases. In this study, we compare various state-of-the-art one- and two-stage
object detectors in both 2D (slice-based) and 3D (volumetric patches). For the sake
of unrestricted comparability, all methods including Retina Net are implemented in one
framework, using the same backbone FPN [188] based on a ResNet50 [103] as identical
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architecture for feature extraction. In our FPN implementation, anchor sizes are divided
by a factor of 4 to account for smaller objects in the medical domain resulting in anchors








}. In the 3D
implementation, the z-scale of anchor-cubes is set to {1, 2, 4, 8}. For Retina Net, two
adaptations were made deviating from the original version: To factor in the existence of





. This comes at a computational price, since a vast number of dense
positions are produced in the higher resolution P
2
level. We further exchanged the sig-
moid non-linearity in the classification sub-network for a softmax operation, to account
for mutual exclusiveness of classes due to non-overlapping objects in 3D images.
6.3.2. Retina U-Net
Retina Net is complemented with architectural elements from the U-Net, resulting in the
proposed Retina U-Net. Training signals for full semantic supervision are added to the top-




, including the respective skip
connections. The resulting Feature Pyramid resembles the symmetric U-Net architecture
(see Figure 6.3), which in the following we refer to as U-FPN for clarity. The detection




, which keeps the number of parameters at
inference time unchanged. The segmentation loss is calculated from P
0
logits. In addition
to a pixel-wise cross entropy loss L
CE
, a soft Dice loss is applied, which has been shown













where u is the softmax output of the network and v is a one hot encoding of the ground
truth segmentation map. Both u and v have shape I ⇥K with i 2 I being the number of
pixels in the training batch and k 2 K being the classes.
6.3.3. Weighted Box Clustering
Medical images typically are comparatively large, due to e.g. very high resolutions as in
mammograms, or since they are acquired as 3D volumes like in MRI. Image resolutions
are expected to keep rising in the future driven by advances in imaging technologies, such
as the recent introduction of 7T MRI scanners. For this reason models are trained on
patch crops, resulting in a trade-o↵ between patch size and batch size limited by available
GPU memory. If single images exceeds GPU memory, test time inference is performed
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Figure 6.4.: Baseline Models in Medical Object Detection. The upper panel shows all
baselines utilizing a regular FPN feature extractor while the lower panel depicts
baselines that employ a symmetric FPN akin to a U-Net (U-FPN). Subfigures a)
- e) show the detection sub networks (heads) that are characteristic of each model
and operate on FPN features. All models employ their respective head topology to
di↵erent decoder scales which are denoted in red. Boxes in green indicate logits that
are trained on an auxiliary semantic segmentation task.
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patch-wise as well, where tiling strategies are designed to avoid potential artifacts that
arise due to e↵ects at the patch boundaries (e.g. by allowing for su cient overlap between
patches). The tiling strategies as well as test time augmentations and model ensembling
can amount to a large number of predictions per patch and image (particularly in medical
object detection, where validation metrics for model selection are often based on limited
validation data, ensembling over multiple selected epochs is able to reduce noise in the
process). The resulting predictions for di↵erent views of the same image need to be
consolidated, which in semantic segmentation is done via simple per-pixel softmax output
averaging. For consolidation of predictions in object detection, we propose weighted box
clustering (WBC): Similar to the commonly used non-maximum suppression algorithm,
WBC clusters predictions to be consolidated according to an IoU threshold, but instead of
selecting the highest scoring box in the cluster, weighted averages o
c
per coordinate and a
weighted confidence score o
s
per resulting box are computed. Further, the prior knowledge
about the expected number of predictions at a position (number of views from ensembling,
test time augmentations and patch overlaps at the position) is used to down-weight o
s
for




























where i is the cluster members’ index, s and c the corresponding confidence scores and
coordinates. w = f · a · p is the weighting factor, consisting of:
• overlap factor f : weights according to the overlap between a box and the highest
scoring box (softmax confidence) in the cluster.
• area a: assigns higher weights to larger boxes based on empirical observations indi-
cating an increase in image evidence from larger areas.
• patch center factor p: down-weights boxes based on the distance to the input patch
center, where most image context is captured. Scores are assigned according to the
density of a normal distribution that is centered at the patch center.
.
6.3.4. Baseline methods.
The following baseline methods were implemented (see Section 3.3 for background de-
tails.):
• Mask R-CNN ([105]): Adjustments for the 3D implementation: The number of fea-
ture maps in the region proposal network is lowered to 64 to account for increased
GPU memory usage. The poolsize of 3D-RoIAlign, a 3D implementation of the
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re-sampling operation applied in two stage detectors, is set to (7, 7, 3) for the clas-
sification head and (14, 14, 5) for the mask head. The matching IoU for positive
proposals is lowered to 0.3 (see Figure 6.4a).
• Faster R-CNN+: In order to single out the Mask R-CNN’s performance gain ob-
tained by segmentation supervision from the mask head, we run ablations on the
toy datasets while disabling the mask-loss, thereby e↵ectively reducing the model to
the Faster R-CNN architecture [194] except for the RoIAlign operation (indicated
in the method’s name by an additional +) (see Figure 6.4b).
• Retina U-Net
2stage
: To analyze the gain of additional semantic segmentation super-
vision in two-stage detectors, we implemented a two-stage variant of Retina U-Net
by deploying Faster R-CNN+ on top of U-FPN. (see Figure 6.4d).
• U-Net+Heuristics: Essentially formulating the problem as a semantic segmentation
task, as commonly done in medical imaging, we implement a U-Net-like baseline
using U-FPN. Therefore, softmax predictions were extracted from P
0
via 1x1 con-
volution and utilized to identify connected components for all foreground classes.
Subsequently, bounding boxes (or cubes) are drawn around connected components
and the highest softmax probability per component and class is assigned as object
score (see Figure 6.4e). As an alternative to max aggregation, mean aggregation has
been implemented without notable changes in performance.
6.4. Experimental Setup
6.4.1. Clinical Studies and Utilized Datasets
Lung Nodule Detection and Classification on CT
A lung nodule detection and categorization task is performed on the publicly available
LIDC-IDRI data set [195], consisting of 1035 lung CT scans with pixel-wise lesion anno-
tations and malignancy likelihood scores (1-5) from four experts. We fuse annotations of
raters per lesion by applying a pixel-wise majority voting and averaging the malignancy
scores. Scores are then re-labelled into benign (1-2: 1319 cases) and malignant (3-5: 494
cases). This is both a di cult and very frequent problem setting in radiology and therefore
constitutes a highly-relevant domain of application.
Breast Lesion Detection and Classification on DWI
A breast lesion detection and categorization task is performed on an in-house Di↵usion
MRI data set of 331 Patients with suspicious findings in previous mammography (an
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updated version of the dataset described in Section 4.2, i.e. extended by 109 additional
patients). Pixel-wise annotations of lesions are provided by experts. Categorisation labels
are given by subsequent pathology results (benign: 141 cases, malignant: 190 cases).
Both clinical datasets require the detection and categorisation (benign vs. malignant) of
lesions.
Lung Cancer Detection on PET-CT
While promising results have been reported recently for deep learning-based early de-
tection of lung cancer on large high-resolution CT datasets [196, 197], the detection of
advanced tumors, when performed solely based on CT, remains challenging [198]. In
clinical practice, it is well recognized that the positron emission tomography (PET) us-
ing 18F-fluorodeoxyglucose (FDG) as radiotracer contains unique metabolic information
that enables tumor characterization and staging [199, 200] (see Section 2.1.2). Therefore,
FDG-PET/CT is currently the status quo for the diagnostic workup of patients with lung
cancer as it combines this metabolic information with anatomy and morphology derived
from CT [201]. However, to the best of our knowledge to date there has been no study on
localizing and classifying lung cancer with end-to-end learning models using the combined
FDG-PET/CT protocol. Thus, we aim to explore the performance of Retina U-Net for
the detection of T (primary tumor), N (cancerous lymph node) and M-lesions (metastasis,
secondary tumor) in patients with primary lung cancer on a FDG-PET/CT dataset of
364 patients, 1913 lesions including pixel-wise annotations, and histologically confirmed
tumors of all stages. While the dataset is certainly large for medical standards, the task
of sub-categorization of lesions drastically decreases the training cases per category and
hence is considered di cult. Thus, for this initial study, we opt for the simpler task of
general lesion detection, i.e. grouping lesions into one foreground class to be distinguished
from background. This serves as a preparatory study for prospective clinical trials of our
algorithm planned at the university hospital Basel. The resulting model could be inte-
grated in to the diagnostic workflow by flagging ROIs to the radiologist for subsequent
analysis. Since manual annotation of datasets of the provided size are expensive, in this
preliminary study we are interested in whether the annotated training examples of pri-
mary tumors (T) can be enhanced by additionally exploiting annotated secondary tumors
such as tumorous lymph nodes (N), or metastases (M). Specifically, we aim to examine
how the sensitivity of the model behaves when trained under varying foreground defini-
tions. Thereby, the underlying hypothesis is that looking for instance at the detection
rate of primary tumors, the inclusion of remaining sub-groups into the foreground class
increases the general incentive of the algorithm to predict any candidate as foreground
and hence results in a higher number of true positive and false positive predictions for the
primary tumor class, and vice versa considering the remaining sub-groups as background
is expected to result in a higher number of true negative and false negative predictions.
Specifically, we aim to quantify and visualize the extend of these e↵ects and the associated
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impact on overall detection performance.
The Dataset comprises 364 FDG-PET/CTs of patients with primary lung cancer acquired
at the university hospital Basel. Scans were obtained one hour after intravenous injec-
tion of the radioactive tracer (see Section 2.1.2 for background information on Positron
Emission Tomography). The CT component of the combined PET/CT examination was
acquired with a slice thickness of 3mm. The TNM classification scheme used during an-
notation distinguishes four main T-categories (T1-T4; depending on size and features like
e.g. invasiveness), three N-categories (N1-N3, depending on location) and one M-category
[202]. This scheme follows the o cial TNM classification, slightly simplified, leaving out
the sub-sub categories (e.g. T1a, T1b, etc.). Annotation and 3D image segmentation
with reference to the anonymized written PET/CT report was performed manually by
a dual-board-certified radiologist and nuclear medicine physician as well as a supervised
radiology resident. Each lesion was segmented as a 3D volume defined by multiple 2D re-
gions of interest that were drawn on contiguous transverse sections of the CT component.
Fusion with PET information was used in addition whenever the borders of a lesion were
not clearly definable on CT.
The mean patient age was 67.1 years (SD: 10.3 years). 72.5% of the patients were male
(n = 264), 27.5% were female (n = 100). The complete dataset was randomly split into a
training dataset (50%), a validation dataset (25%) and testing dataset (25%). After the
randomization process, we checked the distribution of the T-category of the main tumor
of each case (T1-T4) to make sure that all categories were represented in all datasets. For
the three datasets (training, validation, testing), there were no statistically significant dif-
ferences in mean volumes of lung tumors ( 2 = 4.81, p = 0.090), malignant lymph nodes
( 2 = 3.12, p = 0.211) and distant metastasis ( 2 = 0.86, p = 0.650). The testing dataset
contained n = 87 T-lesions, n = 216 N-lesions and n = 76 M-lesions. Further, there were
no statistically significant di↵erences in the data splits of training, validation and testing
regarding age (F = 1.13, p = 0.323) or gender ( 2 = 1.38; p = 0.501). The whole dataset
contained 576 T-lesions with a mean tumor volume of 39.9 cm3 (SD: 100.7 cm3), 1025
N-lesions with a mean volume of 4.8 cm3 (SD: 12.4 cm3) and 312 M-lesions with a mean
volume of 6.2 cm3 (SD: 15.0 cm3).
Input images were resampled to the most common spacing of 0.97 in planar dimensions
and 3.27 in the z-dimension. Intensity values were clipped at [-600, 1200], rescaled to [0,1]
and z-score normalized. Images were cropped on the z-axis to slices containing lung tissue
according to a lung segmentation based on intensity-thresholding and connected compo-
nent analysis. We trained three foreground-background scenarios: (A) by defining only
T-lesions as foreground, all other voxels as background (T-Model). (B) with T- and N-
lesions defined as foreground, all other voxels as background (TN-Model). And (C), with
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T-, N- and M-lesions defined as foreground, all other voxels as background (TNM-Mode).
We did not di↵erentiate subclasses according to TNM for training.
Toy Datasets
We created a series of three toy experiments to separately evaluate on sub-tasks commonly
involved in object-categorisation on medical images (see Figure 6.9). More specifically,
the aim is to investigate the importance of full segmentation supervision in the context
of limited training data:
1. Distinguishing object shapes: Two classes of objects are to be detected and distin-
guished, circles and donuts (cut-out hole in the middle). Here, the corresponding
segmentation mask’s shape explicitly contains the discriminative feature (the cut-out
hole), hence, full semantic supervision is expected to yield significant performance
gains.
2. Learning discriminative object patterns: This task is identical to the previous one,
except the central hole is not cut out from the segmentation masks of the donuts
(class 2). This requires the model to pick up the discriminative pattern without
explicitly receiving the respective training signal by means of the mask’s shape.
This setup could be considered more realistic in the context of medical images.
3. Distinguishing object scales: Circles of two di↵erent sizes (19 vs. 20 pixel diameter)
are to be detected and distinguished. Here, class information is entirely encoded in
object scales and hence in target box coordinates. No significant gain from semantic
supervision is expected.
Each toy data set consists of 2500 artificially generated 2D images of size 320⇥ 320 (1000
train / 500 val / 1000 hold-out test). Images are zero-initialized and foreground objects
imprinted by increasing intensity values by 0.2. Subsequently, uniform noise is added to
all pixels.
6.4.2. Training & Evaluation Setup.
For comparability, experiments for all methods are run with identical training and infer-
ence schemes, as described below. In this study, we compare slice-wise 2D processing,
while feeding the ±3 neighbouring slices as additional input channels (2Dc) [203], against
3D convolutions. Oversampling of foreground regions is applied when training on patch
crops. To account for the class-imbalance of object level classification losses, we stochas-
tically mine the hardest negative object candidates according to softmax probability.
Models are trained in a 5-fold cross validation (splits: train 60% / val 20% / test 20%)
(except Lung Cancer Study on PET-CT which is trained on a single fold) with batch size
20 (8) in 2D (3D) using the Adam optimizer (with default settings) at a learning rate of
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10 4. Extensive data augmentation in 2D and 3D is applied to account for overfitting. To
compensate for unstable statistics on small datasets, we report results on the aggregated
inner loop test sets and ensemble by performing test-time mirroring as well as by testing
on multiple models selected as the 5 highest scoring epochs according to validation met-
rics. Consolidation of box predictions from ensemble-members and overlapping tiles is
done via clustering and weighted averaging of scores and coordinates (WBC, see Section
6.3.3). Since evaluation is performed entirely in 3D, an adaption of non-maximum sup-
pression (NMS) is applied to consolidate box predictions from 2D networks to 3D cube
predictions: Boxes of all slices are projected into one plane while retaining the slice-origin
information. When applying NMS, only boxes with direct or indirect connection to the
slice of the highest scoring box are considered as matches. The minimal and maximal slice
numbers of all matches are assigned as z-coordinates to the resulting prediction cube. Ex-
periments are evaluated using Mean Average Precision (mAP) [204] (see Appendix A).
We determine mAP at a relatively low matching intersection over union (IoU) threshold
of IoU = 0.1, which respects the clinical need for coarse localization and also exploits the
non-overlapping nature of objects in 3D. Note that evaluation and matching is performed
in 3D for all models and processing setups. Additionally, we report the AP of patient-
scores, which are determined as the maximum of scores per class and patient (aggregating
predictions as well as labels over potentially multiple lesions per patient).
6.5. Results
6.5.1. Detection and Classification of Lung Nodules and Breast Lesions
Results for the lesion detection and categorization tasks are shown in Table 6.1. Retina
U-Net performs best on the 2Dc setups (50.2mAP on and 33.4mAP on Breast DWI).
In 3D, Retina U-Net performs best on Breast DWI (35.8mAP) and only slightly worse
(49.8mAP) than Retina U-Net
2stage
(50.5mAP) on LIDC. Comparing these results to the
remaining baselines shows the importance of semantic segmentation supervision. Mask-
R-CNN for instance, which is trained with instance segmentation supervision instead,
shows overall worse performance presumably due to the issues discussed in Section 6.2.
U-Net performs worse with notable margins, seemingly su↵ering from high confidence
false positive predictions caused by the necessary max-score aggregation (aggregating
scores via mean in an alternative experiment did not improve performance). Evaluating
on patient-level, Retina U-Net performs best on all tasks except 3D LIDC, where Mask
R-CNN achieves the highest score. Example images with model predictions are shown in
Figure 6.5.
6.5.2. Detection of Lung Cancer on Pet-CT
The results are shown in Figure 6.8 demonstrating increased sensitivity for primary cancer
detection when assigning N-lesions or M-lesions to the foreground class. Surprisingly, the
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Figure 6.5.: Example Detections on Medical Images. Predictions of a malignant lesion in
a CT scan of the lung (left) and a benign lesion on a Di↵usion MRI of the breast
(right). The numbers before and after the vertical bar denote the predicted class-id
and the prediction confidence in percent, respectively.
Table 6.1.: Test Set Results for Lung Lesion Detection on CT (LIDC) and Breast
Lesion Detection on DWI.Mean Average Precision (mAP)reported on the object-
level (mAP
10







Retina U-Net (ours) 50.2 73.9 33.4 86.9
Mask R-CNN 45.4 69.1 32.3 86.4
2Dc Retina Net 48.2 71.5 33.2 84.4
Retina U-Net
2stage
(ours) 49.1 71.6 33.2 84.7
U-Net+Heuristics 41.1 66.1 25.8 81.6
Retina U-Net (ours) 49.8 70.4 35.8 88.0
Mask R-CNN 48.3 71.8 34.0 84.8
3D Retina Net 45.9 68.8 31.9 86.4
Retina U-Net
2stage
(ours) 50.5 70.7 35.1 86.5
U-Net+Heuristics 36.6 62.8 26.9 85.1
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number of false positives is not increased accordingly when adding M-lesions, indicating an
overall improved detection performance of the TNM-model over the TN-model. Notably,
drawing conclusions from false positive detections has to be taken with a grain of salt,
since the foreground definition of di↵erent models itself might be a nuisance factor for
this variable, e.g. the additional false positive predictions in the TN-model might be
the M-lesions defined as foreground in the TNM-model. This predicament is the reason
behind not applying standard detection metrics such as mAP or FROC and opting for a
sensitivity study instead, and expected to be resolved in future work by performing false-
positive matching, i.e. revealing the original class labels (or the background identity)
of all false positive predictions. In summary, the results suggest potential in exploiting
additional annotations in datasets if aiming for upstream integration into the diagnostic
workflow in form of sensitive flagging of primary cancer ROIs. Qualitative examples of
true positive detections are shown in Figure 6.6, while Figure 6.7 provides examples of
false positive predictions.
6.5.3. Toy Datasets
Results for the toy experiments are shown in Figure 6.10. In the first task, where ex-
plicit class information is contained in segmentation annotations, models which opti-
mally leverage those, i.e. Retina U-Net and Retina U-Net
2stage
, perform best (again, the
instance-based segmentation training of Mask R-CNN seems to yield inferior performance
presumably due to issues discussed in Section 6.2. The resulting margin increases with
decreasing amount of available training data. The second task, where class information
is e↵ectively removed from segmentation annotations, shows similar margins of Retina U-
Net and Retina U-Net
2stage
to other models. This indicates the importance of full semantic
segmentation supervision even in implicit setups and shows a particularly strong edge in
the small dataset regime, where models that discard this supervision essentially collapse.
In the third task, where class information is entirely contained in the target boxes, no gain
from segmentation supervision is observed, at least for small training datasets. Surpris-
ingly, two-shot detectors perform better at this task, which seems counter-intuitive given
the scale-invariance enforced by the RoIAlign operation. We hypothesize, that discarding
the spatial scale e↵ectively forces the optimizer to encode this information into the fea-
ture maps previous to the RoIAlign operation, which seems to not hamper performance
and possibly even cause a beneficial regularization e↵ect. Comparing Mask R-CNN to
Faster R-CNN+, the sub-optimal mask-supervision seems to yield no gains in detection
performance when working with limited training data.
6.6. Medical Detection Toolkit
Medical Detection Toolkit is a comprehensive code framework based on the study pre-
sented in this chapter addressing object detection on medical images [38]. It is publicly
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Figure 6.6.: Qualitative Results for Lung Cancer Detection on PET-CT. This figure
visualizes true positive predictions of the TNM-model showing the raw CT input
(left column), the CT input overlayed with PET (middle column) and the overlayed
input with the model prediction (green box and confidence score in white) and the
pixel-wise ground truth annotation (green mask). The top row shows a solitary
lung tumor in the superior segment of the left lower lobe with invasion of the chest
wall (T3). The middle row shows a metastatic lymph node (N) in the mediastinum
(the central compartment of the thoracic cavity). The bottom row shows a bone
metastasis in the 10th vertebra of the thoracic spine (M).
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Figure 6.7.: False Positive Predictions in Lung Cancer Detection on PET-CT. This
figure shows two false positive predictions with relatively low confidence threshold.
The left figure shows a prediction on an extracorporal foreign body, while the right
figure shows a physiological metabolism of the cardiac muscle.
available at https://github.com/mic-dkfz/medicaldetectiontoolkit, where it en-
joys a fair amount of popularity due to multiple exclusive features with respect to other
existing object detection repositories: To the best of our knowledge, the framework holds
the first 3D implementations of prevalent object detection and instance segmentation
models such as Retina Net [106] or Mask R-CNN [105]. Moreover, it is designed to han-
dle large 3D images that exceed GPU memory, i.e. it features automated patching for
training as well as tiling and stitching for test time inference including aggregation of box
predictions over di↵erent overlapping patches or tiles (see Weighted Box Clustering in
Section 6.3.3. Figure 6.11 visualizes the corresponding prediction pipeline. As for model
evaluation, Medical Detection Toolkit integrates the o cial metric computation of the
COCO object detection challenge [204].
6.7. Dicsussion
In this chapter, we addressed the task of end-to-end object detection and classification
on medical images. Thereby, we identified a predicament between aligning the output
structure of predictive models to the requirements of the intended clinical task and main-
taining data e cient training on small datasets - a vivid example for the challenges faced
when aiming for successful clinical application of deep learning systems. We saw, that
the encountered predicament is currently worked around by either applying subpar post-
processing heuristics or simply neglecting the classification scale of the clinical interest,
which results in clinically irrelevant evaluation metrics and fuels the gap between research
in medical image analysis and translation to real life applications. Thus, we vouch for con-
sidering clinical relevance an integral part of research project design including the choice
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Figure 6.8.: Sensitivity Study for Primary Lung Cancer Detection on PET-CT. All
plots show sensitivities when scanning over the confidence score (softmax probabil-
ity of foreground class) of all test set predictions for di↵erent models, except the plot
on the upper right corner, which shows the total number of false positives over con-
fidence. The first three plots show sensitivities for the three tumor classes Primary
Tumor (T), Tumorous Lymph Nodes (N), or Metastases (M), while the plot on the.
The four plots on the bottom show sensitivities for the distinguished the subclasses
of primary tumors T1-T4. The three di↵erent models evaluated are the T-model
(only trained with primary tumors as foreground class), TN-model (trained with T
and N as foreground class), and the TNM-model (trained with T, N, and M lesions
as foreground class).
Figure 6.9.: Example Images of the Toy Dataset for Medical Object Detection. left:
Example images for tasks 1 (distinguishing object shapes) and 2 (learning discrimi-
native object patterns) of the toy experiment series. The left object is a filled circle,
while the object on the right is a donut (cut-out hole in the middle). right: Example
images for task 3 (distinguishing object scales), the circle on the left has a diameter
of 19 pixels, as opposed to 20 pixels diameter of the circle on the right.
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Figure 6.10.: Results of the of toy experiment series. The three tasks are displayed as
(a) distinguishing objects of di↵erent shapes, (b) learning discriminative image
patterns unrelated to an object’s shape, and (c) distinguishing objects of di↵erent
scales. Explored models are divided into two groups: One-stage methods have
blue/green color, while two-stage methods are drawn in red. n denotes the number
of training images.
Figure 6.11.: Prediction Pipeline of the Medical Detection Toolkit. Images exceeding
GPU memory are automatically tiled in overlapping 3D patches. Prediction in-
stances of the same regions can amount to large numbers due to test time aug-
mentations, ensembling strategies and patch overlaps. The resulting list of box
predictions per image position are consolidated using the Weighted Box Clustering
algorithm described in section 6.3.3.
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Figure 6.12.: Stereotypical Research Workflow in Medical Image Analysis and Pro-
posed Modifcations. This Figure follows the scenario depicted in Section 6.1
and (somewhat cheekily) draws a stereotypical process of choosing the classifica-
tion scale when designing a research model (black arrows): Faced with a clinical
task, there are multiple factors influencing the choice of methodology, including
the amount and spatial resolution of annotations in the training data, the personal
expertise or experience with certain types of models, existing reference solutions.
The classification scale of the clinical interest behind the task is often just one
more factor to consider. The resulting methodology outputs predictions on the
corresponding scale and the subsequent evaluation is often performed with metrics
chosen to match this output scale, which results in diminished clinical relevance
of the study results. However, in order to increase the overall clinical relevance of
research studies, we consider it crucial to instead first define the scale of evaluation
metrics according to the clinical interest and consider the pre-defined metrics an
additional factor in the subsequent decision for model classification scale (red cross
and green arrows). If the resulting model prediction scale happens to mismatch the
scale of evaluation metrics it is necessary to aggregate the predictions accordingly
before evaluation.
of methodology. Figure 6.12 visualizes the discrepancy between a stereotypical research
workflow and the modifications deemed necessary towards crossing the AI chasm.
Following this narrative, we address the task of end-to-end lesion detection and classifica-
tion under limited training data and propose Retina U-Net, a simple but e↵ective method
for leveraging segmentation supervision in object detection. We showed the importance
of exploiting pixel-wise training signals at full resolution on multiple datasets, input di-
mensions and meticulously compared against the prevalent models in object detection,
semantic segmentation and instance segmentation with a particular emphasis on the con-
text of small datasets.
On the publicly available lung CT dataset as well as on the breast lesion DWI dataset,
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Retina U-Net yields detection performance superior to models without full segmentation
supervision. By means of a set of toy experiments we shed light on an important set of
scenarios that can profit from the additional full supervision: Any such problem where
there is discriminative power in features beyond mere scale can expect to pocket an edge
in detection performance. In the preliminary sensitivity study on PET-CT, Retina U-Net
showed robust detection of primary cancer and we observed indication that the associ-
ated performance increases when secondary cancer lesiosn are included into the foreground
class during training.
A current limitation of Retina U-Net is that it does not allow for end-to-end patient
level detection. Many scenarios e.g. in cancer screening utilize lesion detection on object-
level as an explicit localization task to alleviate the data burden during training, but are
ultimately interested in decisions on the patient-level (this problem in a sense repeats the
general problem statement of this study, which however focused on on the finer-scale level
of pixel-wise supervision for object detection tasks.). Currently, we required heuristics to
aggregate object-level scores to patient-level scores as reported in Section 6.4.2. In theory,
Retina U-Net could be extended to allow for end-to-end patient-level prediction while ex-
ploiting supervision on object-level and pixel-level in order to prevent overfitting due to
sparse training signals from patient-level labels. This could be implemented by branching
o↵ a patient-prediction path in the bottleneck of the Feature Pyramid Network (FPN). In
practice, however, this model clashes with a further nuisance factor a↵ecting the choice of
classification scales for clinical tasks: Hardware constraints in form of e.g. limited GPU
memory. Since lowering the resolution of input images is expected to drastically hamper
detection of small objects, models are trained on patches cropped out of the whole image
at full resolution. This is an acceptable workaround, as long as it is possible to assign
meaningful labels to patches, such as on pixel-level or object-level, but introduces incon-
gruous gradients when patches are trained with patient-labels (e.g. a background patch
might be associated with the label ”cancer” during training). Further, we argue that the
aggregation process of object scores to patient-level entails less noise than aggregating
individual pixels 1 and deem our approach the current best practice for patient-level tasks
with spatially resolved annotations.
Among other distinguishing characteristics, the domain of medical image analysis holds
one prominent feature: scarcity of labeled data. Retina U-Net is designed to make the
most of the given supervision signal which is a crucial aspect for robust model generaliza-
tion on small datasets as high-lighted by our experiments. Taken together, Retina U-Net
1
Beside the fact that individual pixels are subject to higher intensity fluctuations than aggregated object scores,
”patient” as the target of aggregation constitutes one single instance of fixed extend as opposed to the need




aims to enable end-to-end diagnostics by optimizing for model robustness under limited
training data while ensuring clinical relevance of model predictions - two key factors in
the strive towards closing the gap between research and real life application of end-to-end
learning systems. On an anecdotal level, the relevance of addressing this challenge is
highlighted by the fact that Turing award winner Yann LeCun mentions Retina U-net as
the one application of segmentation in medical image analysis in a recent essay on the
status and future of deep learning [205].
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”If biases and initial knowledge are at the heart of the ability to generalize beyond observed
data, then e↵orts to study machine learning must focus on the combined use of prior
knowledge, biases, and observation in guiding the learning process. It would be wise to
make the biases and their use in controlling learning just as explicit as past research has
made the observations and their use.”
Tom Mitchell, 1980 [31]
The robustness of learning algorithms is the ability to generalize to unseen data regardless
of varying data properties [31]. In the context of notoriously limited annotated training
data in the medical domain model robustness is considered the key obstacle towards clin-
ical application of learning algorithms [27]. Following Tom Mitchell’s above quote in his
report from 1980 and the discussion provided in Section 3.4, one way to increase robust-
ness in learning algorithms under limited training data is to transform prior knowledge
into informed inductive biases in order to constrain the space of possible solutions [31].
Components composing a model’s inductive bias, i.e. possible injection points for prior
knowledge in this context, are architecture, loss function, training data, and optimiza-
tion [128]. From this perspective, the auxiliary segmentation loss deployed in Chapter 6
transforms task-relevant knowledge from pixel-wise annotations into additional constraints
baked into the model during training thus increasing the model’s ability to generalize to
unseen data. In this chapter, we explore further leverage points in existing end-to-end
learning systems, where domain knowledge can be condensed into informed constraints,
this time harnessing all four components of the models’ inductive bias. The main contri-
butions in this chapter are:
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• Robustness against rater confusion: We address the challenge of erroneous training
annotations by substituting the classification component of end-to-end object detec-
tion for regression, which enables to train models directly on the continuous scale of
underlying pathological processes [40].
• Robustness against input variations: When trained models are deployed across clin-
ical sites they commonly face performance drops due to input domain shifts such as
missing or altered modalities. We inject domain knowledge in form of a biophysical
model that recaptures the original training domain from altered inputs and thus
restores robust model generalization. [41].
• Robust Hyperparameters: We address the highly unsystematic, cumbersome and sub-
jective trial-and-error process of finding a robust set of hyperparameters for a given
task by condensing domain knowledge into a set of key design choices and systematic
rules thus enabling automated and robust deep learning pipeline configuration on a
large variety of medical datasets. [42].
The work regarding regression for mitigation of ambiguous annotations was presented
at the UNSURE workshop at MICCAI 2019 as a spotlight talk [40] and the associated
code is publicly available at https://github.com/MIC-DKFZ/RegRCNN . The work re-
garding domain adaptation towards robustness against input shifts was presented as
a spotlight talk at the workshop on Image Analysis for Moving Organs, Breast and
Thoracic Images at MICCAI 2018 and elected one of three best paper award nomi-
nees [41]. The work regarding automated model design is currently under review at
Nature Methods with a preprint available on arXiv [42]. The code is publicized at
https://github.com/MIC-DKFZ/nnUNet .
7.1. Robustness against Rater Confusion: End-to-End Regres-
sion
When adopting state-of-the-art object detectors for end-to-end lesion grading, there is
one peculiarity in medical images that is currently unconsidered: The clinical grading of
lesions denotes a subjective discretization of naturally continuous and ordered features
(such as scale or intensity) to semantic categories with clinical meaning, e.g. the BI-
RADS score [112], Gleason score [206], PI-RADS score [207], or TNM staging [126]. This
is in contrast to typical tasks on natural images, where categories can be described as an
unordered set (no natural ordinal relation exists between dogs and cars). Since state of
the art object detection models are commonly developed based on natural images, they
phrase the categorization as a classification task and are trained using cross-entropy loss,
thus do not consider the continuous ordinal relation between classes.
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In this study, we argue that the described underlying relation represents important prior
knowledge that should be integrated into the training signal in order to enhance the biases
inducted during optimization to the task at hand. Specifically, by considering ordinal class
relations, we expect a gain in the models’ robustness against ambiguity in training annota-
tions: Medical images often contain highly ambiguous information that reflects in drastic
variability of human annotations e.g. in the delineation of prostate cancer [208, 209],
breast cancer [210], or lung cancer [211]. Under the assumption that rater confusions fol-
low a distribution around the underlying ground truth grading, distance metrics used in
regression such as the L1-distance are expected to be more tolerant to mild deviation from
the target value as opposed to the categorical cross entropy which penalizes all o↵-target
predictions in equal measure [212].
To this end, we propose Reg R-CNN, an end-to-end object detection and regression model
that builds upon Mask R-CNN [105] by substituting the classification component with
a regression component. Thus, training penalties for the categorization task follow a
distance metric, i.e. directly operate on the underlying continuous scale. We show the
superiority of Reg R-CNN in the task of lesion detection and grading on a public dataset
with 1026 patients and a series of toy experiments.
7.1.1. Methods
Regression vs. Classification Training
In order to see why we expect the training of regression models to be more robust to label
noise than classification models for the case when target classes lie on a continuous scale,
let us first revisit the objective commonly minimized by classifiers. This objective is the
cross entropy (CE), defined as








between a target distribution p(X) over discrete labels j 2 C and the predicted distribu-
tion q(X) given data X. For mutually exclusive classes, the target distribution is given
by a delta distribution p(X) = { 
ij
}
j2C . To produce a prediction q(X), the network’s
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From Eq. 7.3 it is apparent that the standard CE loss treats labels as an unordered bag
of targets, where all o↵-target classes (j 6= i) are penalized in equal measure, regardless
of their proximity to the target class i. Distance metrics on the other hand, as their name
suggests, take into account the distance of a prediction to the target. This lets the loss
scale in the deviation of prediction to target. Allowing to be more accepting of mild dis-
crepancies, it better accommodates for noise from potentially conflicting labels in settings
where the target labels lie on a continuum.
In the range of experiments below, we compare classification against regression setups,












for predicted value p and target value t. Other works have investigated adaptions to the
CE loss to account for noisy labels in classification tasks, e.g. [213, 214]. Our approach
is complementary to those works as it exploits label continua on medical images.
Reg R-CNN & Baseline
The proposed Reg R-CNN architecture is based on Mask R-CNN [105], a state-of-the-art
two-stage detector (see Section 3.3). In Mask R-CNN, first, objects are discriminated from
background irrespective of class, accompanied by bounding-box regression to generate re-
gion proposals of variable sizes. Second, proposals are re-sampled to a fixed-sized grid and
fed through three head networks: A classifier for categorization, a second bounding-box
regressor for refinement of coordinates, and a fully convolutional head producing output
segmentations (the latter are not further used in this study except for the additional
pixel-wise loss during training). Reg R-CNN (see Fig. 7.1) simply replaces the classifica-
tion head by a regression head, which is trained with the smooth L1 loss instead of the
cross-entropy loss.
For the final filtering of output predictions, non-maximum suppression (NMS) is per-
formed based on detection-confidence scores. In Mask R-CNN, these are provided by the
classification head. Since the regression head does not produce confidences, we use the
objectness scores from the first stage instead.
In this study, we compare Reg R-CNN against Mask R-CNN as the classification counter-
part of our approach. Only minor changes are made with respect to the original publica-
tion [105] regarding the adoption to operating on 3D images: The number of feature maps
in the region proposal network is lowered to 64 to account for GPU memory constraints.
The poolsize of 3D RoIAlign (a 3D re-implementation of the resampling method used to
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Figure 7.1.: Reg R-CNN Model for Joint Detection and Continuous Grading of Ob-
jects. The architecture is closely related to Mask R-CNN [105], where grading is
done with a classification head instead of the displayed “Score Regressor” head net-
work. FPN denotes Feature Pyramid Network [188], RPN denotes Region Proposal
Network (RPN) and RoIAlign is the operation which re-samples object proposals
to a fixed-sized grid before categorization.
create fixed-sized proposals) is set to (7, 7, 3) for the classification head and (14, 14, 5)
for the mask head. The matching Intersection over Union (IoU) for positive proposals
is lowered to 0.3. Objectness scores are used for the final NMS to reflect the desired
disentanglement of detection and categorization tasks. All changes equally apply to Reg
R-CNN, thus the only di↵erence between the two compared models is the substitution of
the classification task with a regression task.
Evaluation
Comparing the performance of regression to classification models requires taking into ac-
count additional considerations since both are trained along an upstream detection task.
In order to evaluate continuous regression in comparison to discrete classification out-
puts, we bin the continuous regression output after training, such that bin centers match
the discrete classification targets. What’s more, the joint task of object detection and
categorization is commonly evaluated using Mean Average Precision (mAP) [215] (see
Appendix A). However, Mean Average Precision (mAP) requires per-category confidence
scores, which are, as mentioned before, not provided by regression outputs. Instead, we
borrow a metric commonly used in viewpoint estimation, the Average Viewpoint Precision
(AVP) [216]. Based on AVP, we phrase the lesion scoring as an additional task on top of
foreground vs. background object detection: In order for a box prediction to be consid-
ered a true positive, additionally to the requirement posed by the detection task to match
the ground-truth box with an IoU > 0.1 (this relatively low matching threshold respects
the clinical need for coarse localization and exploits the non-overlapping nature of objects
in 3D images), in AVP the malignancy prediction score is required to lie in the correct
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Figure 7.2.: Visualization of Rater Dissent on the LIDC Dataset. a) A confusion-matrix-
style display of annotator dissent in the LIDC dataset. Rows represent the binned
mean ratings of lesions (in place of the true class in a standard confusion matrix),
columns the ratings of the corresponding single annotators. “MS” means malignancy
score. Matrix is row-wisely normalized, hence cell values indicate distribution of
lesion ratings within a bin. b)-d) Example slice from the LIDC dataset showing
GT, Reg R-CNN, and Mask R-CNN prediction separately. GT note “sa. MS”
shows the single-annotator grades (grade 0 means no finding), “agg. MS” their
mean. In the predictions, “FG” means foreground confidence (objectness score),
“MS” denotes the predicted malignancy score. Mask R-CNN MS can be non-integer
due to Weighted Box Clustering 6.3.3. Color symbolizes bin.
category bin. This way, AVP condenses both the detection and malignancy-scoring perfor-
mance of the model in one metric. We additionally disentangle the two tasks and evaluate
separate metrics. To this end, we report the mAP to assess foreground vs. background
detection (this poses an upper bound on AVP, since the additional requirement posed by
AVP is missing) and the bin accuracy to assess categorization performance. The latter
is determined by pre-selecting true positive predictions according to the detection metric
and subsequently only consider this selection when counting malignancy-score matches
with the target bin.
7.1.2. Experimental Setup
Utilized Datasets
Lung CT dataset The utilized LIDC-IDRI dataset is identical to the one described in
Section 6.4.1 [195], except that the four rater assessments per lesions are not fused, but
considered independent training cases and the corresponding malignancy scores are not
mapped to binary values 0 and 1, but left on the original scale of 1-5. Having disposable
multiple gradings from distinct annotators is a rare exception on medical images and al-
lows to investigate the exhibited label noise [217].
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Full agreement, which we define as all raters assigning the same malignancy label to
all lesions (RoIs) in a patient, is observed on a mere 163 patients (this includes patients
void of findings by all raters). This corresponds to a rater disagreement with respect to
the malignancy scoring on 84% of the patients. On a lesion level (ROI-wise), the dataset
comprises 2631 lesions when considering all lesions with a positive label by at least one
rater. This number drops to 1834, 1333, or 821, when requiring 2, 3, or 4 positive labels,
respectively. This shows that the labeling is both ambiguous with respect to whether or
not a lesion is present as well as the prospective lesion’s grading. The former has bearings
on the detection head’s performance, while the latter influences the network’s classifica-
tion or, respectively, regression head.
In order to evaluate the grading performance, the following malignancy statistics include
only patients with at least one finding. Among those, we count 99 lesions (3.8% of all
lesions) with full rater agreement, leaving disagreement on 2532 (or 96.2%). The standard
deviation of the 4 graders averaged over all lesions amounts to 1.05 malignancy-score val-
ues (ms). In Fig. 7.2 a), we show how the single graders’ malignancy ratings di↵er given
the binned mean rating. The figure reveals significant label confusion across adjacent la-
bels and even beyond. Figs. 7.2 b)-d) display example Reg and Mask R-CNN predictions
next to the corresponding ground truth.
In order to investigate the models’ performance under label noise, we randomly sam-
ple a rater assessment including pixel-wise annotation and malignancy score for a given
lesion from the 4 given ratings at each training iteration. At test time, we however employ
the lesions’ ground truth label as the mean malignancy score, in order to approximate the
”real” ground truth by reducing the noise of inter-rater variability.
Toy dataset Since the underlying ground truth on the LIDC dataset can only be approx-
imated by computing the mean of all provided ratings, as no further clinical assessments
such as biopsies are available, we design a toy dataset, where we are able to carefully con-
trol the ground truth as well as the associated distributions of rater confusions. The aim
is to gain additional confirmation of the underlying hypotheses in this study without the
noise of a real life clinical dataset. The artificial task is the joint detection and categoriza-
tion of 3D cylinders, where five categories are distinguished as cylinders of five di↵erent
radii. In order to simulate label confusion, Gaussian noise is added to the isotropic target
radii during training, sampled with standard deviation   = r/6 around object radius r,
as depicted in Figs. 7.3 c) and d). This causes targets (especially of large-radius objects)
to be shifted into wrong, yet mostly adjacent target bins. Fig. 7.3 a) portrays that these
ambiguities are imprinted on the images as a belt of reduced intensity with width 2 
around the actual radius. At test time, model predictions are evaluated against the exact
target radii without noise. The dataset consists of 1.5k randomly generated samples for
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training and validation, as well as a hold-out test set of 1k images.
Training & Inference Setup
Both the LIDC and the toy dataset consist of volumetric images. In this study, we
evaluate instances of the compared models that operate in 3D as well as in 2D (slice-
wise processing). For the sake of comparability, all methods are implemented in a single
framework and run with identical hyperparameters. Networks are trained on patch crops
of sizes 160 ⇥ 160 ⇥ 96 (LIDC) and 320 ⇥ 320 ⇥ 8 (toy), oversampling of foreground
regions is applied. Class imbalances in object-level classification losses are accounted
for by stochastically mining the hardest negative object candidates according to softmax
probability. On LIDC, models are trained for 130 epochs, each composed of 200 batches
with size 8 (20) in 3D (2D) at a learning rate of 10 4. Training is performed as a five-fold
cross validation (splits: train 60% / val 20% / test 20%). At test time, we ensemble
the four best performing models from all epochs according to validation metrics and
generate four test-time views (three mirroring augmentations) in each fold. Aggregation
of box predictions from ensemble members is done via clustering and weighted averaging of
scores and coordinates (see Weighted Box Clustering (WBC) in Section 6.3.3). Predictions
from 2D models are consolidated along the z-axis by means of an adaption of NMS and
evaluated against the 3D ground truth.
7.1.3. Results
Results are shown in Table 7.1. In addition to the fold means of the metrics we report
the corresponding standard deviations. On LIDC, Reg R-CNN outperforms Mask R-CNN
on both input dimensions and all three considered metrics. On the toy dataset, Reg R-
CNN shows superior performance in AVP
10
and Bin Accuracy. AP
10
reaches 100% in both
models indicating that the detection task is solved entirely, i.e., the object grading task has
been isolated successfully (hence, results for AVP
10
converge towards the Bin Accuracy).
All experiments demonstrate the superiority of distance losses in the supervision of models
performing continuous and ordered grading under noisy labels. Interestingly, there is a
marked increase in performance for both setups when running in 3D as opposed to 2D,
suggesting that additional 3D context is generally beneficial for the task.
7.1.4. Discussion
Simultaneously detecting and grading objects is a common and clinically highly relevant
task in medical image analysis. As opposed to natural images, where object categories
are mostly well defined, the categorizations of interest for clinically relevant findings com-
monly leave room for interpretation. This ambiguity can bear on machine-learning models
in the form of noisy labels, which may hamper the performance of classification models.
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Figure 7.3.: Visualization of the Toy Experiments for End-to-end Regression. a) Cylin-
ders (2D projections) of all five categories (r1-r5) in the toy experiment. b) Exact
GT. c) Examples of a noisy GT for each category (r1-r5). r
a
indicates the annotated
radius (target regression value). d) Gaussian sampling distributions used to gener-
ate the noisy GT. Green vertical lines depict the exact ground-truth values, while
blue lines are the corresponding label-noise distributions. Green rectangles are the
bins (borders enlarged for illustration) used for training of the classifier as well as
for evaluation of both methods. Note that distributions reach into neighboring bins
leading to label confusions.
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Table 7.1.: Test Set Results of the Reg R-CNN study on LIDC and a Toy Dataset.
AVP
10
measures joint detection and categorization performance, while AP
10
mea-
sures the disentangled detection performance and Bin Accuracy shows categorization
performance (conditioned on detection)









Reg R-CNN 0.259±0.035 0.628±0.038 0.477±0.035
Mask R-CNN 0.235±0.027 0.622±0.029 0.411±0.026
2D
Reg R-CNN 0.148±0.046 0.414±0.052 0.468±0.057




Reg R-CNN 0.881±0.014 0.998±0.004 0.887±0.014
Mask R-CNN 0.822±0.070 1.000±.000 0.826±0.069
2D
Reg R-CNN 0.859±0.021 1.000±0.000 0.860±0.021
Mask R-CNN 0.748±0.022 1.000±0.000 0.748±0.021
Clinical label categories however often reside on a continuous and ordered scale, suggest-
ing that label confusions are likely more frequent between adjacent categories.
For this case, we show that both the performance of lesion detection and malignancy
grading can be improved upon over a state-of-the-art detection model when simply trad-
ing its classification for a regression head and altering the loss accordingly. We document
the success of the ensuing model Reg R-CNN on a large lung CT dataset and on a toy
dataset that induces artificial ambiguity. We attribute the edge in performance to the loss
formulation of the regression task, which naturally accounts for the continuous relation
between labels and is therefore less prone to su↵er from conflicting gradients from noisy
labels. As Eq. 7.4 shows, we employ a metric approach to ordinal data. In general,
this is not hazard-free as model performance may su↵er from the imposed metric if the
scale actually is non-metric [218]. In other words, our approach implicitly assumes the
grading scale has su ciently metric-like properties. To address this limitation, we plan
to study alternative non-metric approaches in future work [219, 220]. In summary, we
demonstrated how prior knowledge about the underlying task can be baked into the loss
function in order to facilitate the learning process, i.e. increase the e ciency of extracting
information from available training data, thus improving the generalization ability of the
resulting model.
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7.2. Robustness against Input Variations: Model-based Domain
Adaptation
In Section 5 we demonstrated, how a Roi-to-end CNN (R2E) outperforms DKI-based ap-
proaches by integrating all components of the diagnosis pipeline into a CNN architecture
and allowing for joint optimization with respect to the ultimate clinical task. However,
a limitation of this approach is the intrinsic input dependence of CNNs [221], which in
the studied clinical scenario is trained on specific di↵usion-weighted images acquired at
certain b-values, i.e. strengths and timings of gradient fields. This limitation is crucial
for large-scale clinical application, since DWI scanning protocols deviate between sites
and standardization is not expected in the near future [222]. Furthermore, due to limited
training data, it is desirable to ship trained models across clinical sites for inference with-
out re-training on unseen images acquired with arbitrary local protocols. This procedure
implies heterogeneities between training data and local inference data, e.g. in the form of
shifted or missing b-values.
Generative models such as generative adversarial networks [223, 224] and variational auto
encoders [225, 226] have recently succeeded at domain transformations. Such models could
potentially be used to transform images of altered test-time modalities to original images
corresponding to the modalities originally seen during training, yet do not eliminate input
dependencies: Similar to other domain adaptation methods such as transfer learning or
learning common representations of varying inputs [227], all these workarounds themselves
require explicit training on possible future input alteration modes, i.e. are not designed
to generalize to arbitrary future input alterations. Since model-based approaches such as
DKI come with an intrinsic robustness towards input variations (i.e. predictions based on
inductive biases from previous training are substituted for an on-the-fly model fit on the
test data), input independence could potentially be achieved by operating the CNN on the
output coe cients of the model-fit instead of raw DWI inputs. However, the robustness of
model-fits is proportional to the number of observed data points, which, as will be shown,
is not su cient in typical DWI acquisition setups.
To this end, we propose Model-based Domain Adaptation (MBDA), where the domain
shift encountered by the CNN is minimized by reconstructing original training modalities
using DKI on the varied inputs at test time. This method does not require re-training to
specific input alterations and hence can be deployed in any clinical setting without prior
assumptions about protocol deviations. MBDA significantly reduces input dependencies
of CNNs while still exploiting the advantages of learning algorithms over entirely model-
based approaches. To demonstrate the superiority of our approach, we compare against
the intrinsic domain adaptation of DKI, i.e. against a network trained directly on output
coe cients of DKI fits (fit-to-end, F2E).
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7.2.1. Methods
The utilized dataset is described in Section 4.2 with the updated train test splits and ex-
tended patient cohort described in 6.4.1. The CNN for lesion classification (”Roi-to-end”,
R2E) as well as the ADC and AKC baselines are identical to the ones in Section 5.3. The
dataset comprises measurements at b-values of 0, 100, 750 and 1500 smm 2.
To overcome the dependency on specific b-values and enable clinical applicability of le-
sion classification regardless of scanning protocols, we propose to perform Model-based
Domain Adaptation (MBDA): During inference, the DKI model is fit to the signal inten-
sities of all available (potentially altered) b-values. In order to restore the original set of
b-value modalities seen during CNN training, estimates of the original signal intensities
S(b) are interpolated or extrapolated per voxel from the fitted DKI model (see Equation
4.1). Subsequently, the restored set of inputs is fed into the trained CNN to perform
test time inference (see Figure 7.4 top). To compare our approach against the intrinsic
domain adaptation of DKI, we train a baseline method on DKI fit parameters ADC and
AKC by feeding the parameter maps directly into the feature extraction and classification
modules of the CNN (F2E) (see Figure 5.1). At test time, ADC and AKC are fit using
the altered inputs (see Figure 7.4 bottom). For inference of subsets containing only two
b-values, which causes the DKI model to be under-constrained, we set AKC = 0.
7.2.2. Experimental Setup
Two exemplary scenarios of inputs variations at test time were studied: shifted scenario,
where one b-value seen by the CNN during training is provided at a di↵erent (shifted)
value at test time, and missing scenario, where one training b-value is missing at test
time. Both scenarios were imitated by training and testing on respective subsets of the
four b-values provided by the utilized dataset. Note, that scenarios comprising alterations
of multiple inputs were not studied due to the limited number of b-values provided. Fur-
thermore, no alterations were applied to b0 as in practice all protocols include at least
one b-value equal or close to zero [50, 228].
An upper bound performance for MBDA is given by training and testing on the same
subset of b-values (matched input). A lower bound performance for MBDA is given by
testing on the altered inputs without accounting for the discrepancy to the training data
(altered input).
The network details and training setup are equal to the setup reported in 5.4. The net-
works are trained using 5-fold cross validation with with 60% training- , 20% validation-
and 20% test data and the best epoch is selected based on the lowest validation error.
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Figure 7.4.: Conceptual Setup for Model-Based Domain Adaptation. Visualization of
the proposed MBDA for the scenario of missing input modalities at test time (
missing scenario) (top). The missing b-value input channel is reconstructed voxel-
wise from a DKI-model that has been fit to the remaining channels. The fit-to-
end architecture trained on the DKI output coe cients ADC and AKC is used for
comparison (bottom), where at test time ADC and AKC are re-fit under the altered
inputs.
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Evaluation is conducted by comparing the area under the receiver operator curves (AUC).
Significance tests were performed using DeLong’s method and corrected for multiple test-
ing using the Holm-Bonferroni-Method (initial ↵ = 0.05).
7.2.3. Results
Results are shown in Table 7.2.
Matched Input These results represent the upper bound on the performance in this study.
When decreasing the general number of b-value inputs (but identical during training an
testing), the observed decrease of performance is moderate indicating a general redun-
dancy of information across the four input images corresponding to four b-values in this
dataset. For instance, subsets of three b-values seem to roughly contain the same infor-
mation as the original four b-values with respect to overall performance.
Altered Input These results represent the lower bound on the MBDA performance in this
study. Strong input dependence with an average performance drop of 19.2% is observed for
R2E, when inputs di↵er between training and testing and no domain adaptation is applied.
The baseline method F2E, The intrinsic domain adaptation of the baseline method F2E
seems to work to some extend reducing the performance drop to an average of 10.6%.
Model-Based Domain Adaptation MBDA is able to significantly increase the lower bound
performance in the shifted scenario by 12.4% and in the missing scenario by 16.8% (see
Figure 7.5). Compared to F2E, MBDA considerably outperforms F2E by 5.3% for the
shifted scenario and 12.4% for the missing scenario. Notably, extrapolation to large b-
values is a poorly constrained problem, which causes performance drops across all explored
methods. As expected, F2E only works when constraining the DKI model (setting AKC =
0) during CNN training.
7.2.4. Discussion
The results of this study suggest that Model-based Domain Adaptation (MBDA) is an
e↵ective approach to overcome input dependencies and avoid re-training at clinical sites
during large-scale application of DWI-based lesion classification. Our approach signifi-
cantly increases the performance for both missing and shifted input scenarios by combining
optimal exploitation of input correlations of raw DWI with DKI-based signal estimation
to restore information lost due to altered input. In other words, MBDA is a “minimal
invasive” method, which leaves unaltered input untouched, while the implicit domain
adaptation performed by training and testing on fit parameters generates entirely new fit
parameters given partly altered input, discarding unaltered correspondences. The latter
works in theory, given a su cient number of b-value images, but su↵ers from fitting insta-
bilities in a typical DWI setup. In addition, when relying on implicit domain adaptation
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Table 7.2.: Results of the Model-based Domain Adaptation Study. Results comparing
all explored methods. All numbers report AUC except for p-values. x marks the
available b-values. o marks the derived b-value. * marks significance according to
statistical testing.
101
7. Increasing Robustness of End-to-end Medical Image Classification
Figure 7.5.: Visualization of Key Results from Input Variation Study. Mean AUC de-
rived from Figure 7.2. Matched input represents the upper bound with matching
b-value subsets during training and inference. Altered Input represents the lower
bound by testing on the altered subset without MBDA (intrinsic domain adapta-
tion in baseline method F2E is present). The Roi-to-end CNN (R2E) with MBDA
significantly improves the robustness towards heterogeneous inputs compared to the
intrinsic domain adaptation of DKI present in F2E in both scenarios.
of DKI, strong assumptions have to be made on the amount of b-value images available
during clinical inference prior to CNN training (as manually constraining the model by
setting AKC = 0 might be required), which contradicts the desire for input indepen-
dence. Future research includes studying multiple input alterations on datasets providing
a larger number of b-values, application on whole image breast DWI including the task
of lesion localization, investigating the generalization of deep learning models trained on
large DWI datasets and exploring the applicability to further entities. In summary, this
study shows how domain knowledge in form of a biophysical model can be exploited to
increase the robustness of learning-based systems in real life clinical scenarios.
7.3. Robust Hyperparameters: Systematic and Automated Method
Configuration
While often underconsidered in applied research such as medical image classification, the
choice of a model’s hyperparameters a↵ects all components of inductive bias, i.e. archi-
tecture, training data, loss function, and optimization, thus finding a good configuration
of hyperparameters for a given task is essential for the model’s ability to generalize to
unseen data. Currently, this process requires high levels of expertise and experience, with
small errors leading to strong performance drops [30]. Especially in 3D medical imaging,
where dataset properties like imaging modality, image size, (anisotropic) voxel spacing or
class ratio vary drastically, the pipeline design can be cumbersome, because experience on
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what constitutes a successful configuration may not translate to the dataset at hand. The
numerous expert decisions involved in designing and training a neural network range from
the exact network architecture to the training schedule and methods for data augmenta-
tion or post-processing. Each sub-component is controlled by essential hyperparameters
like learning rate, batch size, or class sampling. An additional layer of complexity on the
overall setup is posed by the hardware available for training and inference [205].
Attempts at alleviating this highly empirical task by algorithmic optimization range from
large sweeps over possible configurations such as Grid Search or Random Search [229] to
learning successful configurations directly from the data such as in AutoML [230, 231]
or Neural Architecture Search [232]. However, algorithmic optimization of co-dependent
design choices in this high dimensional space of hyperparameters amplifies both the num-
ber of required training cases as well as compute resources by orders of magnitude [232],
vastly exceeding the common setup in medical imaging applications. As a consequence,
the end-user is commonly left with an iterative trial and error process during method
design that is mostly driven by their individual experience, only scarcely documented and
hard to replicate, inevitably evoking suboptimal segmentation pipelines and methodolog-
ical findings that do not generalize under shifts of data domains [30, 229].
Thus, following this chapter’s introductory quote, in this study we condense domain
knowledge into a set of key design choices and heuristic rules in order to pose constraints
on the space of hyperparameters, shortcut the associated optimization process, and ulti-
mately enable robust and systematic model configuration.
As a prove of concept, we turn to the field of 3D semantic segmentation on biomedi-
cal images (see Section 3.3), the most popular methodological sub-field in medical image
analysis with 64% of contributions at MICCAI 2019 being related to it and 70% of in-
ternational competitions in the biomedical sector being segmentation tasks [170]. This
widespread interest has resulted in an unprecedented variety of public datasets provid-
ing a standardized environment for algorithm benchmarking, which is a key criterion for
meaningful validation of a concept regarding automatic adaptation to arbitrary datasets.
The challenges faced when designing a method for a medical image segmentation task
are further complicated by an unmanageable number of research papers that propose ar-
chitecture variations and extensions for performance improvement. This bulk of studies is
incomprehensible to the non-expert and di cult to evaluate even for experts [30]. Approx-
imately 12000 studies cite the 2015 U-Net architecture on biomedical image segmentation
[108] (see Section 3), many of which propose extensions and advances. We put forward
the hypothesis that a basic U-Net is still hard to beat if the corresponding pipeline is
designed adequately.
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To this end, we propose nnU-Net (“no new net”), which automatically adapts to arbitrary
datasets and enables out-of-the-box segmentation on account of two key contributions: 1.
We formulate the hyperparameter optimization problem in terms of a data fingerprint
(representing the key properties of a dataset) and a pipeline fingerprint (representing the
key design choices of a segmentation algorithm); And 2. We make their relation explicit
by condensing domain knowledge into a set of heuristic rules that robustly generate a
high quality pipeline fingerprint from a corresponding data fingerprint while considering
associated hardware constraints. In contrast to algorithmic method design that is formu-
lated as a task-specific optimization problem, nnU-Net readily executes systematic rules
to generate deep learning methods for previously unseen datasets. The superiority of
this concept is demonstrated by setting a new state of the art in numerous international
challenges by simply applying our algorithm without requiring additional user interaction.
Thus, nnU-Net advances the field of medical image segmentation in the following ways:
• nnU-Net is an open source tool that enables state-of-the-art segmentation for users
with little deep learning experience or researchers that require segmentations for
their task without the need for manual intervention.
• nnU-Net is a blueprint configuration for high precision tasks such as clinical applica-
tions, i.e. may serve as a robust starting point for further task-specific optimization
giving access superior configurations under limited compute and data budgets.
• nnU-Net is an integrative framework fostering the ambition and the ability of re-
searchers to validate novel ideas on larger numbers of datasets.
• nnU-Net is the first standardized baseline method in biomedical image segmentation
without the need for task-specific optimization, thus alleviating the noise currently
present in literature and catalyzing scientific progress in the field of biomedical deep
learning.
7.3.1. Analysis Current Practice and Formalizing the Process
We first provide a quantitative motivation for our contribution by shining light on the
importance of method configuration for performance of segmentation models, in contrast
to what often seems to be perceived as the crucial factor: the network architecture. To
this end, we take an in-depth look at the 2019 Kidney and Kidney Tumor Segmentation
(KiTS) semantic image segmentation challenge hosted by the MICCAI society [233]. The
MICCAI society has consistently been hosting at least 50% of all annual biomedical image
analysis challenges [170]. Challenges are international competitions that can be seen as
the equivalent to clinical trials for algorithm benchmarking. Typically, they are hosted by
individual researchers, institutes, or societies, aiming to assess the performance of mul-
tiple algorithms in a standardized environment [170]. With more than 100 competitors,
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the KiTS challenge was the largest competition at MICCAI 2019.
Network architecture is no guarantee for a successful model A thorough analysis
of the KiTS leaderboard (see 7.6) a reveals several insights on the current landscape of
deep learning based segmentation methods: First, the top-15 methods were o↵spring of the
(3D) U-Net architecture from 2016, confirming its impact on the field of biomedical image
segmentation. Second, the figure demonstrates that contributions using the same type of
network result in performances spread across the entire leaderboard. This observation is
in line with Litjens et al., who, in their review from 2017, found that ”many researchers
use the exact same architectures [...] but have widely varying results” [30]. Third, when
looking closer into the top-15, none of the commonly used architectural modifications (e.g.
residual connections [234, 103], dense connections [235, 104], attention mechanisms [236]
or dilated convolutions [109, 237]) represent a necessary condition for good performance
on the KiTS task. By example this shows that many of the previously introduced algo-
rithm modifications may not generally be superior to a properly tuned baseline method.
Again, this finding agrees with an observation by Litjens et al., who concluded that ”the
exact architecture is not the most important determinant in getting a good solution” [30].
Our findings below confirm this observation across multiple international challenges.
Details in pipeline configuration make the di↵erence Figure 7.6b details the results
for the challenge-winning architecture, a 3D U-Net with residual connections. While one
of the contributions using this architecture won the challenge, other contributions based
on the same principle cover the entire range of metric scores and rankings. A selection of
the key pipeline configuration parameters are shown for all non-cascaded residual U-Nets,
illustrating the co-dependent design choices that each team made during pipeline design.
The drastically varying configurations submitted by contestants indicate the underlying
complexity of the high-dimensional optimization problem implicitly posed by designing
a deep learning method for biomedical 3D image segmentation. This finding is again in
agreement with Litjens et al., who noted that from a range of manually found sets of
hyperparameters ”disappointingly, no clear recipe can be given to obtain the best set of
hyper-parameters as it is a highly empirical exercise” [30]. We refer to the entirety of
choices being made during method design as the pipeline fingerprint.
Di↵erent datasets require di↵erent pipeline configurations We extract the key
properties of 19 biomedical segmentation datasets including parameters like image sizes,
voxel spacing information or class ratios. We refer to this condensed representation charac-
terizing each dataset as the data fingerprint. The key parameters of these fingerprints
(as visualized in Figure 7.7) document an exceptional dataset diversity in biomedical
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Figure 7.6.: Pipeline Fingerprints from KITS 2019 Leaderboard Entries [233]. a)
Coarse categorization of leaderboard entries by architecture variation. All top 15
contributions are encoder-decoder architectures with skip-connections, 3D convolu-
tions and output stride 1 (“3D U-Net-like”, purple). No clear pattern arises from
further sub-groupings into di↵erent architectural variations. Also, none of the an-
alyzed architectures guarantees good performance, indicating a large dependency
of performance beyond architecture type. b) Finer-grained key parameters selected
from the pipeline fingerprints of all non-cascade 3D-Unet-like architectures with
residual connections (displayed on z-score normalized scale). The contributions vary
drastically in their rankings as well as their fingerprints. Still, there is no evident
or mono-parametric relation between single parameters and performance. Abbrevi-
ations: CE = Cross entropy loss function, Dice = Soft Dice loss function, WBCE =
Weighted binary cross entropy loss function.
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Figure 7.7.: Data Fingerprints Across Di↵erent Challenge Datasets. The data finger-
prints show the key properties (displayed on z-score normalized scale) for the 19
datasets used in the nnU-Net experiments (see Appendix D.3 for detailed dataset
properties and references). Datasets vary tremendously in their properties, requir-
ing intense method adaptation to the individual dataset and underlining the need
for evaluation of methodological claims on a larger number of datasets. Abbrevia-
tions: EM = Electron Microscopy, CT = Computed Tomography, MRI = Magnetic
Resonance Imaging.
107
7. Increasing Robustness of End-to-end Medical Image Classification
imaging. This diversity is the fundamental reason behind the lack of segmentation algo-
rithms that generalize across datasets. For each individual dataset, methods need to be
adapted and tuned for optimal performance. In this process, optimal pipeline settings
either directly or indirectly depend on the data fingerprint, resulting in a complex high-
dimensional optimization landscape of co-dependent parameters: To give one example,
we note that the image size a↵ects the size of patches the model sees during training,
which in turn a↵ects the required network topology (i.e. number of downsampling steps,
size of convolution filters, etc.). The network topology itself again influences several other
hyperparameters in the pipeline.
7.3.2. Methods
Figure 7.8a shows the current practice of adapting segmentation pipelines to a new dataset.
This process is expert-driven and involves manual trial-and error experiments that are
typically specific to the task at hand [30]. As shown in Figure 7.8b, nnU-Net addresses
the adaptation process systematically. Hyperparameters are divided into three groups:
blueprint, inferred and empirical parameters. The blueprint parameters represent fun-
damental design choices (such as using a plain U-Net-like architecture template) as well
as hyperparameters for which a robust default value can simply be picked (for example
loss function, training schedule and data augmentation). The inferred parameters encode
the necessary adaptations to a new dataset and include modifications to the exact net-
work topology, patch size, batch size and image preprocessing. The link between a data
fingerprint and the inferred parameters is established via execution of a set of heuristic
rules, without the need for expensive re-optimization when applied to unseen datasets.
Note that many of these design choices are co-dependent: The target image spacing, for
instance, a↵ects image size, which in return determines the size of patches the model
should see during training, which has to be counterbalanced by the size of training mini-
batches in order to not exceed GPU memory limitations. nnU-Net strips the user of the
burden to manually account for these co-dependencies. The empirical parameters are
autonomously identified via cross-validation on the training cases. Per default, nnU-Net
generates three di↵erent U-Net configurations: a 2D U-Net, a 3D U-Net that operates at
full image resolution and a 3D U-Net cascade where the first U-Net operates on down-
sampled images and the second is trained to refine the segmentation maps created by
the former at full resolution. After cross validation nnU-Net empirically chooses the best
performing configuration or ensemble. Finally, nnU-Net empirically opts for “non-largest
component suppression” as a postprocessing step when performance gains are measured.
The output of nnU-Net’s automated adaptation and training process are fully trained
U-Net models that can be deployed to make predictions on unseen images. For a more
detailed description and implementation details please see Appendix D.1.
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Figure 7.8.: Manual and Proposed Automated Configuration of Deep Learning Meth-
ods. a) Current practice of configuring a deep learning method for biomedical
segmentation: An iterative trial and error process of manually choosing a set of hy-
perparameters and architecture configurations, training the model, and monitoring
performance of the model on a validation set. b) Proposed automated configura-
tion by nnU-Net: Dataset properties are summarized in a “dataset fingerprint”. A
set of heuristic rules operates on this fingerprint to infer the data-dependent hy-
perparameters of the pipeline. These are completed by blueprint parameters, the
data-independent design choices to form ”pipeline fingerprints”. Three architectures
are trained based on these pipeline fingerprints in a 5-fold cross validation. Finally,
nnU-Net automatically opts for the optimal ensemble of these architectures and
performs postprocessing if required.
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7.3.3. Results
nnU-Net handles a wide variety of target structures and image properties
We tested nnU-Net by participating in various international biomedical image segmenta-
tion challenges that comprised 19 datasets and 49 segmentation tasks across a variety of
organs, organ substructures, tumors, lesions and cellular structures in magnetic resonance
imaging (MRI), computed tomography scans (CT) as well as electron microscopy (EM)
images. In all tasks, nnU-Net was trained from scratch using only the provided challenge
data. The nnU-Net blueprint parameter choices as well as the exact definition of heuris-
tic rules for inferred parameter generation were optimized in an expert-driven process on
basis of the 10 di↵erent Decathlon challenge training datasets. The remaining datasets
and tasks were used for independent testing, i.e. all nnU-Net settings were frozen and
simply applied without further optimization. Qualitatively, we observe that nnU-Net is
able to handle a large disparity in dataset properties and diversity in target structures,
i.e. generated pipeline configurations are in line with what human experts consider a
reasonable or sensible setting. Examples for segmentation results generated by nnU-Net
are presented in Appendix D.1.
nnU-Net outperforms specialized pipelines in a range of diverse tasks
Most international challenges use the Soerensen-Dice coe cient as a measure of overlap
to quantify segmentation quality [233, 178, 238, 34]. Here, perfect agreement results in a
Dice coe cient of 1, whereas no agreement results in a score of 0. Other metrics used by
some of the challenges include the Normalized Surface Dice (higher is better) [121] and the
Hausdor↵ Distance (lower is better), both quantifying the distance between the borders of
two segmentations. Figure 7.9 provides an overview of the quantitative results retrieved
by nnU-Net and the competing challenge teams across all 49 segmentation tasks. Despite
its generic nature, nnU-Net outperforms most existing semantic segmentation solutions,
even though the latter were specifically optimized towards the respective task. Overall,
nnU-Net sets a new state of the art in 29 out of 49 target structures and otherwise shows
performances on par with or close to the top leaderboard entries.
Multiple tasks enable robust design decisions
nnU-Net is a framework that enables benchmarking of new modifications or extensions
of methods across multiple datasets without having to manually reconfigure the entire
pipeline for each dataset. To demonstrate this, and also to support some of the core
design choices made in nnU-Net, we systematically tested the performance of common
pipeline variations in the nnU-Net blueprint parameters on 10 di↵erent datasets (Figure
7.10): the application of two alternative loss functions (Cross-entropy and TopK10 [239]),
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Figure 7.9.: nnU-Net Outperforms Most Specialized Deep Learning Pipelines. Quan-
titative results from all international challenges that nnU-Net competed in. For each
segmentation task, results achieved by nnU-Net are highlighted in red, competing
teams are shown in blue. For each segmentation task the respective rank is displayed
in the bottom right corner as nnU-Net’s rank / total number of submissions. Axis
scales: [DC] Dice coe cient, [OH] other score (higher is better), [OL] other score
(lower is better).
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the introduction of residual connections in the encoder, using three convolutions per reso-
lution instead of two (resulting in a deeper network architecture), two modifications of the
optimizer (a reduced momentum term and an alternative optimizer (Adam [240])), batch
norm instead of instance norm [111] and the omission of data augmentation. Ranking
stability was estimated by bootstrapping as suggested by the challengeR tool [241].
The volatility of the ranking between datasets demonstrates how single hyperparame-
ter choices can a↵ect segmentation performance depending on the dataset. The results
clearly show that caution is required when drawing methodological conclusions from eval-
uations that are based on an insu cient number of datasets. While five out of the nine
variants achieved rank 1 in at least one of the datasets, neither of them exhibits consistent
improvements across the ten tasks. The original nnU-Net configuration shows the best
generalization and ranks first when aggregating results of all datasets.
In current research practice, evaluation is rarely done on more than two datasets and
even then the datasets often have very similar properties (such as both being abdominal
CT scans). As we show here, this evaluation practice is unsuitable for drawing general
methodological conclusions. nnU-Net alleviates this shortcoming in two ways: the orig-
inal nnU-Net serves as a plug-and-play, standardized and state-of-the-art baseline, and
the presented underlying framework can be extended to enable e↵ective evaluation of new
concepts across multiple tasks.
7.3.4. Discussion
In this study, we demonstrated how the cumbersome trial-and-error process of deep learn-
ing model configuration can be automated without the excessive requirements on data
and compute posed by algorithmic optimization such as in learning based-approaches
[230, 229, 232, 231]. Instead, we condense years of expertise and domain knowledge into
identifying robust key design choices and a set of systematic rules, thus posing constraints
on the space of possible configurations and shortcutting the optimization process. More-
over, while algorithmic optimization approaches require task-specific re-optimization on
the data at hand, our heuristics are developed on the basis of 10 di↵erent datasets of the
Medical Segmentation Decathlon [173]. The diversity within these 10 datasets has proven
su cient to achieve robustness to the variability encountered in all the remaining chal-
lenge participations. This is quite remarkable given the underlying complexity of method
design and strongly confirms the suitability of condensing the process in a few generally
applicable rules that are simply executed when given a new dataset fingerprint and do
not require any further task-specific actions. The formal definition and also publishing
of these explicit rules is a step towards systematicity and interpretability in the task of
hyperparameter selection, which has previously been considered a “highly empirical exer-
cise” for which “no clear recipe can be given”, as noted by Litjens et al. in their review
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Figure 7.10.: Evaluation of method design decisions across multiple tasks. (a-j) Evalu-
ation of exemplary model variations on ten datasets of the medical segmentation
decathlon (D1-D10, see Figure 7.7 for dataset references). The analysis is done for
every dataset by aggregating validation splits of the five-fold cross-validation into
one large validation set. 1000 virtual validation sets are generated via bootstrap-
ping (drawn with replacement). Algorithms are ranked on each virtual validation
set, resulting in a distribution over rankings. The results indicate that evaluation
of methodological variations on too few datasets is prone to result in a mislead-
ing level of generality, since most performance changes are not consistent over
datasets. (k) The aggregation of rankings across datasets yields insights into what
design decisions robustly generalize.
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from 2017 [30].
Specifically, we presented nnU-Net, a deep learning framework for biomedical image anal-
ysis that automates model design for 3D semantic segmentation tasks. The method sets a
new state of the art in the majority of tasks it was evaluated on, outperforming all respec-
tive specialized processing pipelines. The strong performance of nnU-Net is not achieved
by a new network architecture, loss function or training scheme (hence the name nnU-Net
- “no new net”), but by replacing the complex process of manual pipeline optimization
with a systematic approach based on explicit and interpretable heuristic rules. Requiring
zero user-intervention, nnU-Net is the first segmentation tool that can be applied out-of-
the-box to any dataset. and is thus the ideal tool for users who require access to semantic
segmentation methods and do not have the expertise, time, data resources or compute
resources required to manually adapt existing solutions to their problem.
Our analysis on the KITS leaderboard as well as nn-UNet’s performance across 19 datasets
confirms our initial hypothesis that common architectural modifications proposed by the
field during the last 5 years may not necessarily be required to achieve state-of-the-art
segmentation performance. Instead, we observed that contributions using the same type
of network result in performances spread across the entire leaderboard. This observation
is again in line with Litjens et al., who found that ”many researchers use the exact same
architectures [...] but have widely varying results” [30]. There are several possible reasons
for the fact that architectural extensions proposed by the literature may not hold beyond
the dataset they were proposed on: Many of them are evaluated on a limited amount
of datasets, often as low as a single one. In practice this largely limits their success on
unseen datasets with varying properties, because the quality of the hyperparameter con-
figuration often overshadows the e↵ect of the evaluated architectural modification. This
finding agrees with another observation by Litjens et al., who concluded that ”the ex-
act architecture is not the most important determinant in getting a good solution” [30].
Moreover, as shown above, it can be di cult to tune existing baselines to a given dataset.
This obstacle can unknowingly, but nonetheless unduly, make a new approach look better
than the baseline, resulting in biased literature.
In this work, we demonstrated that nnU-Net is able to alleviate this bottleneck of current
research in biomedical image segmentation in two ways: On the one hand, nnU-Net serves
as a framework for methodological modifications enabling simple evaluation on an arbi-
trary number of datasets. On the other hand, nnU-Net represents the first standardized
method that does not require manual task-specific adaptation and as such can readily
serve as a strong baseline on any new 3D segmentation task.
Despite its strong performance across 49 diverse tasks, there might be segmentation tasks
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for which nnU-Net’s automatic adaptation is suboptimal. For example, nnU-Net was de-
veloped with a focus on the Dice coe cient as performance metric. Some tasks, however,
might require highly domain specific target metrics for performance evaluation, which
could influence method design. Also, yet unconsidered dataset properties could exist
which may cause suboptimal segmentation performance. One example is the synaptic
cleft segmentation task of the CREMI challenge (https://cremi.org). While nnU-Net’s
performance is highly competitive (rank 6/39), manual adaptation of the loss function as
well as electron microscopy-specific preprocessing may be necessary to surpass state-of-
the-art performance [242]. In principle, there are two ways of handling cases that are not
yet optimally covered by nnU-Net: For potentially re-occurring cases, nnU-Net’s heuris-
tics could be extended accordingly; for highly domain specific cases, nnU-Net should be
seen as a good starting point for necessary modifications.
In summary, nnU-Net sets a new state of the art in various semantic segmentation chal-
lenges and as such displays strong generalization characteristics without need for any
manual intervention, such as the tuning of hyper-parameters. As pointed out by Litjens
et al. and quantitatively confirmed here, hyper-parameter optimization constitutes a ma-
jor di culty for past and current research in biomedical image segmentation. nnU-Net
automates the otherwise often unsystematic and cumbersome procedure and may thus
help alleviate this burden. We propose to leverage nnU-Net as an out-of-the box tool
for state-of-the-art segmentation, a framework for large-scale evaluation of novel ideas
without manual e↵ort, as a standardized baseline method to compare ideas against, and
as a starting point for further task-specific tuning in high performance tasks such as real
life applications giving access to superior configurations under limited compute and data
budgets.
While this study focused on semantic segmentation as a prove of concept e↵ectively lim-
iting the scope to end-to-end predictions on pixel-level, we currently work on adapting
the presented method to generating predictions on object-level (such as in Chapter 6).
Future work will further focus on leveraging cross-task information: The remarkable per-
formance of nnU-Net compared to specialized solutions might be related to a regularizing
e↵ect stemming from cross-task information transfer. We hypothesize that nnU-Net only
scratches the surface of the potential that lies withing exchanging knowledge and infor-
mation between tasks, because currently the transfer happens on an abstract and implicit
level of pipeline configuration, but models are still trained from scratch on each task





The work presented here aims to study the potential of end-to-end learning in clinical
classification systems and contribute towards crossing the ’AI chasm’ in medical image
analysis, i.e. the gap between remarkable results of deep learning based diagnosis in re-
search environments and their stuttering performance in clinical practice, by identify key
leverage points where domain knowledge can be transformed into informed inductive bi-
ases to increase model robustness.
In Chapter 4 and 5 we studied the potential of learning algorithms for clinical diag-
nosis starting with the current clinical standard and gradually substituting single pipeline
components by learning algorithms. In Chapter 4, we replaced current rule-based decision
making in DWI-based breast cancer classification with large scale Radiomics feature ex-
traction and machine learning-based classification and achieved human-level performance
on an independent test set comprising images from a di↵erent clinical site acquired from
a di↵erent scanner[32]. In clinical numbers, our approach is able to prevent 46 out of 66
unnecessary biopsies while detecting 60 out of 61 cancerous cases. We further showcase
an application of this approach to cardiac diagnosis on cine-MRI and ranked second in
an international competition [42, 34]. In Chapter 5 we continued to follow the dogma of
end-to-end learning, i.e. the idea that enabling simultaneous optimization of all pipeline
components with respect to the ultimate clinical target improves upon compound rule-
based diagnosis pipelines. To this end, we proposed a CNN architecture designed to
integrate the biophysical model for image normalization utilized in DWI, handcrafted
(Radiomics) feature extraction as well as clinical categorization, enabling ROI-based clas-
sification of breast lesions on DWI [35]. In an in-depth analysis, we revealed potential
hidden in DWI by demonstrating the benefits of learned image normalizations as com-
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pared to the biophysical model currently deployed in clinical research and provide results
indicating a complementary value of representations learned in the CNN with respect
to handcrafted feature extraction [36]. The fact, that the CNN is not showing results
considerably superior to the radiomics approach based on handcrafted features indicates
that the utilized dataset is not large enough to reveal the advantage of unbounded model
complexity intrinsic to end-to-end learning. While Chapters 4 and 5 studied the benefits
of learning algorithms in clinical diagnosis systems, one important part of the pipeline
was not taken into account: The localization of Regions of Interest (ROIs) in the image.
The Machine Learning Classifier based on Radiomics features presented in Chapter 4 as
well as the CNN presented in Chapter 5 relied on previous manual annotation of lesions
(or previous automated annotation of cardiac structures in the case of cardiac diagno-
sis, see Section 4.1.2). This scenario, however, fails to significantly alleviate the current
workload related to human readout of medical images, which is to a large extend assigned
to location of ROIs [169]. When including the task of localizing ROIs into the learning
process to enable true end-to-end diagnosis starting at the raw images in Chapter 6, there
are three deep learning methodologies to be considered that attend to the problem at
three di↵erent granularity levels of image classification, which translate to specific model
evaluation metrics and in return answer to di↵erent clinical questions. This relation is
in practice distorted by several nuisance factors inducing discrepancies between model
evaluation in research environments and actual clinical requirements, ultimately leading
to incongruous evaluation metrics and in return contributing to preventing end-to-end di-
agnosis systems from clinical application [27, 129, 130]. Specifically, we revealed a largely
neglected predicament between the strive for crossing the AI chasm by evaluating mod-
els at clinically relevant scales on one side, and optimizing for e cient training under
the burden of data scarcity on the other side. To address this challenge, we proposed
Retina U-Net, a deep learning architecture that fuses state-of-the-art object detection
with pixel-wise training signals from semantic segmentation. We demonstrated, how the
additional segmentation supervision poses an additional constraint on the training pro-
cess, which increases data e ciency and thus enables end-to-end object detection and
classification on medical images, which corresponds to aligning the model output to the
clinically relevant scale [37]. We showcased the superiority of this concept by means of an
in-depth comparison to prevalent models from object detection, semantic segmentation
and instance segmentation operating in 2D as well as 3D on Breast DWI, CT of the Lung
and a series of toy experiments. The corresponding code was open sourced as the Medical
Detection Toolkit, the first comprehensive framework for object detection on medical im-
ages including e.g. modular implementations of all explored models operating in 2D and
3D [38]. We finally applied our approach to the task of lung cancer staging on PET-CT
and performed a sensitivity study under varying clinical training scenarios, indicating the
complementary value of secondary tumor annotations for the overall sensitivity of pri-
mary tumors. This study was performed in preparation for prospective clinical trials of
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our algorithm to be performed in the university hospital Basel [39]. While Chapters 4
and 5 reveal large potential of learning algorithms for diagnosis systems compared to the
current clinical standard, Chapter 7 continued on the path of Chapter 6 in identifying
further leverage points in existing end-to-end learning systems and presented three exam-
ples, where expertise specific to the domain of medical image analysis is condensed into
inductive biases aiming to increase model robustness. First, we addressed the challenge of
erroneous training annotations by substituting the classification component of end-to-end
object detection for regression, which enables to train models directly on the continuous
scale of underlying pathological processes, thus elevating the models’ robustness against
rater confusions [40]. Secondly, we addressed the challenge of input heterogeneities faced
by trained models when deployed across clinical sites by proposing model-based domain
adaptation, which recaptures the original training domain given altered inputs and thus
restores robust generalization [41]. And finally, we addressed the highly unsystematic,
elaborate and subjective trial-and-error process of finding a robust set of hyperparame-
ters for a given task by introducing a method that condenses domain knowledge in a set
of key design choices and systematic rules and thus enables automated and robust deep
learning pipeline configuration on a large variety of medical datasets [42].
8.2. Outlook
Chapter 1 outlined the rise of deep learning in medical image analysis and the tremendous
hopes and expectations regarding its impact on the future of health care. As summarized
in Section 8.1, the work presented in this thesis experimentally confirms the vast po-
tential of end-to-end learning in diagnosis systems and contributes towards solutions of
some of the key obstacles that currently prevent widespread clinical application such as
data scarcity, discrepancy between evaluation metrics and clinical relevance, ambiguity in
training annotations, or the high manual e↵ort of method adaptation to unseen datasets.
In this Section, we shine light on how the findings and contributions presented here tie
into the bigger picture of the digital transformation of health care in the 21st century and
discuss implications for the projected future of three key players: Researchers, clinicians,
and patients.
Quo Vadis Medical Image Analysis?
The success of deep learning has had severe impact on the core identity of applied re-
search fields such as medical image analysis: The shift of research focus away from the
engineering of task-specific systems and towards the successful adaptation of existing deep
learning methods drastically clashes with research’s intrinsic strive for methodological nov-
elty. The consequential re-definition of what constitutes a ”novel contribution” in such
research areas, where large parts of domain specific knowledge have become seemingly
unhelpful or even bothering overnight, is an ongoing process. While deep learning has
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brought the long-existing objective of automated medical image classification into reach,
it also projected a drastic dependency on training data onto the field. As a consequence,
the current endeavors in both medical image analysis and deep learning research align to
large extents in addressing the challenge of sample e ciency and model generalization.
One possible way for researchers from within the applied domain to move towards the
overarching goal of widespread clinical application of deep learning systems has been
demonstrated in this thesis as identifying key leverage points, where domain knowledge
can be condensed into inductive biases that reduce the space of possible solutions during
generalization and thus increase model robustness. Other promising lines of research from
within the medical domain include the attempt to tackle data scarcity at the source in
form of federated learning algorithms that enable decentralized training across multiple
clinical sites while circumventing patient privacy issues that often prevent large-scale cen-
tralized data platforms [243, 244, 245], or the deployment of probabilistic models, which
resolve and quantify ambiguities in medical images thus enhancing systematic decision
making under limited evidence [217, 246, 247].
Due to the close alignment of methodological challenges, a look at current endeavors
in artificial intelligence research might amount to a complementary perspective on the
future of research in the medical domain. We observe that current considerations in this
field nicely tie in with one of the driving principles of this thesis: To scrutinize end-to-end
learning and insert prior knowledge into models in order to increase sample e ciency.
In the AI community, the paradigm of end-to-end learning is increasingly rivaled by the
preceding paradigm of ”Symbolic AI”, which, while object to varying interpretations, is
described as increasing the prior knowledge in models to enforce symbolic entities as well
as logical reasoning among them [248]. There is a strong current believe that true machine
intelligence can only be accomplished by a combination of the two paradigms [249, 250].
Turing award winner and AI pioneer Geo↵rey Hinton, for instance, devoted large extends
of his research in recent years to this idea, specifically to increasing the sample e ciency of
CNNs by complementing their inherent translational invariance towards objects in images
by additional prior knowledge in form of capsule structures that enable to exploit rota-
tional invariance as well as scale invariance. [251, 252, 253]. Moreover, his fellow Turing
award recipient and AI pioneer Yoshua Bengio recently urged for scrutinizing end-to-end
learning and drawing inspiration from ”high level cognition” in human learning, instead
of simply striving for larger datasets, larger models and larger computers [254, 255]. In
contrast to pure end-to-end learning, the narrative of combining the two paradigms is
backed up by strong evidence from neurology, where high level reasoning on top of ob-
servation learning in the human brain seems to drastically increase sample e ciency and
enable robust generalization [256, 257]. On the other hand, there does not appear to be a
global objective in the brain that is optimized by backpropagating error signals [258, 259].
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Instead, the biological brain is highly modular and learns predominantly based on local
information [260]. Taken together, there is an increasing call for approaches to artificial
intelligence beyond pure learning from observations, which results in a growing number
of publications in this direction, one of which bearing the vivid title ”Putting an End to
End-to-End” [261].
Will Artificial Intelligence Replace Radiologists?
As elaborated on in Chapter 1, hopes are high regarding the impact of deep learning based
diagnosis systems on health care, mainly due to an increasing number of models reaching
human-level performance on specific tasks [15, 16, 17, 18]. While challenges such as in-
su cient model robustness under data shift or incongruous evaluation metrics in research
environments currently hamper clinical translations, there exist numerous promising ap-
proaches to overcoming this AI chasm, many of which have been demonstrated or discussed
in the scope of this thesis. Following increased generalization abilities and sound tech-
nical validation, a growing number of proposed models is expected to enter the clinical
validation stage, i.e. the evaluation of algorithms in prospective studies and randomized
clinical trials [262, 26, 27, 263]. In this context, widespread clinical application of deep
learning based diagnosis systems is arguably not a matter of if, but when. The questions
remain, will this innovation result in a significant change of day-to-day clinical workflows?
And will technology eventually replace radiologists?
Geo↵rey Hinton stated in late 2016 it is “quite obvious that we should stop training
radiologists” as image perception algorithms are very soon going to be demonstrably bet-
ter than humans. Radiologists are, he said, “the coyote already over the edge of the cli↵
who hasn’t yet looked down” [264]. This statement is to be seen in contemporary context
of the peaking AI-hype in 2016 inspiring a considerable number of reputable figures from
science [264], economy [265] and health care [266] to predict a looming redundancy of radi-
ologists. Many of these voices, including Geo↵ry Hinton, have since revised their thinking
[267] by courtesy of two key reasons that make automated decision making in medical
diagnostics appear more like a distant dream than an imminent revolution: Coverage of
rare diseases and ethical concerns.
As Curtis Langlotz, Radiology Professor at Stanford, states in his editorial from 2019,
the ability to identify a single disease, as commonly pursued in current attempts at deep
learning based diagnosis systems, is a drastic oversimplification of what radiologists do
[268]: A comprehensive catalog of radiology diagnoses lists nearly 20000 terms for dis-
orders and imaging observations and over 50000 causal relations [269]. According to
Langlotz, ”an AI algorithm that diagnoses common chest conditions [...] is a major step
forward, an incredible asset to underserved regions, and could serve as a valued assistant
for a subspecialty radiologist. But human radiologists are also trained to detect uncom-
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mon diseases in the long tail of the distribution including rheumatoid arthritis, sickle cell
disease, and posttransplantation lymphoproliferative disorder”.
Further, it is unsurprising that the idea of algorithmic decisions regarding human health
raises more than one red flag among ethics committees, legal scholars and regulators [270],
whose concerns mainly revolve around three topics: fairness, accountability, and trans-
parency [263]: Learning algorithms can be shaped unwittingly by biases in the training
data such as under-representation of certain sub-groups of the population e.g. concerning
age, gender, ethnicity or social status, thus potentially amplify existing fairness issues
in health care systems around the globe. There is a further risk of “automation bias,”
meaning that humans start to rely entirely on the work of a machine, instead of applying
their own critical judgment and scrutiny [271]. Such biases highlight the role of radiolo-
gists to guide AI developers, users, and regulators and to hold them accountable to ensure
algorithms are safe and unbiased [263]. Moreover, it is unclear how courts will assign lia-
bility for patient harm resulting from an algorithm’s decision, because moral responsibility
is, at least in the developed world, widely accepted as an intrinsically human property
that cannot be allocated or shifted to algorithms or machines, however sophisticated they
may be [272]. Since AI systems exhibit ‘autonomy’ to some degree, the European Group
on Ethics requires ”meaningful human control” being maintained and that humans ulti-
mately remain in control of the decision-making process [272]. This postulate is commonly
referred to as ‘human in the loop’. An exception could be made in poor-resource areas
such as in the developing world, where more radical setups might be required, because a
large number of patients are currently treated by nurses or paramedical health workers,
who could be trained to receive diagnostic decisions from automated tools to compensate
for a lack of doctors [273, 274].
Taken together, the clinical role for automated diagnosis systems in current projections
is not one of fully autonomous and unsupervised decision making, but one of decision
support for specific tasks. This innovation, however, signifies an imperative component
in future health care enabling clinicians to cope with aging populations and increasing
demand of medical imaging [6, 4]. Specifically, automation is expected to take on the bur-
den of repetitive perception duties such as image annotation or disease detection and at
the same time enable radiologists to focus on other important tasks such as embedding of
imaging into clinical workflows and patient history, image acquisition, high level decision
making and reporting, research and innovation, or patient interaction [275]. Eric Topol
describes this transformation in his book ”Deep Medicine: How Artificial Intelligence can
make Health Care Human Again” as follows: “What we need in medicine is more inter-
human contact and bonding [...]. [Radiologists] could come out of the basement, which is
where they live in the dark” [276]. And Curtis Langlotz concisely summarizes the current
perspectives on the future of radiology as: “AI won’t replace radiologists, but radiologists
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who use AI will replace radiologists who don’t” [268].
The Patient of the Future
Finally the question remains: How is the AI-driven automation of health care in general,
and of medical image classification in particular, going to a↵ect the lives of patients in the
future? At present, nearly every patient will experience a diagnostic error in their life-
time, sometimes with devastating consequences [277]. In the united states, medical errors
amount to the third leading cause of death [278]. The promise of AI-driven automation
in health care is to diminish erroneous decision making by enabling personalized care on
the basis of all known information about a patient in real time while incorporating lessons
from a collective experience based on vast amounts of data [279]. In radiological diag-
nostics, 60–80% of errors happen during image perception [280], implying an urgent need
for automated medical image classification. Further, automation is expected to bring
down costs and to reduce sources of human error such as fatigue or misinterpretation
[276], ultimately driving a transformation towards preventive, personalized and ubiqui-
tous health care [27, 276]. In his recent book ”The patient will see you know: The future
of medicine is in your hands” [281], Eric Topol ties this process into the bigger picture
of global digitalization and predicts a ”Gutenberg moment” for medicine, that, similar to
how the printing press took learning out of the priestly class, AI-driven automation and
the mobile internet will give unprecedented control to patients over their own health care,
and eventually lead to a democratization of medicine.
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A. Evaluation Metrics for Classification
Tasks
Classification models assign events (i.e. images, objects, or pixels according to the gran-
ularity level of the model) to di↵erent classes. Evaluation is commonly performed on a
per-class basis, meaning each possible class is evaluated individually by checking whether
the model assigned events correctly or incorrectly to this class according to some ground
truth value. This results in the evaluation scheme depicted in Figure A.1, where for each
class, events are grouped into the categories True Positive (TP), False Positive (FP),
False Negative (FN) and True Negative (TN). Based on this event categorization, several
standard metrics can be computed:
Accuracy = (TP + TN) / (TP + TN + FP + FN) (A.1)
Sensitivity = TP / (TP + FN) (A.2)
Specificity = TN / (TN + FP) (A.3)
Precision = TP / (TP + FP) (A.4)
F1  Score = 2TP / (2TP + FN + FP) (A.5)
While Accuracy might be the most intuitive measurement by simply representing the ratio
of correctly classified events, it leads to deceived interpretation on imbalanced datasets.
Consider for instance a binary task, where 99.9% of events belong to class 1. By simply
predicting class 1 for all events, the model would achieve an accuracy of 99.9%. Thus, in
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research, models are often evaluated by reporting a trade-o↵ between sensitivity an either
precision or specificity, such as the F1-Score.
In practice, classification models often do not predict discrete class assignments of events,
but rather continuous scores that may sometimes be interpreted as the confidence or
probability of an event belonging to a certain class. The common evaluation strategy for
such continuous predictions is to apply discretization operations and subsequently pro-
ceed with standard counting metrics as described above. In multi-class setups, argmax
is typically applied for discretization, where events are assigned to the class with the
highest prediction score. In binary classification problems (or class-individual evaluation
of multi-task setups) on the other hand, discretization is achieved by selecting a cut-o↵
value and separating events by whether their associated prediction score lies above or
below this threshold. This process of discretization, however, entails loss of fine-grained
information regarding the model’s predictions and thus performance. In binary classi-
fication setups, there are attempts at recapturing this information by reporting metrics
for a whole range of cut-o↵ values. The most prominent example are Receiver Operating
Characetristic (ROC) curves, where sensitivity and specificity are reported for all possible
cut-o↵ values in a 2-dimensional plot. ROC curves can be reduced to a single score for
simplified reporting by integrating the area under the ROC curve. The resulting score is
referred to as the Area Under the Receiver Operating Characetristic Curve (AUC). Con-
straining the AUC to certain subranges of sensitivity in order to enable task-specific focus
of evaluation results in the partial AUC (pAUC). Since ROC includes the computation
of specificity and hence depends on the amount of true negatives, it has recently been
reported to exhibit brittle behavior e.g. in binary tasks, where a large part of events can
easily be assigned to the background class resulting in high amounts of true negatives
without requiring separation power by the model [282]. It has thus been suggested to
report the PRC on such imbalanced datasets, which substitutes specificity by precision
to discard the dependency on true negatives. Equivalently to AUC the integral under the
PRC is reported as the Area under the Precision Recall Curve (AUPRC). The latter is in
practice often reported as Average Precision (AP), with the small di↵erence that instead
of numerical integration (i.e. trapezoidal interpolation) precision values at all sensitivity
values are simply averaged. Multi-class setups are dealt with by computing AP over all
individual classes and averaging the results, which is referred to as mAP.
Evaluating Image Classification at Di↵erent Levels of Granularity Image clas-
sification models generate output predictions at di↵erent levels of granularity. This is
important, because the meaning of associated model evaluation changes across levels and
in return a↵ects which initial question about the data is a model answers to (such as di↵er-
ent clinical questions in medical applications). While the di↵ering strategies for evaluation
were introduced above by generically describing the classification of ”events”, the defini-
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Figure A.1.: Evaluation Scheme of a Classification Model.
tion of a event changes across granularity levels, i.e. evaluation on patient-level essentially
counts correctly vs. incorrectly classified patients, etc. . Evaluation on Patient-level and
pixel-level tasks is straightforward, often reporting AUC for binary problems and F1-
score for multi-class setups (in segmentation tasks on pixel-level, F1-score is often called
Soerensen-Dice-Coe cient.), while evaluation on object-level needs some additional con-
siderations. Here, the set of classified events is not predefined such as the number of
images or pixels in a dataset, but depends on an upstream detection task. This task is
implemented as an additional localization requirement on predictions in the form of Inter-
section over Union (IoU) matching, i.e. box coordinates associated with predictions need
to exhibit minimum overlap with the coordinates of the ground truth object according to
some IoU-threshold. Predictions not satisfying this criterion are filtered out, i.e assigned
to either false-positives or true-negatives according to the associated confidence score an
the current classification-threshold. As a consequence, true negative-based metrics such
as AUC) su↵er from skewed datasets during evaluation of the downstream classification.
Consider for instance a detection algorithm that predicts many objects on background
with low confidence score. These low-confidence objects would result in high amounts of
true negative predictions leading to over-optimistic AUC values. As a consequence, mAP,
which does not consider true negatives by substituting specificity for precision, is often
reported in object-level evaluation such as performed in object detection tasks. Alter-
natively, object-level evaluation in the medical domain often reports the Free-Response
Receiver Operating Characteristic (FROC) curve, where sensitivity is plotted over the
number of false positives per image (or patient). This curve is sometimes condensed into
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Table B.1.: Histopathology of Lesions in the Breast DWI Dataset.
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Table B.2.: Lesions Size Statistics of the Breast DWI Dataset.
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We calculated a total number of 359 imaging features, divided in four groups as follows: (1) 
21 first-order features (FO) (2) 17 volume and shape features (VSF) and (3) 321 texture 
features (TF). Briefly, FO were calculated from the histogram of voxel intensities using first-
order statistics. VSF include diametral, volumetric and surface measurements, however also 
shape features, e.g. compactness or sphericity. TF are able to characterize the topography 
of intensity distribution and periodicity in the tumor volume and include co-occurrence, run-
length, size-zone, as well as neighbourhood gray level based features. Wavelet 
decompositions of the original images evaluate the radiomics features at varying spatial 
frequencies and resolutions with pronounced focus on edge information, along the three 
spatial directions. 
 
Group 1: First order statistics 
 
First order statistics describe the distribution of gray values within an image. Let 𝑿 and 𝑿𝒂𝒍𝒍 
denote the intensity values of all voxels within the corresponding Region of Interest (ROI) 
with 𝑁 voxels and the whole image, respectively. The mean value of the gray values within 
the ROI is 𝑋. 
The probability vector of the first order histogram with 𝑁𝑙 discrete bins is denoted with 𝑷 and 
the center gray values with 𝑩. 
 
1. Covered Image intensity Rage: 
𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑟𝑎𝑛𝑔𝑒 ≔  
max 𝑿 − min 𝑿
max 𝑿𝒂𝒍𝒍 − min 𝑿𝒂𝒍𝒍
 
2. Energy: 










𝑘𝑢𝑟𝑡𝑜𝑠𝑖𝑠 ∶=  
∑ 𝑷(𝑖) ∗ (𝑩(𝑖) −  𝑋)
4𝑁𝑙
𝑖
(√∑ 𝑷(𝑖) ∗ (𝑩(𝑖) − 𝑋)𝑁𝑙𝑖 )
4 
5. Maximum: 
The maximum intensity value in 𝑿, i.e.  max 𝑿 
6. 10%-Percentile 
The 10%-Percentile is the lowest intensity value 𝑿10 which is higher than the intensity 
of at least 10% of the observation.  
7. 90%-Percentile 
The 90%-Percentile is the lowest intensity value 𝑿90 which is higher than the intensity 
of at least 90% of the observation.  
8. Interquantile Range  
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The interquantile range is defined as the difference between 75% and the 25% 
quantile:  
𝐼𝑛𝑡𝑒𝑟𝑞𝑢𝑎𝑛𝑡𝑖𝑙𝑒 𝑅𝑎𝑛𝑔𝑒 ≔  𝑿𝟕𝟓 − 𝑿𝟐𝟓 
9. Mean: 







10. Mean absolute deviation: 




11. Robust Mean Absolute Deviation 
The robust mean absolute deviation is the ‘mean absolute deviation’ for all 
observations between the 10% and 90% Percentile.  
12. Median: 
The median value of all intensity values in 𝑿, i.e. the gray value 𝑥𝑀𝑒𝑑𝑖𝑎𝑛 for which  
| {𝑥 | 𝑥 ∈  𝑿 𝑎𝑛𝑑 𝑥 < 𝑥𝑀𝑒𝑑𝑖𝑎𝑛} | =  | {𝑥 | 𝑥 ∈  𝑿 𝑎𝑛𝑑 𝑥𝑀𝑒𝑑𝑖𝑎𝑛 < 𝑥} | 
13. Minimum: 
The minimum intensity value in 𝑿, i.e.  min 𝑿 
14. No. of Voxels: 
The number of voxels in 𝑿, i.e.  𝑛𝑜. 𝑜𝑓 𝑣𝑜𝑥𝑒𝑙𝑠 ∶=  |𝑿| 
15. Range:  
𝑟𝑎𝑛𝑔𝑒 ≔  max 𝑿 − min 𝑿 
16. Root Means Square (RMS): 





𝑘𝑢𝑟𝑡𝑜𝑠𝑖𝑠 ∶=  
∑ 𝑷(𝑖) ∗ (𝑩(𝑖) −  𝑋)
3𝑁𝑙
𝑖
(√∑ 𝑷(𝑖) ∗ (𝑩(𝑖) − 𝑋)𝑁𝑙𝑖 )
3 
18. Standard deviation: 
𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 ∶=  √
1
𝑁 − 1 





19. Sum of intensities: 










𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 ∶=  
1
𝑁 − 1 








Group 2: Volume and shape based features 
 
The features that are described within this group assess the shape and size of a given 
Region of Interest. A mesh is generated from the voxel-based annotation and used to 
calculate the surface area 𝐴. The corresponding volume 𝑉 is estimated based on voxel 
number.  
22. Compactness 1: 






23. Compactness 2: 




24. Compactness 3:  






25. Maximum 3D diameter: 
The maximum 3D diameter is defined as the largest Euclidean distance between any 
two voxels on the surface of the ROI area.  
26. Spherical disproportion: 









with R being the radius of a sphere with volume V 
27. Sphericity: 
















29. Surface area: 
The surface area is defined as the area of the ROI. It is calculated by summing the 
area of all triangles of the mesh generated from the ROI annotation.  
30. Surface to volume ratio: 




31. Center of mass shift: 
The center of mass shift specifies the differences between the geometric center of 
mass if each voxel is weighted equally to the geometric center of mass if each voxel 
is weighted according to its intensity.   
32. Volume (mesh based): 
The mesh based volume estimation 𝑉𝑚𝑒𝑠ℎ is calculated by summing the volume of the 
segmented voxels. 
33. Volume (Voxel based): 
The volume (V) is estimated as the number of the voxel  in the ROI times the voxel 
spacing, i.e. 
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𝑉 ≔  𝑁 ∗ 𝑟𝑙𝑎𝑡 ∗ 𝑟𝑐𝑜𝑟 ∗ 𝑟𝑎𝑥 
34. PCA Major Axis: 
A Principal Component Analysis (PCA) of the locations of the annotated voxels leads 
to three orthogonal eigenvectors and three eigenvalues𝜆1, 𝜆2, 𝜆3. These eigenvalues 
can be ordered so that 𝜆𝑚𝑎𝑗𝑜𝑟 ≥ 𝜆𝑚𝑖𝑛𝑜𝑟 ≥ 𝜆𝑙𝑒𝑎𝑠𝑡. The PCA Major Axis is then defined 
as:  
𝑃𝐶𝐴 𝑚𝑎𝑗𝑜𝑟 𝑎𝑥𝑖𝑠 ≔ 4√𝜆𝑚𝑎𝑗𝑜𝑟 
35. PCA Minor Axis:  
𝑃𝐶𝐴 𝑚𝑖𝑛𝑜𝑟 𝑎𝑥𝑖𝑠 ≔ 4√𝜆𝑚𝑖𝑛𝑜𝑟 
36. PCA Least Axis: 
𝑃𝐶𝐴 𝑙𝑒𝑎𝑠𝑡 𝑎𝑥𝑖𝑠 ≔ 4√𝜆𝑙𝑒𝑎𝑠𝑡 
37. PCA Elongation: 




38. PCA Flatness: 





Group 3: Texture features 
 
While first order statistics describe the distribution of the gray values within an image, they do 
not contain information about the texture of a given region. This can be done by using Gray-
Level-co-occurences or Run-length based features.  
Gray-level co-occurrence based texture features 
Gray-level co-occurrence based texture features provides information about the textural 
presentation within a given ROI. The gray values are binned into 𝑁𝑔bins. Based on these 
binned gray values a gray-level co-occurrence matrix (GLCM) 𝑷 with the size 𝑁𝑔 × 𝑁𝑔. The 
(𝑖, 𝑗)th element of the matrix is defined as the number of times a voxels is binned into bin 𝑖 
and the voxel in a distance 𝛿 and direction 𝛼 is binned in bin 𝑗.  Following is two-dimensional 
examples image I and the corresponding GLCM for 𝛿 = 1, 2, 3 and horizontal direction: 
 
I= 
2 4 1 1 2  
GLCM= 
1 2 2 0 0 
1 3 5 5 1 1 0 2 1 1 
2 3 4 2 3 1 0 0 1 2 
1 2 5 2 1 1 1 0 0 0 
5 3 1 3 5 1 1 1 0 1 
 
We calculated the GLCM-based features in 3D, reporting the mean and standard deviation of 
all features calculated on all 13 possible directions and a pixel distance of either 𝛿 = 1, 2, 3.   
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Definitions used during the definition of the features:  
x 𝑁𝑔: Number of discrete intensity levels in the image 
x 𝑷𝜶,𝜹(𝑖, 𝑗) = 𝑷(𝑖, 𝑗): Probability of co-occurrence matrix for the pair 𝑖, 𝑗.  
x 𝜇 be the mean of 𝑷(𝑖, 𝑗) 
x 𝜎 be the standard deviation of  𝑷(𝑖, 𝑖) 
x 𝑷𝒙(𝑖) = ∑ 𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗  : marginal row probabilities 
x 𝜇𝑥 be mean of 𝑷𝒙(𝑖) 
x 𝜎𝑥 be the standard deviation of 𝑷𝒙(𝑖) 















x 𝑯𝑿 ∶=  − ∑ 𝑷𝒙(𝑖) log2 𝑷𝒙(𝑖)
𝑁𝑔
𝑖=1  










39. – 44. Autocorrelation (mean and std.dev. for = (𝟏, 𝟐, 𝟑) ) 






45. – 50. Cluster Prominence (mean and std.dev. for = (𝟏, 𝟐, 𝟑) ) 






51. – 56. Cluster Shade (mean and std.dev. for = (𝟏, 𝟐, 𝟑) ) 






57. – 62. Cluster Tendency (mean and std.dev. for = (𝟏, 𝟐, 𝟑) ) 






63. – 68. Contrast / Inertia (mean and std.dev. for = (𝟏, 𝟐, 𝟑) ) 






69. – 74. Correlation (mean and std.dev. for = (𝟏, 𝟐, 𝟑) ) 












75. – 80. Difference Average (mean and std.dev. for = (𝟏, 𝟐, 𝟑) ) 




81. – 86. Difference Entropy (mean and std.dev. for = (𝟏, 𝟐, 𝟑) ) 




87. – 92. Difference Variance (mean and std.dev. for = (𝟏, 𝟐, 𝟑) ) 






93. – 98. Dissimilarity (mean and std.dev. for = (𝟏, 𝟐, 𝟑) ) 






99. – 104. Energy (mean and std.dev. for = (𝟏, 𝟐, 𝟑) )  






105. – 110. Entropy (mean and std.dev. for = (𝟏, 𝟐, 𝟑) )  

















117. – 122. Inverse Difference (Homogeneity 1) (mean and std.dev. for = (𝟏, 𝟐, 𝟑) )  
𝑖𝑛𝑣𝑒𝑟𝑠𝑒 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 ∶= ∑ ∑
𝑷(𝑖, 𝑗)






123. – 128. Inverse Difference Moment (Homogeneity 2, IDM) (mean and std.dev. for 
𝜹 = (𝟏, 𝟐, 𝟑)) 
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𝐼𝐷𝑀 ∶= ∑ ∑
𝑷(𝑖, 𝑗)






129. – 134. Inverse Difference Moment Normalized (IDMN) (mean and std.dev. for =
























141. – 146. Inverse Variance (mean and std.dev. for = (𝟏, 𝟐, 𝟑) )  
𝑖𝑛𝑣𝑒𝑟𝑠𝑒 𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 ∶= ∑ ∑
𝑷(𝑖, 𝑗)
(𝑖 − 𝑗)2






147. – 152. Maximum Probability (mean and std.dev. for = (𝟏, 𝟐, 𝟑) )  
𝑚𝑎𝑥𝑖𝑚𝑢𝑚 𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦 ∶= max{𝑷(𝑖, 𝑗)} 
153. – 158. Sum Average (mean and std.dev. for = (𝟏, 𝟐, 𝟑) )  




159. – 164 Sum Entropy (mean and std.dev. for = (𝟏, 𝟐, 𝟑) )  




165. – 170. Sum Variance (mean and std.dev. for = (𝟏, 𝟐, 𝟑) )  






171. – 176. Variance (mean and std.dev. for = (𝟏, 𝟐, 𝟑) )  






177. – 182. Joint Average (mean and std.dev. for = (1,2,3) )  
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183. – 188. First measure of Information Correlation (mean and std.dev. for = (1,2,3) )  




189. – 194. Second measure of Information Correlation (mean and std.dev. for = (1,2,3))  
𝑠𝑒𝑐𝑜𝑛𝑑 𝑚𝑒𝑎𝑠𝑢𝑟𝑒 𝑜𝑓 𝑖𝑛𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 ∶= √( 1 − exp(−2(𝐻𝑋𝑌2 − 𝐻𝑋𝑌)) )  
Gray-level run-length based texture features 
 
A gray level run length matrix (GLRLM) 𝑷 can be used to assess the structure of an image. 
Each element (𝑘, 𝑙) of such a matrix describes the number of runs with 𝑙 consecutively voxels 
within a gray level bin 𝑘 in a given direction 𝜃. The gray values are binned into 𝑁𝑔different 
bins to avoid short bins due to noise.  Following is two-dimensional examples image I and 
the corresponding GLRLM in horizontal direction: 
 
I= 
2 4 1 1 2  
GLRLM 
= 
3 2 0 0 0 
1 1 5 5 5 4 0 1 0 0 
2 3 4 2 3 4 0 0 0 0 
1 2 2 2 1 2 0 0 0 0 
5 3 1 3 5 2 0 1 0 0 
 
We calculated the GLRLM -based features in 3D, reporting the mean and standard deviation 
of the features based on all possible 13 directions.  
Necessary definitions: 
x 𝑷𝜽(𝑘, 𝑙) = 𝑷(𝑘, 𝑙): Number of runs with gray value 𝑘 and length 𝑙 in direction 𝜃 
x 𝑁𝑔: Number of discrete gray values 
x 𝑁𝑟: Number of discrete run lengths 
x 𝑁𝑟𝑢𝑛: Number of different runs 
x 𝑁𝑝: Number of voxels in ROI 
195. –  200. Gray level nonuniformity (GLN) (mean and std.dev. , Ng = (64,128,256))  
𝐺𝐿𝑁 ≔   
1
𝑁𝑟𝑢𝑛











𝐺𝐿𝑁𝑁 ≔   
1
𝑁𝑟𝑢𝑛2







207. –  212. High gray level run emphasis (HGLRE) (mean and std.dev. , Ng = 
(64,128,256))  
𝐻𝐺𝐿𝑅𝐸 ≔  
1
𝑁𝑟𝑢𝑛






213. –  218. Long run emphasis (LRE) (mean and std.dev. , Ng = (64,128,256))  
𝐿𝑅𝐸 ∶=  
1
𝑁𝑟𝑢𝑛






219. –  224. Long run high gray level emphasis (LRHGLE) (mean and std.dev. , Ng = 
(64,128,256))  
𝐿𝑅𝐻𝐺𝐿𝐸 ∶=   
1
𝑁𝑟𝑢𝑛






225. –  230. Long run low gray level emphasis (LRLGLE) (mean and std.dev. , Ng = 
(64,128,256))  












231. –  236. Low gray level run emphasis (LGLRE) (mean and std.dev. , Ng = 
(64,128,256))  












237. –  242. Number of runs (mean and std.dev. , Ng = (64,128,256))  






243. –  248. Run length nonuniformity (RLN) (mean and std.dev. , Ng = (64,128,256)) 
 𝑅𝐿𝑁 ∶=  
1
𝑁𝑟𝑢𝑛







249. –  254. Run length nonuniformity normalized (RLNN) (mean and std.dev. , Ng = 
(64,128,256)) 
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 𝑅𝐿𝑁𝑁 ∶=  
1
𝑁𝑟𝑢𝑛2







255. –  260. Run percentage (RP) (mean and std.dev. , Ng = (64,128,256))  

















267. –  272. Short run high gray level emphasis (SRHGLE) (mean and std.dev. , Ng = 
(64,128,256))  












273. –  278. Short run low gray level emphasis (SRLGLE) (mean and std.dev. , Ng = 
(64,128,256)) 
  
























GLV is defined as:  
𝐺𝐿𝑉 ≔  
1
𝑁𝑠

















RLV is defined as:  
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𝑅𝐿𝑉 ≔  
1
𝑁𝑠






 291. –  296. Run Length Entropy (RLE) (mean and std.dev. , Ng = (64,128,256))  











Gray-level size zone based texture features 
A gray level size zone matrix (GLSZM) P can be used to assess the structure of an image. 
Each element (k, l) of such a matrix gives the number of connected areas with the 
discretized intensity k and l connected voxels. A 26 neighborhood is used to determine the 
connectivity between two voxels.  The gray values are binned into Ngdifferent bins to avoid 




2 4 1 1 2  
GLSZM 
= 
4 1 0 0 0 
1 1 5 5 5 2 0 0 0 5 
2 3 4 2 3 4 0 0 0 0 
1 2 2 2 1 2 0 0 0 0 
5 3 1 3 5 2 0 1 0 0 
 
We calculated the GLRLM -based features in 3D. 
Necessary definitions: 
x 𝑷(𝑘, 𝑙): Number of areas with gray value 𝑘 and voxel count 𝑙  
x 𝑁𝑔: Number of discrete gray values 
x 𝑁𝑧: Largest voxel count 
x 𝑁𝑉: Number of voxels 




𝑖=1 : Number of zones 
x 𝑷(𝑘,⋅) ≔  ∑ 𝑷(𝑘, 𝑗)𝑁𝑧𝑗=1  : Number of areas with gray value 𝑘  
x 𝑷( ⋅, 𝑙 ) ≔  ∑ 𝑷(𝑖, 𝑙)𝑁𝐺𝑖=1   : Number of areas with voxel count 𝑙 
 
 
297. –  299. Small Zone Emphasis (SZE) (Ng = (64,128,256) )  
  













300. –  302. Large Zone Emphasis (LZE) (Ng = (64,128,256) )  
  
𝐿𝑍𝐸 ≔  
1
𝑁𝑠





303. –  305. Low Gray Level Zone Emphasis (LGLZE) (Ng = (64,128,256) )  
  










306. –  308. High Gray Level Zone Emphasis (HGLZE) (Ng = (64,128,256) )  
  
𝐻𝐺𝐿𝑍𝐸 ≔  
1
𝑁𝑠





309. –  311. Small Zone Low Gray Level Emphasis (SZLGLE) (Ng = (64,128,256) )  
  












312. –  314. Small Zone High Gray Level Emphasis (SZHGLE) (Ng = (64,128,256) )  
  












315. –  317. Large Zone High Gray Level Emphasis (LZHGLE) (Ng = (64,128,256) )  
  
𝐿𝑍𝐻𝐺𝐿𝐸 ≔  
1
𝑁𝑠

























321. –  323. Gray Level Non-Uniformity (GLNU) (Ng = (64,128,256) )  
  







324. –  326. Gray Level Non-Uniformity Normalized (GLNUN) (Ng = (64,128,256) )  
  








327. –  329. Zone Size Non-Uniformity (ZSNU) (Ng = (64,128,256) )  
  
𝑍𝑆𝑁𝑈 ≔  
1
𝑁𝑠




330. –  332. Zone Size Non-Uniformity Normalized (ZSNU) (Ng = (64,128,256) )  
  
𝑍𝑆𝑁𝑈𝑁 ≔  
1
𝑁𝑠2




















 𝑷(𝑖, 𝑗) 









 𝑷(𝑖, 𝑗) 
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 𝑷(𝑖, 𝑗) 









 𝑷(𝑖, 𝑗) 
 
 















Neighborhood Gray Level Difference based texture features 
Different statistical measures are calculated for each intensity value 𝑖 to calculate 
Neighborhood Gray Level Difference based texture features: 
x 𝑁𝑣 Number of all annotated voxels 
x 𝑁𝐺: Number of discrete gray values 
x 𝑁𝐺𝑃: Number of discrete gray values that are actually present in the region 




 : Probability for the occurrence of intensity 𝑖  
x 𝑎𝑥 : Average Intensity of all voxels in a defined neighborhood around voxel 𝑥, 




∑ 𝑎𝑥𝑥 ∀ 𝐼(𝑥)=𝑖  : The mean value of all 𝑎𝑥 that correspond to voxels with 
the intensity 𝑖 
x 𝑠𝑖 =  {
|𝐴?̅? − 𝑖 | for 𝑛𝑖 > 0
0 otherwise
  
An example of some if these features is given below. Note that only the dark area is used as 
calculation input, the border area is necessary to be able to calculate the 1-size 
neighborhood.  
 
       𝑖 𝑛𝑖 𝑝𝑖 𝑠𝑖 
I=  1 2 2 3  Features 1 0 0 0 
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1 2 3 3 2 2 0.5 1 
4 2 4 1 3 1 0.25 0.625 
4 1 2 3 4 1 0.25 1.825 
 








348. –  350. Contrast (Ng = (64,128,256) )  
  
𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡 ≔  (
1
𝑁𝐺𝑃(𝑁𝐺𝑃 − 1)
























,         𝑝𝑖 ≠ 0, 𝑝𝑗 ≠ 0 
 












        𝑝𝑖 ≠ 0, 𝑝𝑗 ≠ 0 
357. –  359. Strength  (Ng = (64,128,256) )  
  
𝑠𝑡𝑟𝑒𝑛𝑔𝑡ℎ ≔








        𝑝𝑖 ≠ 0, 𝑝𝑗 ≠ 0 
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D. nnU-Net Extended Information
D.1. Details of nnU-Net implementation
Dataset fingerprints
nnU-Net creates a dataset fingerprint that captures all relevant parameters and properties
from the provided training data: image sizes (i.e. number of voxels per spatial dimension),
image spacings (i.e. the physical size of the voxels), modalities (read from metadata) and
number of classes for all images as well as the total number of training cases. Furthermore,
the fingerprint includes the mean, standard deviation as well as the 0.5 and 99.5 percentiles
of the intensity values in the foreground regions, i.e. the voxels belonging to any of the
class labels, computed over all training cases. As a first processing step that precedes
fingerprint extraction, nnU-Net crops all images to their nonzero region. While this
had no e↵ect on most datasets in our experiments, it reduced the image size of brain
datasets such as D1 (Brain Tumor) and D15 (MSLes) substantially and thus improved
computational e ciency. In order to enable the dataset fingerprint extraction, nnU-Net
expects its input data in a specific format (see https://github.com/MIC-DKFZ/nnUNet
for more detail).
Pipeline fingerprints
nnU-Net automizes the design of deep learning methods for biomedical image segmenta-
tion by generating a so-called pipeline fingerprint that contains all relevant information.
Importantly, nnU-Net reduces the design choices to the really essential ones and automat-
ically infers these choices using a set of heuristic rules. These rules condense the domain
knowledge and operate on the above-described data fingerprint and the project-specific
hardware constraints. These inferred parameters are completed by blueprint parame-
ters, which are data-independent, and empirical parameters, which are optimized during
training.
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Blueprint parameters
Architecture template: All U-Net architectures configured by nnU-Net originate from the
same template. This template closely follows the original U-Net [108] and its 3D coun-
terpart [283]. According to our hypothesis that a well-configured plain U-Net is still hard
to beat, none of our U-Net configurations make use of recently proposed architectural
variations such as residual connections [103, 284], dense connections [104, 235], atten-
tion mechanisms [236], squeeze and excitation [285] or dilated convolutions [109]. Minor
changes with respect to the original architecture were made: To enable large patch sizes,
the batch size of the networks in nnU-Net is small. In fact, most 3D U-Net configurations
were trained with a batch size of only 2 (see Supplementary Material S1a). Batch normal-
ization [110], which is often used to speed up or stabilize the training, does not perform
well with small batch sizes [286, 287]. We therefore use instance normalization [111] for
all U-Net models. Furthermore, we replace ReLU with leaky ReLUs [288] (negative slope
0.01). Networks are trained with deep supervision: additional auxiliary losses are added
in the decoder to all but the two lowest resolutions, allowing gradients to be injected
deeper into the network and facilitating the training of all layers in the network. All
U-Nets employ the very common configuration of two blocks per resolution step in both
encoder and decoder, with each block consisting of a convolution, followed by instance
normalization and a leaky ReLU nonlinearity. Downsampling is implemented as strided
convolution (motivated by representational bottleneck, see [289]) and upsampling as con-
volution transposed. As a tradeo↵ between performance and memory consumption, the
initial number of feature maps is set to 32 and doubled (halved) with each downsampling
(upsampling) operation. To limit the final model size, the number of feature maps is
additionally capped at 320 and 512 for 3D and 2D U-Nets, respectively.
Training schedule: Based on experience and as a tradeo↵ between runtime and reward,
all networks are trained for 1000 epochs with one epoch being defined as iteration over
250 minibatches. Stochastic gradient descent with nesterov momentum (µ = 0.99) and
an initial learning rate of 0.01 is used for learning network weights. The learning rate
is decayed throughout the training following the ‘poly’ learning rate policy [109]: (1  
epoch/epoch
max
)0.9. The loss function is the sum of cross-entropy and Dice loss [290]. For
each deep supervision output, a corresponding downsampled ground truth segmentation
mask is used for loss computation. The training objective is the sum of the losses at all








+ . . . . Hereby, the weights halve with each decrease
in resolution, resulting in w
2




= 1/4 · w
1
, etc. and are normalized to sum
to 1. Samples for the mini batches are chosen from random training cases. Oversampling
is implemented to ensure robust handling of class imbalances: 66.7% of samples are from
random locations within the selected training case while 33.3% of patches are guaranteed
to contain one of the foreground classes that are present in the selected training sample
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(randomly selected). The number of foreground patches is rounded with a forced mini-
mum of 1 (resulting in 1 random and 1 foreground patch with batch size 2). A variety of
data augmentation techniques are applied on the fly during training: rotations, scaling,
Gaussian noise, Gaussian blur, brightness, contrast, simulation of low resolution, gamma
and mirroring. Details are provided in Supplementary information ZZ.
Inference: Images are predicted with a sliding window approach, where the window size
equals the patch size used during training. Adjacent predictions overlap by half the size
of a patch. The accuracy of segmentation decreases towards the borders of the window.
To suppress stitching artifacts and reduce the influence of positions close to the borders,
a Gaussian importance weighting is applied, increasing the weight of the center voxels in
the softmax aggregation. Test time augmentation by mirroring along all axes is applied.
Inferred Parameters
Intensity normalization: There are two di↵erent image intensity normalization schemes
supported by nnU-Net. The default setting for all modalities except CT images is z-
scoring. For this option, during training and inference, each image is normalized inde-
pendently by subtracting its mean, followed by division with its standard deviation. If
cropping resulted in an average size decrease of 25% or more, a mask for central non-zero
voxels is created and the normalization is applied within that mask only, ignoring the
surrounding zero voxels. For computed tomography (CT) images, nnU-Net employs a
di↵erent scheme, as intensity values are quantitative and reflect physical properties of the
tissue. It can therefore be beneficial to retain this information by using a global normal-
ization scheme that is applied to all images. To this end, nnU-Net uses the 0.5 and 99.5
percentiles of the foreground voxels for clipping as well as the global foreground mean and
standard deviation for normalization on all images.
Resampling: In some datasets, particularly in the medical domain, the voxel spacing
(the physical space the voxels represent) is heterogeneous. Convolutional neural networks
operate on voxel grids and ignore this information. To cope with this heterogeneity, nnU-
Net resamples all images to the same target spacing (see paragraph below) using either
third order spline, linear or nearest neighbor interpolation. The default setting for image
data is third order spline interpolation. For anisotropic images (maximum axis spacing /
minimum axis spacing ¿ 3), in-plane resampling is done with third order spline whereas out
of plane interpolation is done with nearest neighbor. Segmentation maps are resampled
by converting them to one hot encodings. Each channel is then interpolated with linear
interpolation and the segmentation mask is retrieved by an argmax operation. Again,
anisotropic cases are interpolated using “nearest neighbor” on the low resolution axis.
Target spacing: The selected target spacing is a crucial parameter. Larger spacings result
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in smaller images and thus a loss of details whereas smaller spacings result in larger im-
ages preventing the network from accumulating su cient contextual information under a
given patch size. Although this tradeo↵ is in part addressed by the 3D U-Net cascade (see
below), a sensible target spacing for low and full resolution is still required. For the 3D
full resolution U-Net, nnU-Net uses the median value of the spacings found in the train-
ing cases computed independently for each axis as default target spacing. For anisotropic
datasets, this default can result in severe interpolation artifacts or in a substantial loss
of information due to large variances in resolution across the training data. Therefore,
the target spacing of the lowest resolution axis is selected to be the 10th percentile of
the spacings found in the training cases if both voxel and spacing anisotropy (i.e. the
ratio of lowest spacing axis to highest spacing axis) are larger than 3. For the 2D U-Net,
nnU-Net generally operates on the two axes with the highest resolution. If all three axes
are isotropic, the two trailing axes are utilized for slice extraction. The target spacing
is the median spacing of the training cases (computed independently for each axis). For
slice-based processing, no resampling along the out-of-plane axis is required.
Adaptation of network topology, patch size and batch size: Finding an appropriate U-
Net architecture configuration is crucial for good segmentation performance. nnU-Net
prioritizes large patch sizes while remaining within a predefined GPU memory budget.
Larger patch sizes allow for more contextual information to be aggregated and thus typi-
cally increase segmentation performance. They come, however, at the cost of a decreased
batch size which results in noisier gradients during backpropagation. To improve the sta-
bility of the training, we require a minimum batch size of 2 and choose a large momentum
term for network training (see blueprint parameters). Image spacing is also considered in
the adaptation process: Downsampling operations may operate only on specific axes and
convolutional kernels in the 3D U-Nets can operate on certain image planes only (pseudo-
2D). The network topology for all U-Net configurations is chosen on basis of the median
image size after resampling as well as the target spacing the images were resampled to. A
flow chart for the adaptation process is presented in the Supplements inFigure S1a. The
adaptation of the architecture template, which is described in more detail in the following,
is computationally inexpensive. Due to the GPU memory consumption estimate being
based on feature map sizes, no GPU is required to run the adaptation process.
Initialization: The patch size is initialized as the median image shape after resampling.
If the patch size is not divisible by 2nd for each axis, where n
d
is the number of down-
sampling operations, it is padded accordingly. Architecture topology: The architecture
is configured by determining the number of downsampling operations along each axis de-
pending on the patch size and voxel spacing. Downsampling is performed until further
downsampling would reduce the feature map size to smaller than 4 voxels or the feature
map spacings become anisotropic. The downsampling strategy is determined by the voxel
spacing: high resolution axes are downsampled separately until their resolution is within
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factor 2 of the lower resolution axis. Subsequently, all axes are downsampled simultane-
ously. Downsampling is terminated for each axis individually, once the respective feature
map constraint is triggered. The default kernel size for convolutions is 3⇥ 3⇥ 3 and 3⇥ 3
for 3D U-Net and 2D U-Net, respectively. If there is an initial resolution discrepancy be-
tween axes (defined as a spacing ratio larger than 2), the kernel size for the out-of-plane
axis is set to 1 until the resolutions are within a factor of 2. Note that the convolutional
kernel size then remains at 3 for all axes.
Adaptation to GPU memory budget: The largest possible patch size during configura-
tion is limited by the amount of GPU memory. Since the patch size is initialized to the
median image shape after resampling, it is initially too large to fit into the GPU for most
datasets. nnU-Net estimates the memory consumption of a given architecture based on
the size of the feature maps in the network, comparing it to reference values of known
memory consumption. The patch size is then reduced in an iterative process while up-
dating the architecture configuration accordingly in each step until the required budget
is reached (see Figure S1 in the Supplements). The reduction of the patch size is always
applied to the largest axis relative to the median image shape of the data. The reduction
in one step amounts to 2nd voxels of that axis, where n
d
is the number of downsampling
operations.
Batch size: As a final step, the batch size is configured. If a reduction of patch size
was performed the batch size is set to 2. Otherwise, the remaining GPU memory head-
room is utilized to increase the batch size until the GPU is fully utilized. To prevent
overfitting, the batch size is capped such that the total number of voxels in the minibatch
do not exceed 5% of the total number of voxels of all training cases. Examples for gener-
ated U-Net architectures are presented in Supplementary Information ZZ.
Configuration of 3D U-Net cascade: Running a segmentation model on downsampled
data increases the size of patches in relation to the image and thus enables the network to
accumulate more contextual information. This comes at the cost of a reduction in details
in the generated segmentations and may also cause errors if the segmentation target is
very small or characterized by its texture. In a hypothetical scenario with unlimited GPU
memory, it is thus generally favored to train models at full resolution with a patch size
that covers the entire image. The 3D U-Net cascade approximates this approach by first
running a 3D U-Net on downsampled images and then training a second, full resolution
3D U-Net to refine the segmentation maps of the former. This way, the “global”, low
resolution network utilizes maximal contextual information to generate its segmentation
output, which then serves as an additional input channel that guides the second, “local”
U-Net. The cascade is triggered only for datasets where the patch size of the 3d full
resolution U-Net covers less than 12.5% of the median image shape. If this is the case,
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the target spacing for the downsampled data and the architecture of the associated 3D
low resolution U-Net are configured jointly in an iterative process. The target spacing is
initialized as the target spacing of the full resolution data. In order for the patch size to
cover a large proportion of the input image, the target spacing is then increased stepwise
by 1% while updating the architecture configuration accordingly in each step until the
patch size of the resulting network topology surpasses 25% of the current median im-
age shape. If the current spacing is anisotropic (factor 2 di↵erence between lowest and
highest resolution axis), only the spacing of the higher resolution axes is increased. The
configuration of the second 3D U-Net of the cascade is identical to the standalone 3D
U-Net for which the configuration process is described above (except that the upsampled
segmentation maps of the first U-Net are concatenated to its input). Figure S1b in the
Supplements provides an overview of this optimization process.
Empirical parameters
Ensembling and selection of U-Net configuration(s): nnU-Net automatically determines
which (ensemble of) configuration(s) to use for inference based on the average foreground
Dice coe cient computed via cross-validation on the training data. The selected model(s)
can be either a single U-Net (2D, 3D full resolution, 3D low resolution or the full resolu-
tion U-Net of the cascade) or an ensemble of any two of these configurations. Models are
ensembled by averaging softmax probabilities.
Postprocessing: Connected component-based postprocessing is commonly used in medical
image segmentation [178, 233]. Especially in organ segmentation it often helps to remove
spurious false positive detections by removing all but the largest connected component.
nnU-Net follows this assumption and automatically benchmarks the e↵ect of suppress-
ing smaller components on the cross-validation results. First, all foreground classes are
treated as one component. If suppression of all but the largest region improves the average
foreground Dice coe cient and does not reduce the Dice coe cient for any of the classes,
this procedure is selected as the first postprocessing step. Finally, nnU-Net builds on the
outcome of this step and decides whether the same procedure should be performed for
individual classes.
Implementation details
nnU-Net is implemented in Python utilizing the PyTorch [291] framework. The Batch-
generators library [292] is used for data augmentation. For reduction of computational
burden and GPU memory footprint, mixed precision training is implemented with Nvidia
Apex/Amp (https://github.com/NVIDIA/apex). For use as a framework, the source
code is available on GitHub (https://github.com/MIC-DKFZ/nnUNet). Users who seek
to use nnU-Net as a standardized benchmark or to run inference with our pretrained
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models can install nnU-Net via PyPi. For a full description of how to use nnU-Net, please
refer to the online documentation available on the GitHub page.
D.2. Qualitative Results of nnU-Net
Figure D.1 shows segmentation generated by nnU-Net on a variety of datasets and modal-
ities. Test set target structures from di↵erent international segmentation challenges are
shown in 2D projected onto the raw data (left) and in 3D together with a volume ren-
dering of the raw data (right). All visualizations are created with the MITK Workbench
[148].
D.3. Details of Datasets utilized for nnU-Net evaluation
Table D.1 provides an overview of the datasets used in this manuscript. The numeric
values presented here are computed based on the training cases for each of these datasets.
They are the basis of the dataset fingerprints presented in Figure 7.7.
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Figure D.1.: nnU-Net Handles a Broad Variety of Datasets and Target Image Proper-
ties. Dataset references point to Table D.1. a: heart (green), aorta (red), trachea
(blue) and esophagus (yellow) in CT images (D18). b: synaptic clefts (green) in
electron microscopy scans (D19). c: liver (yellow), spleen (orange), left/right kid-
ney (blue/green) in T1 in-phase MRI (D16). d: thirteen abdominal organs in CT
images (D11). e: liver (yellow) and liver tumors (green) in CT images (D14). f:
right ventricle (yellow), left ventricular cavity (blue) myocardium of left ventricle
(green) in cine MRI (D13). g: prostate (yellow) in T2 MRI (D12). h: lung nodules
(yellow) in CT images (D6). i: kidneys (yellow) and kidney tumors (green) in CT
images (D17). j: edema (yellow), enhancing tumor (purple), necrosis (green) in
MRI (T1, T1 with contrast agent, T2, FLAIR) (D1). k: left ventricle (yellow) in
MRI (D2). l: hepatic vessels (yellow) and liver tumors (green) in CT (D8).
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D2 Heart [173] MRI
115x320x232
(1.37, 1.25, 1.25)
1 4.010 3 20 left ventricle
D3 Liver [173], [178] CT
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(1, 0.77, 0.77)
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D6 Lung [173] CT
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1 3.910 4 63 lung nodules












D9 Spleen [173] CT
90x512x512
(5, 0.79, 0.79)
1 4.710 3 41 spleen
D10 Colon [173] CT
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(5, 0.78, 0.78)
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